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AFPMH News 
 
 
AFPMH and Regional Meetings of WPA 
 
 
In the year 2007, the ASEAN Federation 
for Psychiatry and Mental Health 
(AFPMH) joined the World Psychiatric 
Association (WPA) Regional Meetings in 
Seoul and Shanghai between 18-20 April 
and 20-23 September, respectively. 
 
At the WPA Regional Meeting in Seoul, 
the AFPMH had a symposium on “Teach-
ing of Psychiatry for Medical Students in 
ASEAN: Sharing of Good Practices”. 
There were 5 topics as follows: 
 1. Teaching of Psychiatry: Customising 
the Curriculum of Medical Students for 
ASEAN  
   Prof. Pichet Udomratn (President, 
AFPMH) 
 2. From Psychiatric Services to Teach-
ing of Psychiatry: Realigning of Objectives 
   Prof. M Parameshvara Deva (Conve-
ner, AFPA) 
 3. What Makes a Good Medical 
Teacher?: Perception of Medical  Students 
and Teachers 
   Prof. Ee Heok Kua (National Univer-
sity of Singapore) 
 4. Undergraduate Psychiatric Education 
in Malaysia 
   Prof. Hussain Habil (President, Ma-
laysian Psychiatric Association) 
 5. Undergraduate Psychiatric Education 
in Thailand: Lessons Learned from Prince 
of Songkla University (PSU)                         
   Assoc. Prof. Sawitri Assanang-
kornchai (Editorial board, Journal of the 
Psychiatric Association of Thailand) 
 
At the WPA Regional Meeting in Shang-
hai, the AFPMH had a symposium on 
“Globalization and Suicide in ASEAN: 
Sharing Good Practice for Suicide Preven-
tion”. There were 4 topics as follows:  
 1. Suicide and Suicide Prevention in 
Thailand 
    Dr.Apichai Mongkol (Department of 
Mental Health, Thai Ministry of Public 
Health) 
   Prof. Pichet Udomratn (President, 
Psychiatric Association of Thailand) 
 2. Suicide in Singapore: The National 
Response  
   Dr. Hong Choon Chua (President, 
Singapore Psychiatric Association) 
 3. Managing Suicidal Patients: A Ma-
laysian Experience 
   Dr.Hussain Habil (President, Malay-
sian Psychiatric Association) 
 4. Suicide in the Philippines 
   Dr. Dinah Pacquing-Nadera (Secre-
tary-General, Philippines Psychiatric Asso-
ciation) 
 
Both symposiums were arranged to support 
the hosting organizations, Korean Neuro-
psychiatric Association (KNPA) and Chi-
nese Society of Psychiatry (CSP). These 
activities also strengthened the relationship 
between the AFPMH and both societies 
under the program called “AFPMH plus 3” 
(CSP, JSPN, KNPA) partnership program 
initiated by Prof. Pichet Udomratn, the 
current president of AFPMH. 
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Abstract 
Objective: This study aimed to determine the association between the personality traits and 
social factors with compliance to anti-hypertensive pharmachotherapy. Methods: This cross 
sectional study was conducted from 1
st
 of June until 31st of December 2004, which involved 
Hospital Universiti Kebangsaan Malaysia Primary Polyclinic in Bandar Tasik Selatan, 
Cheras and Salak Polyclinic in Sepang, Selangor. A total of 200 patients who fulfilled all the 
inclusion criteria, were selected as respondents. This study used the Mini International Neu-
ropsychiatric Interview (M.I.N.I) for the psychiatric diagnoses and personality characteristics 
were assessed by using Personality Assessment Schedule (PAS) Results: The prevalence rate 
of non-compliance was 38.5%. Paranoid personality trait (27.3%) was the most common type 
of personality traits that associated with non-compliance to the medications prescribed. The 
results of this study revealed a statistically significant difference between drug compliance 
and age, race, gender and the site where the study was conducted. No association was found 
between patients’ education level, occupation, income, marital status, family history of hyper-
tension and personality traits and drug compliance. Conclusion: This study suggested that 
drug compliance among hypertensive patients was influenced by the presence of psychosocial 
factors. Hence, it is important for medical practitioners to understand these factors and admin-
ister treatment more individual. 
 
Key words: hypertension, non-compliance, personality 
 
 
Introduction 
In Malaysia, it was estimated that about 
14% to 25% of the population aged 15 
years and above suffered from hypertension 
[1]. As blood pressure increases from 
normal to severe elevations, the risk for 
coronary heart disease, stroke, end stage 
renal disease and peripheral vascular dis-
ease increases markedly [2,3]. Anti-
hypertensive drug therapy can reduce high 
blood pressure effectively and thus reduce 
the excess risk significantly. However, 
despite the existence of efficacious medica-
tions and improvements in awareness of 
hypertension, many patients in actual 
practice remain with uncontrolled hyper-
tension. Hypertensive patients often experi-
ence poor compliance to treatment, a fre-
52   Baharudin A, et al. 
 
quent cause of uncontrolled blood pressure.  
 
Medication compliance has been defined in 
terms of an agreement between patient’s 
behaviour of taking medications and the 
clinical prescription [4]. Compliance rates 
for many long-term drug therapies have 
been shown to be strikingly low, often no 
more than 40%-50% [5-7]. Non-
compliance with medications is one of the 
major factors in the failure of therapeutic 
programs in patients having a chronic 
disease [4]. Non-compliance can contribute 
greatly to the variability observed in a 
drug’s therapeutic effect if the clinician 
incorrectly attributes the patient’s worsen-
ing condition to an absence of drug activ-
ity. This erroneous conclusion may lead to 
unnecessary diagnostic testing and changes 
in dose or regimen. Sub-optimal compli-
ance can compromise the patient-provider 
relationship, because misconceptions about 
the effects of a therapy on the part of either 
the patient or the provider may lead to a 
breakdown in communication and nega-
tively affect the patient’s views about care.  
 
Generally in Malaysia, the problem of 
blood pressure control is not lack of thera-
peutic options but due to patients’ non-
compliance. Lim and colleagues found out 
that 26% out of 168 of patients were not 
compliance to their medications [8]. Com-
pliance to treatment depends on many 
factors, and no simple explanation for non-
compliance exists. Potential determinants 
of compliance include sociodemographic 
characteristics, specific aspects of the 
treatment regimen (type, complexity, side 
effects, and duration), and features of the 
illness or potential illness (i.e., symptoms, 
duration, disability and medically defined 
seriousness) [9].  
 
Elevated blood pressure has been associ-
ated with certain personality traits. Som-
mers-Flanagan and Greenberg (1989) 
found that hypertensive individuals were 
more likely to be characterized by difficul-
ties with anger expression and interpersonal 
anxiety and frequently exhibited defence 
mechanism such as denial and repression 
[10]. Recent meta-analyses revealed con-
flicting findings in studies on the relation-
ship between the blood pressure and per-
sonality [11,12]. Nevertheless, Jorgensen 
and colleagues (1996) reported that in-
creased blood pressure and hypertension 
were associated with greater negative affect 
and defensiveness and less affect expres-
sion [11]. Rosmond and colleagues (2001) 
found out that a deficient dopamine D2 
receptor formation or action may contribute 
to hypertension via an increase of cate-
cholamine release [13]. Paranoid and 
schizoid personality disorders are also 
associated with a polymorphism of the 
DRD2, which demonstrated low density of 
this receptor. A cross-sectional community 
survey in northern Japan found a relation-
ship between personality and home blood 
pressure value [14]. Personality extrover-
sion score positively affected the systolic 
blood pressure value, whereas no signifi-
cant relationship was observed between 
personality psychoticism or neuroticism 
and blood pressure value. In other study, 
hypertensive patients had scored signifi-
cantly higher in somatization, aggres-
sion/hostility and neuroticism [15].  
 
Generally there is a lack of consensus on 
which personality or psychological traits 
related to the blood pressure [16]. The 
purpose of this study was to investigate the 
relationship between anti-hypertensive drug 
compliance with personality profiles. The 
results of the study may contribute to 
increase the awareness of health care 
providers particularly physicians on the 
issue of compliance and understanding 
their patients. These may aid to develop 
strategies for improvement of compliance. 
 
Methods 
The study was done after received approval 
from the Ethics Committee of Faculty of 
Medicine, Universiti Kebangsaan Malaysia 
and Research Committee of Psychiatry 
Department, Faculty of Medicine, Univer-
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siti Kebangsaan Malaysia.. Those who 
were found to have psychiatric disorder 
were referred to the nearest psychiatric 
clinic for further evaluation and manage-
ment. 
 
Locations and subjects 
This study was conducted at the Universiti 
Kebangsaan Malaysia Hospital (HUKM) 
Primary Polyclinic, Bandar Tasik Selatan, 
Kuala Lumpur and Salak Polyclinic at 
Sepang, Selangor. Primary polyclinic is a 
primary health care clinic of HUKM. It is 
situated in a 5-storey shop houses at Ban-
dar Tasik Selatan commercial area. The 
total population for Bandar Tasik Selatan is 
11,304. Of these, 5,944 (52.6%) were 
Chinese, followed by 4,365 (38.6%) Ma-
lays and 995 (8.8%) Indians. There were 
about 5,826 (49.2%) males and 6,016 
(50.8%) females in this area [17]. It is an 
urban area, situated about 20 kilometers 
from the heart of Kuala Lumpur. Among 
the population, some of them were doing 
their own business, working at private 
companies or with the government agen-
cies. The other centre is Salak Polyclinic, 
which situated in Selangor. It is a govern-
ment polyclinic that is under the manage-
ment of Ministry of Health, Malaysia. It is 
located about 48 kilometers from HUKM. 
It also provides primary health services. 
The total population here is 51,824. Of 
these 27,478 (53.0%) were Malays, fol-
lowed by 13,262 (25.6%) Chinese and 
11,075 (21.4%) Indians. This area is a rural 
area, majority of the populations’ works as 
a farmer or at the palm oil or rubber planta-
tions. As this place is near to the new Kuala 
Lumpur International Airport, many of the 
younger generation found their employ-
ment there. 
 
This is a cross sectional study conducted at 
HUKM Primary Polyclinic in Bandar Tasik 
Selatan and Salak Polyclinic in Sepang 
from the first week of July 2004 to the last 
week of December 2004. 
 
The sample population was all the hyper-
tensive patients who attended the HUKM 
Primary Polyclinic in Bandar Tasik Selatan 
and Salak Polyclinic in Sepang during the 
study period. The sample size was deter-
mined using Epiinfo 2000 Statistical Pack-
age which was based on the power of study 
of 80% with alpha-level of 0.05 (95% 
confidence interval). Assuming and ex-
pected frequency of poor compliance 
towards anti-hypertensive pharmachother-
apy in the population was around 26% [8]. 
The sample size was calculated to be 
around 197. An author had to divide her 
time to attend both clinics. To reduce the 
sampling bias the author attended the 
polyclinics on alternate days. Universal 
sampling was used in the recruitment 
process. All new and old hypertensive 
patients who came for their appointments at 
the time of the author presence at the 
respective polyclinics were approached.  
 
The inclusion criteria included patients 
with essential hypertension, aged 40 years 
old and above, on anti-hypertensive phar-
macotherapy for at least 3 months, agreed 
to participate in the project and could give 
written informed consent. They also must 
have sufficient command in Malay or 
English. The exclusion criteria included 
pregnancy, diagnosed to have secondary 
hypertension, no renal impairment (serum 
creatinine>125 mmoll/L) within the last six 
months of recruitment date, no impaired 
liver function tests (>3 times the upper 
limit of normal range), no concomitant 
disease such as diabetes mellitus, ischaemic 
heart disease, congestive cardiac failure, 
cerebrovascular accidents, bronchial 
asthma and chronic obstructive pulmonary 
disease. Patient’s with blood pressure of 
200/120 mmHg or more were also ex-
cluded. 
 
Study instruments 
1. Biodata and sociodemographic data: 
The variables included name, age, sex, 
marital status, occupation, total household 
monthly income, highest academic qualifi-
cation, hypertension history (i.e., duration 
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of hypertension and family history of 
hypertension), history of smoking, alcohol 
intake, body mass index measurement and 
vital signs. 
2. Mini international Neuropsychiatric 
interview (M.I.N.I): M.I.N.I was used to 
assess psychiatric diagnosis among respon-
dents. It was designed as a brief structured 
interview for the major Axis I psychiatric 
disorders in DSM-IV and ICD-10 psychiat-
ric disorders. The diagnosis is available in 
lifetime and 12 months version. M.I.N.I is a 
tool designed to meet the need for a short 
but accurate structured psychiatric inter-
view that can be use in a variety of cultures, 
for epidemiological and clinical research 
purposes.  
 
3. Personality Assessment Schedule 
(PAS): The personality profile of respond-
ers in this study was assessed by using the 
PAS [18]. It is an instrument designed to 
formalize the assessment of personality 
disorder. It may be used with any subject 
irrespective of psychiatric status. The 
instrument is a semi-structured, with the 
emphasis on the patient’s premorbid status. 
The PAS is a standardized interview in 
which the interviewee is asked for informa-
tion related to 24 personality characteris-
tics, and where the answer is positive he or 
she is asked to provide examples of rele-
vant behaviours. Ratings for each trait are 
made on a nine-point scale from 0-8, on 
which the ratings of 0-3 are trait accentua-
tions in the absence of impairment of social 
functioning or distress to the subject or 
those around her. The scores are combined 
using formulae described by Tyrer et al. 
(1988) to derive either 13 personality 
disorder categories, or four summary 
categories [18]. The instrument also has 
been shown to possess adequate inter-rater 
and test-retest reliability and to be predic-
tive of treatment outcome. The Kappa for 
this instrument was 0.65. The temporal and 
trans-cultural reliability is generally good 
to excellent. In this study, inter reliability 
assessment on assessing personality disor-
der/traits between researcher and her su-
pervisor shows a good agreement between 
them with the Kappa of 0.7. 
 
When the patient had fulfilled the inclusion 
criteria, written consent was obtained. The 
respondent was then interviewed by the 
researcher using the M.I.N.I. It was rec-
ommended that the screening schedule was 
used to make the diagnostic formulation of 
psychiatric problems. If this was not carried 
out there is a danger that the personality 
ratings will be contaminated by the mental 
state. They were then indulged in another 
interview, during which the researcher 
assessed their personality by using the 
PAS.  
 
Outcomes 
In the treatment of hypertension, a mini-
mum compliance of 80% is generally 
needed to achieve an adequate reduction in 
blood pressure [8]. For this study, medica-
tion compliance is based on the pill count-
ing, the compliance ratio is then calculated 
using the formula of Z/T, where X = known 
fixed number of tablet dispensed; Y = 
residual number of tablets in the container 
after eight weeks; Z = number of tablet that 
have been removed from the container; and 
presumably consumed (X-Y = Z); T = 
number of tablets which should have been 
consumed for a particular dose regime over 
the 8 weeks period. A ratio of 0.8 (80%) to 
1.2 (120%) are used as the criteria for 
adequate drug compliance [24]. 
 
Data analysis 
Data were analyzed by using the Statistical 
Package for Social Sciences (SPSS) Ver-
sion 12.0. The relationships between the 
study parameters were analyzed using 
appropriate statistical tests. 
 
Results 
A total of 205 patients were approached to 
participate in the study. However, only 200 
patients were qualified for the study. Out of 
5 patients excluded from the study, 2 had 
difficulties understanding the interview and 
questionnaires because of language prob-
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lems, 1 was later diagnosed to have diabe-
tes mellitus and another 2 patients refused 
to participate in the study. Thus the re-
sponse rate was 97.5%.  
 
Table 1 shows the frequency distribution of 
sociodemographic variables of the respon-
dents. The mean age for HUKM Primary 
Polyclinic was 54.7 (SD±8.5), while for 
Salak Polyclinic was 52.5 (SD±7.6). There 
was no significant difference in age be-
tween HUKM Primary Polyclinic and 
Salak Polyclinic (t=1.85, d.f=198, p=.071). 
Both centers had majority of Malay re-
spondents, however HUKM Primary Poly-
clinic had more Chinese respondents 
(42.9%) as compared to Salak Polyclinic 
(4.9%). Most of the respondents (88.2%) 
were married. Majority of the respondents 
at Salak Polyclinic (77.8%) had total 
monthly income less than RM 1,500.00, 
whereas majority of the respondents at 
HUKM Primary Polyclinic (56.3%) had 
total monthly income more than RM 
1,500.00. Respondents at HUKM Primary 
Polyclinic were more educated as 61.3% 
had at least secondary level of education 
and 17.6% had received tertiary education.  
 
Table 2 shows that anxiety disorders were 
the most common type of psychiatric 
disorders (70.0%). Panic disorder was the 
most common form of anxiety disorders 
(40.0%). Only one respondent had agora-
phobia without panic disorder (10.0%). 
 
Table 3; shows that paranoid personality 
trait was the most common type of person-
ality trait (25.5%), followed by anxious 
trait (21.0%) and sensitive aggressive trait 
(19.0%). The least trait presented was 
histrionic, and none of the respondent had 
sociopathic trait. Respondents from Salak 
Polyclinic (84%) had more single personal-
ity trait. HUKM Primary Polyclinic re-
spondents (29.4%) had a high rate of mul-
tiple personality traits as compared to Salak 
Polyclinic respondents (16.0%). There was 
a significant difference between sites of 
study and number of personality traits 
(p<.05). 
 
This study revealed that only 38.5% of the 
respondents did not compliant to the pre-
scribed medications. Salak Polyclinic 
respondents had better drug compliance 
(53.7%) as compared to HUKM Primary 
Polyclinic respondents (46.3%). About 
80.5% of the non-compliers were from 
HUKM Primary Polyclinic. There was a 
significant association between the sites 
 
 
Table 1: Frequency distribution of study 
population by socio-demographic variables 
 
Variables HUKM 
Primary 
Polyclinic 
(n=119) 
Salak 
Polyclinic 
(n=81) 
Age 
40-49 
50-59  
60-69  
70-79  
80-89  
 
37 (31.1%) 
51 (42.9%) 
26 (21.8%) 
4 (3.4%) 
1 (0.8%) 
 
34 (42.0%) 
36 (44.4%) 
8 (9.9%) 
3 (3.7%) 
0 (0.0%) 
Gender 
Male 
Female 
 
64 (53.8%) 
55 (46.2%) 
 
33 (40.7%) 
48 (59.3%) 
Race 
Malay 
Chinese 
Indian 
 
65 (54.6%) 
51 (42.9%) 
3 (2.5%) 
 
71 (87.7%) 
4 (4.9%) 
6 (7.4%) 
Marital 
Single 
Married 
Widowed/ 
Divorced 
 
6 (5.0%) 
105 (88.2%) 
8 (6.7%) 
 
1 (1.2%) 
77 (95.1%) 
3 (3.7%) 
Total Monthly 
Income 
<RM 1,500 
>RM 1,500 
 
 
52 (43.7%) 
67 (56.3%) 
 
 
63 (77.8%) 
18 (22.2%) 
Education level 
None 
Primary  
   education 
Secondary 
   education 
Tertiary 
   Education 
 
3 (2.5%) 
22 (18.5%) 
 
73 (61.3%) 
 
21 (17.6%) 
 
6 (7.4%) 
29 (35.8) 
 
41 (50.6%) 
 
5 (6.2%) 
Occupation 
Employed  
Unemployed 
Retired 
 
65 (54.6%) 
24 (20.2%) 
30 (25.2%) 
 
39 (48.1%) 
11 (13.6%) 
31 (38.3%) 
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Table 2: Distribution of M.I.N.I. psychiat-
ric diagnoses of the patients 
 
Diagnosis Number 
of cases 
Dysthymia 3 (30.0%) 
Panic disorder without  
   Agoraphobia 
2 (20.0%) 
Panic disorder with  
   Agoraphobia 
2 (20.0%) 
Social phobia 2 (20.0%) 
Agoraphobia without panic 
   disorder. 
1 (10.0%) 
Total 10 
(100.0%) 
 
 
Table 3: Frequency of personality traits 
among respondents according to centers 
 
Personality 
traits 
HUKM 
Primary 
Polyclinic 
(n=119) 
Salak 
Polyclinic 
(n=81) 
1.Sociopathic 0 (0.0%) 0 (0.0%) 
2.Passive  
   dependant 
8 (6.7%) 9 (11.1%) 
3.Anankastic 8 (6.7%) 3 (3.7%) 
4.Schizoid 6 (5.0%) 2 (2.5%) 
5.Explosive 
(impulsive) 
12 (10.1%) 7 (8.6%) 
6.Sensitive- 
   aggressive 
22 (18.5%) 16 (19.8%) 
7.Histrionic 3 (2.5%) 0 (0.0%) 
8.Asthenic 12 (10.1%) 3 (3.7%) 
9.Anxious 28 (23.5%) 14 (17.3%) 
10.Paranoid 36 (30.3%) 15 (18.5%) 
11.Hypochon- 
   driacal 
10 (8.4%) 6 (7.4%) 
12.Dysthymic 11 (9.2%) 14 (17.3%) 
13.Avoidant 8 (6.7%) 5 (6.3%) 
 
 
and drug compliance with a probability of 
p<.05. There was also a significant differ-
ence in age between compliance and non-
compliance respondents (p<.05). Majority 
of the respondents aged 60 and above were 
not compliant to the prescribed medication 
(52.4%). There was a significant difference 
in the drug compliance between male and 
female (p<.05). Female respondents 
(68.9%) were more compliant to the medi-
cation as compared to male respondents 
(53.6%). There was also a significant 
difference between the drug compliance 
and race with a probability of p<.05. Chi-
nese respondents had a high non-
compliance rate (52.7%) to the drug pre-
scribed as compared to other races. Al-
though single respondents had a high 
compliance rate (85.7%) to the drug pre-
scribed, there was no significant difference 
in marital status with drug compliance 
(p>.05). There was no significant differ-
ence between the drug compliance and 
occupation (p>.05). Majority of the non-
compliance (40.4%) were employed and 
had their own business. There was no 
significant difference between drug com-
pliance and education level of the respon-
dents (p>.05). Respondents with no formal 
education (44.4%) had high non-
compliance to the drug prescribed. Re-
spondents with total monthly income of 
more than RM 1,500.00 had high non-
compliance (43.5%) as compared to the 
others. However there was no significant 
difference between drug compliance and 
total monthly income (p>.05). Respondents 
with no family history of hypertension had 
high compliance (64.6%) to the medication 
prescribed. However there was no signifi-
cant difference between drug compliance 
and family history of hypertension (p>.05).  
 
Table 5 shows that paranoid personality 
trait (27.3%) was the most common type of 
personality traits that associated with non- 
compliance to the medication prescribed, 
followed by sensitive aggressive personal-
ity trait (22.1%) and anxious personality 
trait (18.2%). This study also revealed that 
there was no significant difference between 
the number of personality traits and drug 
compliance (p>.05). However respondents 
with multiple personality traits had high 
drug non-compliance as compared to 
respondents with a single personality trait. 
 
Discussion 
The refusal rate for our research was low 
and a small percentage of subjects were 
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Table 4: Descriptive characteristics of sociodemographic data and drug compliance 
 
Variable Compliance Non-compliance 
Age 
40-59 (n=158) 
>60 (n=44) 
 
103 (65.2%) 
20 (47.6%) 
 
55 (34.8%) 
22 (52.4%) 
Sex 
Male (n=97) 
Female (n=103) 
 
52 (53.6%) 
71 (68.9%) 
 
45(46.4%) 
32 (31.1%) 
Race 
Malay (n=136) 
Chinese (n=55) 
Indian (n=9) 
 
90 (73.2%) 
26 (47.3%) 
7 (77.8%) 
 
46 (33.8%) 
29 (52.7%) 
2 (22.2%) 
Marital status 
Single (n=7) 
Married (n=182) 
Others (n=11) 
 
6 (85.7%) 
112 (61.5%) 
5 (45.5%) 
 
1 (14.3%) 
70 (38.5%) 
6 (54.5%) 
Occupation 
Employed & Business (n=104) 
Unemployed (n=74) 
Retired (n= 61) 
 
62 (59.6%) 
60 (81.0%) 
40 (65.6%) 
 
42 (40.4%) 
14 (18.9%) 
21 (34.4%) 
Education level 
No formal (n= 9) 
Primary (n=51) 
Secondary (n=114) 
Tertiary (n=26) 
 
5 (55.6%) 
32 (62.7%) 
70 (61.4%) 
16 (61.5%) 
 
4 (44.4%) 
19 (37.3%) 
44 (38.6%) 
10 (38.5%) 
Monthly income 
< RM 1,500.00 (n=115) 
> RM 1,500.00 (n=85) 
 
75 (65.2%) 
48 (56.5%) 
 
40 (34.8%) 
37 (43.5%) 
Family history of hypertension 
Yes 
No 
 
92 (60.5%) 
31 (64.6%) 
 
60 (39.5%) 
17 (35.4%) 
 
 
excluded, thus it is unlikely to have bias in 
selection of cases. The respondent had an 
age range between 40 and 81 years old, 
with the mean age of 53.8 years old. 
Majority of respondents were aged 60 
years old or less. HUKM Primary Poly-
clinic had more elderly respondents (≥60 
years old) as compared to Salak Poly-
clinic. There is a possibility that the eld-
erly living in rural area had a healthier life 
style and less stress environment as com-
pared to the elderly in urban area. How-
ever this finding may also be due to the 
high awareness of the elderly in the urban 
area to seek treatment, whereas the elderly 
in the rural area rarely came for treatment 
as they always attribute the illness for 
ageing process. In rural area, most of the 
elderly lived with their spouses or on their 
own. As their children lived and worked in 
town, there was nobody to bring them to 
the clinic. The smaller number of respon-
dents in age group 60 years old and above 
could also due to the exclusion of respon-
dents with medical co-morbidity. 
 
The gender distribution was almost equal 
between male and female respondents. 
This finding was consistent with the 
statistics from the Population and Housing 
Census of Malaysia (2000) [17]. Majority 
of them were married. 
 
The ethnic composition of Malaysia com-
prised 65.1% of Malays, 32.0% of Chinese 
and 7.7% of Indians [17]. In this study, 
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Table 5: Distribution of drug compliance 
and personality trait 
 
Personality Compli-
ance 
Non-
compli-
ance 
1..Sociopathic 0 (0.0%) 0 (0.0%) 
2. Passive De 
   pendant 
12 (9.8%) 5 (6.5%) 
3. Anankastic 6 (4.9%) 5 (6.5%) 
4. Schizoid 5 (4.1%) 3 (3.9%) 
5. Explosive  
   (impulsive) 
14 (11.4%) 5 (6.5%) 
6. Sensitive  
   aggressive 
21 (17.1%) 17 (22.1%) 
7. Histrionic 1 (0.8%) 2 (2.6%) 
8. Asthenic 8 (6.5%) 7 (9.1%) 
9. Anxious 28 (22.8%) 14 (18.2%) 
10. Paranoid 30 (24.4%) 21 (27.3%) 
11. Hypochon 
   driacal 
8 (6.5%) 8 (10.4%) 
12. Dysthymic 17 (13.8%) 8 (10.4%) 
13. Avoidant 6 (4.9) 7 (9.1) 
 
 
majority of the respondents were Malays, 
followed by Chinese and Indian. In 
Sepang district, the Malays constitute 
53.0% of the population, followed by 
Chinese (25.6%) and Indian (21.4%) and 
for this study, majority of the respondents 
of Salak Polyclinic were Malays, while the 
others were Chinese and Indian. This 
finding is not consistent with the distribu-
tion of ethnic population the district of 
Sepang, which this clinic serves. The 
possible reason could be that the Chinese 
and Indian have their preference to seek 
treatment from a nearby hospital in an-
other district, which was fully equipped 
and a doctor could treat them. There were 
only one family physician and two doctors 
based at Salak Polyclinic. Besides running 
an out patient clinic at Salak Polyclinic, 
routinely the doctors also had to visit the 
other health centre in Sepang District. 
Thus, most of the time, the medical assis-
tants would treat the patients, and the 
doctor only treat the complicated cases. 
The other reason for not including in this 
study is the language barrier. Majority of 
the respondents at HUKM Primary Poly-
clinic were Malays (54.6%), followed by 
Chinese (42.9%) and Indian (2.5%). This 
finding is also not consistent with the 
distribution of ethnic population in the 
district of Cheras that this clinic serves. 
Even though the Chinese population 
utilizing health services in HUKM Pri-
mary Polyclinic is high, most of them 
could not be included in this study because 
of language barrier.  
 
More than half of the respondents in this 
study had at least secondary education 
with only 13.0% had attended tertiary 
education. Those with tertiary education 
and presumably with high income would 
prefer to seek treatment at private health 
centers where the clinic environment is 
more conducive. 
 
Most of the respondents were employed or 
owned a business. Salak Polyclinic had 
more retired respondents (38.3%) as 
compared to HUKM Primary Polyclinic 
(25.2%). After the retirement certain 
people would prefer to stay in their own 
hometowns. They also would choose to 
live in rural area where life is less stressful 
and not so costly. Majority of the respon-
dents had total monthly income less than 
RM1500 with most of them were from 
Salak, Sepang. HUKM Primary Polyclinic 
is a semi-public clinic where the service 
charge is much higher as compared to the 
fully subsidized public clinic like Salak 
Polyclinic. Thus majority of those who 
came to HUKM Primary Polyclinic were 
employed and had more income. 
 
About three-fourth of the respondents had 
family history of hypertension. The preva-
lence of emotional disorders was 5.8% at 
HUKM Primary Polyclinic and 3.7% at 
Salak Polyclinic. The prevalence of psy-
chiatric morbidity in this study is low in 
comparison to earlier studies in Malaysia. 
Maniam (1994) found the prevalence of 
emotional disorders in an urban private 
general practice of 29.9% [19]. Varma and 
Azhar (1995) found low prevalence of 
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depression (13.2%) and anxiety disorders 
(6.1%) in a primary health setting in 
Kelantan [20]. The prevalence of emo-
tional disorders is higher in urban area as 
compared to rural area. 
 
Hypertensive personality is among the 
most enduring constructs in psychosomatic 
medicine. The construct implies that there 
is an important relationship between 
psychological variables and the likelihood 
of developing high blood pressure. Despite 
the persistence of hypertensive personality 
construct, evidence substantiating its 
existence remains equivocal [21]. Hyper-
tension has been associated with certain 
personality traits. Hypertensive individuals 
were more likely to be characterized by 
difficulties with anger expression and 
interpersonal anxiety, as well as frequently 
exhibited such defence mechanisms as 
denial and repression [10]. Research 
findings have shown that patients with 
hypertension score significantly higher on 
neuroticism and somatization traits [15, 
22]. In this study, we found that majority 
of the respondents had paranoid personal-
ity traits (25.5%), followed by anxious 
trait (21%) and sensitive aggressive trait 
(19%). 
 
Poor compliance with drug treatment is a 
barrier to effective management of hyper-
tension. Compliance is seen as an active, 
intentional and responsible process 
whereby patients work to maintain their 
health in accordance with health regimens 
and in collaboration with health care 
professionals [23]. In this study, the count-
ing pill method was adopted to measure 
medication compliance, where it was done 
manually. Every patient was given more 
medication than required for the period 
under study. The pills were counted with-
out the knowledge of the patients, before it 
was given to them. The patients were then 
reminded to return the left over medication 
during the subsequent follow up. The 
tablets left in the container were count 
when returned. Therefore part of the 
success of this study depends on the trust 
of respondents to be truthful of their 
compliance. During this study, we noted 
that patients who wanted to avoid showing 
that they had missed doses might not 
return the unused medication. The usual 
reported range of non-compliance with 
medication is 25-50% [6]. In this study; 
the prevalence of non-compliance to the 
medication was slightly more than 1/3. 
This can be considered relatively low. The 
reason for this may be that medications 
have developed a great deal during the last 
decade. Therefore, they do not have so 
many side effects and are more effective 
than the predecessors. HUKM Primary 
Clinic respondents had a higher rate of 
non-compliance to the medication pre-
scribed as compared to Salak Polyclinic. 
There was a significant association be-
tween these groups. There were few rea-
sons that can contribute to this significant 
association. This significant difference 
may be explained by the logistic differ-
ences between these two study sites. 
HUKM Primary Polyclinic temporarily 
situated at a five-storey shop lot building 
at a busy commercial area. However, there 
was lack of public transportation for the 
patients as the bus/taxi and LRT stations 
were quite far from the polyclinic. Besides 
that there was not enough parking bay for 
the patients. The polyclinic environment is 
also not conducive for the patients as the 
clinic is always crowded, noisy and small, 
thus, most of the time, patients do not have 
a place to sit. At HUKM Primary Poly-
clinic, patients have long waiting time 
before and during appointments with their 
doctor. They were only able to see the 
doctor based on the appointments. Patients 
who had defaulted were asked to make a 
new appointment. On the contrary, Salak 
Polyclinic was cozier and less hectic. It is 
less crowded and has a large waiting area 
with comfortable chairs. It also has ample 
parking area and a bus station just outside 
the polyclinic area. Patients had shorter 
waiting time before and during appoint-
ments. The patients were allowed to see 
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their doctors if they had missed their 
appointments. Long waiting time before 
and during appointments with the physi-
cian are major reasons that the patients’ 
give for failure to keep subsequent ap-
pointments, and these factors are indirectly 
affect their compliance to medications 
[24].  
 
The relationship between the patient and 
his or her health care practitioners may 
affect drug compliance [25-27]. Specific 
physician practices and continuity of care 
may be important, and compliance can be 
improved by good relationships between 
the client and the health care provider [24]. 
The importance of enabling individuals to 
take an active part in planning their care 
together with the health care personnel 
was crucial. At Salak Polyclinic, the 
relationship between the health staff and 
the patients were closed. Most of the 
health staffs live around the polyclinic area 
and know most of the attendees. The 
doctors and medical assistant in this poly-
clinic are well known among the residents 
as most of them are local people and have 
been giving services for many years as 
compared to those in HUKM Primary 
Polyclinic. Most of the time at HUKM 
Primary Polyclinic, different doctors will 
treat the patients because the doctors were 
postgraduate students. A friendly envi-
ronment and good relationship between 
the health care provider and the respon-
dents at Salak Polyclinic might have 
contributed to the better compliance to 
treatment in these respondents. 
 
Study by Monane et al. (1996) found that 
increased compliance was associated with 
advanced age (85 years and older) but 
another study found that age had no influ-
ence on compliance [28,29]. However 
Aziz et al. (1999) in their study found that 
older age group was statistically signifi-
cant to be non-complier to the prescribed 
medication [30]. In this study there was a 
significant association between age and 
drug compliance, with majority of the 
respondents of the older age group (60 
years and above) was noted to be non-
complier to the prescribed medication. The 
reason for this may be that the elderly has 
memory problem and become forgetful, 
complexity of drug regimen and more 
medication side effects. Drug compliance 
among the elderly may be compromised 
by an increased number of prescribed 
medications, by decreased social support 
and by the increased incidence of memory 
problems in the population [31]. 
 
Majority of the respondents at HUKM 
Primary Polyclinic live in the city and 
have jobs, thus they were busy with earn-
ing their livelihood and hence forget to 
take their medication and attend clinic 
appointments. Unlike respondents from 
Salak Polyclinic where life is less hectic, 
they have more time to come for their 
appointments. The service and medication 
fees were much higher at HUKM Primary 
Polyclinic as compared to Salak Poly-
clinic, where the clients enjoy fully subsi-
dized medical treatment. However, in this 
study there was no significant relationship 
between drug compliance with occupa-
tional status. There was a significant 
association between drug compliance and 
gender. Female respondents were found to 
be more compliant to the medication as 
compared to male respondents. 
 
Aziz et al. (1999) in their study found that 
race was not seen to have influence on 
compliance [30]. However in this study, 
there was a significant association between 
drug compliance and race. The Chinese 
(52.7%) were found to be non-compliant 
to the prescribed medication as compared 
to the other major races. The reason could 
be that, majority of the Chinese in this 
study came from the urban area (94.4%). 
Based on the demographic data, most of 
them run their own business or work in 
private sectors, thus due to busy earned a 
living they might forget to take the medi-
cation. The other reason is that the Chinese 
community had strong believed on their 
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traditional medications, they like to take 
herbs, ginseng and other type of traditional 
medicine instead of the drug treatment.   
 
In this study there was no significant 
association between drug compliance with 
marital status, educational level, income or 
family history of hypertension. Although 
there was no significant relationship 
between educational level and drug com-
pliance, the respondents, who never had 
formal education, had a high non-
compliance rate to the medication pre-
scribed. The reasons for this may be that 
they are illiterate and have less knowledge 
and understanding about the illness. Re-
spondents with income less than RM 1,500 
had good compliance. There is a possibil-
ity that this group of people could not 
afford to fall sick, as they need to earn a 
living. If they fall sick, they could not 
work and have to spent the money on the 
treatment. Thus, it is better for them to 
comply with the medication in order to 
prevent complications of the disease. 
 
Mental health generally has not been 
studied as a predictor of compliance 
among patients with hypertension. The 
idea of personality implies that people’s 
attitudes and behaviours differ characteris-
tically in ways that persist through chang-
ing situations and over long periods of 
time. These traits or habits are assumed to 
be largely unconscious approaches to the 
world expressed in everything a person 
thinks, feels, and does. Thus it caught the 
author interest to study the common type 
of personality trait among patients with 
hypertension. Although, it was found that 
respondents with multiple personality 
traits had poorer compliance, this study 
found no significant association between 
drug compliance with a number of person-
ality traits. However, this study found that 
majority of the respondents with paranoid 
personality trait had poor compliance to 
the medication prescribed. A person with 
paranoid personality trait often has suspi-
cion and mistrustful to others. There was a 
possibility that a person with paranoid 
personality trait thence has suspicion with 
the medication prescribed. 
 
Nevertheless, in conducting this study, the 
researchers were aware of its limitations. 
Firstly was the relatively small sample 
size, which means that caution should be 
applied in generalizing these findings to 
the general population. It is recommended 
that home visits can be done to administer 
questionnaires at patients’ homes or of-
fices. Secondly, the place where the study 
was conducted also influences the results 
of the assessment. As mentioned earlier, in 
HUKM Primary Polyclinic, the clinic 
setting was not suitable to be a clinic as it 
is located in a shop lot space. The waiting 
area was too crowded and has not enough 
rooms to see patients. Thus, there was no 
proper place to interview the respondents. 
Sometimes the respondents were inter-
viewed in the waiting area without any 
privacy when the consultation rooms were 
fully occupied. The respondents would be 
easily distracted by the noise. There were 
some patients who did not appear enthusi-
astic about the study despite their volun-
tary participation, given the fact that they 
had completed the responses in a rather 
short time. Thus, their reply may have 
been erratic and unreliable. Nevertheless, 
such patients were very small in number. 
Thirdly, the urban (HUKM Primary Poly-
clinic) and rural (Salak Polyclinic) cohorts 
may not be representative of the general 
population. Further studies are recom-
mended to replicate these findings by 
using a bigger sample size. 
 
The use of standardized interview sched-
ule such as the PAS, has its limitation too. 
The main problem with the use of human 
interviewer is observer-bias [32]. There is 
a strong tendency for the interviewer 
(researcher) to have strong preconceived 
views or ideas about the hypothesis or 
research subjects, which may influence the 
clinical ratings. To minimize this form of 
bias, a second rater (supervisor) was called 
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in and the degree of agreement (kappa) 
calculated between the two. 
 
Many methods have been used to measure 
compliance, each of which is limited by 
biases and methodological flaws [33]. The 
potential effect of the measurement itself, 
termed the “hawthorne effect,” must be 
considered. This is the effect (often bene-
ficial or positive) of observation itself on 
the outcome. Frequently, an individual’s 
knowledge that he or she is under study 
influences behaviour and may therefore 
affects the compliance.  
 
In this study, the researchers had the 
problem usually encountered in compli-
ance studies, which results in an incom-
plete picture of compliance. Question-
naires were only received from patients 
who visited health providers. The patients 
with the poorest compliance do not visit 
the health care personnel and frequently do 
not participate in the study – therefore 
studied a self-selected population. 
 
By identifying different “characteristic’, 
“prerequisites” and “difficulties that 
describe compliance, it should be possible 
to make treatment more individual. It is 
also important for the individuals to under-
stand that the significance of their own 
contributions. Health care systems have an 
important task in informing these indi-
viduals about their ability to affect their 
hypertension disease via their behaviour 
and treatment. 
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Abstract 
Objectives: To determine the best possible programme that suits our local setting, to deter-
mine the average dose required, and to determine possible problems that can arise from im-
plementing such a programme locally and how best to address them. Methods: The inclusion 
criteria were those above 18, a positive urine test, the presence of a supportive carer and 
willing to engage in the programme. Methadone was initiated and observations relating to 
dose, adverse events, relationship with carers, work performance, crime and high risk behav-
iours were monitored for 18 weeks. Results: Two thirds of the 45 subjects completed the trial 
over the 18 week period. No significant adverse events occurred and improvement in relation-
ship with carers and work performance were noted with reduction in crime and high risk 
behaviours. Conclusion: Methadone is a safe and effective drug that can be used in the local 
Malaysian setting. 
 
Key words: opioid dependence, methadone, harm reduction 
 
 
Introduction 
Drug abuse in Malaysia is not a recent 
phenomenon. Though records show that 
locally, drug abuse dates back to the 8
th
 
century among Arab traders, the problem 
only escalated with the arrival of Europe-
ans, especially during the British rule. 
Chinese migrant labourers, who were 
brought in to work in the tin mines, used 
opium in large amounts. Similarly, Indian 
migrants who were brought to work in 
plantations popularized the use of cannabis 
[1].  
 
The period of drug use in Malaysia de-
scribed above has been termed the “pre 
independence” period. The “post independ-
ence” period started in the 60’s, when 
Malay youths gradually took over from 
Chinese as the main drug users [2]. Rapid 
progress and urbanization brought social, 
economical and political changes within the 
country, and being still fresh from inde-
pendence, a strong ‘British’ influence still 
prevailed. Local youths joined their West-
ern contemporaries in undergoing the 
cultural revolution of the 60’s and in em-
bracing the “hippie” movement. [1]. 
Around this same period, the establishment 
of “The Golden Triangle” in Burma, Laos 
and Thailand increased the supply of drugs 
to the surrounding areas, including Malay-
sia [3]. 
 
This problem escalated tremendously in the 
70’s and 80’s, where from only 711 addicts 
identified in 1970, a total of 26,513 were 
identified in 1982 and, only a year later, 
this rose to 92,310 [1]. Finally on 19th 
February 1983, the Prime Minister declared
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that drugs, as the nations number one 
enemy, and a threat to national security [2]. 
The Drug Dependents (Treatment and 
Rehabilitation) Act was passed in 1983, 
allowing compulsory detainment of drug 
users for up to two years [4]. 
 
Currently, there is estimated to be 400,000 
to 800,000 drug users in Malaysia [2]. 
Within the year 2000, 30,593 drug users 
were detected nationwide, whereby 14,850 
(48.5%) were first time offenders and the 
remaining 15,743 (51.5%) were repeat 
offenders. The majority of those detected 
were males, (98.3%) and 65.9% were 
Malay. One of the main methods of treat-
ment has been rehabilitating drug users in 
“Pusat Serentis” (Government run rehabili-
tation centres), where drug users can be 
detained for up to two years in accord with 
“The Drug Dependents (Treatment and 
Rehabilitation) Act, 1983”. There are 27 
“Pusat Serentis” all over the county which 
detains a total of 8,000 to 9,000 drug users 
at any one time. The drug users are detoxi-
fied ‘cold turkey’ and kept abstinent with-
out any drug substitution for two years. 
This method has largely been ineffective, 
where less than 10 % of rehabilitated 
opioid dependence patients were able to 
eventually stay of drugs. 
 
The current widespread recognition that the 
problem of drug usage brings about a wide 
array of social, economic and health prob-
lems has created more pressure from the 
public for the Government to review its 
treatment approaches and to give an in-
creased role to health workers in managing 
heroin dependence patients. Corruption, 
accidents, prostitution and school drop outs 
have all frequently been associated with 
drug addiction [5]. Widespread substance 
misuse also depletes the human resources 
of a nation, as the majority of drug misus-
ers are within the ages where they could be 
contributing to the nation’s workforce. In 
Malaysia, 83% of drug users detected in 
2000 were below the age of 40 years. Drug 
usage strains the nation’s budget not only 
due to the loss of workforce, but also due to 
the cost of carrying out rehabilitation 
programs, health education and preventive 
programs, medical costs, legal costs and 
loss due to crimes. In Malaysia, the Gov-
ernment spends about RM 30 a day on each 
drug offender at all the rehabilitation cen-
ters. A history of imprisonment is common 
in heroin users in Malaysia. In the year 
2000 lone, the total number of arrests under 
the “Dangerous Drugs Act” was 17,550. 
 
However, it is the issue of health problems, 
particularly HIV, related to the use of 
intravenous heroin that has made the gov-
ernment and public sit up and realize the 
seriousness of the current situation. The 
number of HIV-positive people in Malaysia 
has increased dramatically in recent years. 
Since the first case of AIDS was detected in 
December, 1986, the number of HIV posi-
tive Malaysians has swelled tremendously. 
From only four cases in 1986, it has risen to 
a total of 992 cases by 1990 and 51,256 by 
2002. Malaysia is a country with a HIV 
epidemic that primarily affects IVDUs. As 
of the end of 2001, 76 per cent of all re-
ported HIV infections were to be found 
among IVDUs. The true figure may be 
much higher because HIV testing is only 
regularly done among drug users and sex 
workers rounded up in police raids.  
 
Methadone maintenance was first devel-
oped as a treatment for heroin addiction in 
the mid-1960s [6] and has been proven to 
be an effective and safe mode of treatment 
[7,8]. Methadone maintenance has been 
proven beyond a doubt to be important in 
the reduction of the spread of HIV via 
intravenous drug use [9,10] and a leads to 
reduction in crime rates. Despite the over-
whelming evidence on the benefits of 
methadone, and intense lobbying by certain 
quarters locally, it was only last year that 
methadone was registered locally for use in 
the treatment of opiate dependence. Even 
then, the criticism against its use continued 
and widespread resistance was still met. 
Many believed in total abstinence and 
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viewed methadone as just another drug. It 
was then that we decided to embark on this 
trial to gather local evidence that metha-
done can be a safe and effective drug to use 
in the treatment of heroin dependence in 
Malaysia. The objectives of this study was 
to determine the best possible programme 
that suits the local setting, to determine the 
average dose required in our local popula-
tion and to determine possible problems 
that can arise from implementing such a 
programme locally and how best to address 
them. 
 
Methods 
Subjects were recruited by newspaper 
advertisements and word of mouth. The 
intended study population was the maxi-
mum recruited (not exceeding 100 subjects 
due to budget constraints) within an 18-
week period. Each subject was to be fol-
lowed up for 18 weeks (Day 0-126). The 
inclusion criteria set was those who were 
above 18, a confirmed heroin user (by urine 
test) and with the presence of a supportive 
carer, willing to engage in the programme 
and come once every 1-3 days for follow 
up and willing to buy methadone at their 
own cost after completion of the study 
(should they still require it). The exclusion 
criteria were concurrent use of medication 
that interacts with methadone and a grossly 
abnormal liver function.   
 
During screening (Day 0), consent was 
obtained and physical examination, liver 
function test and drug urinalysis done. 
Demographics along with drug and crimi-
nal histories were noted. Relationship with 
carers was assessed using a visual analog 
scale, scored from 0-10. Eligible subjects 
would then undergo “Methadone Initiation” 
(Day 1), where they would arrive in the 
morning while experiencing withdrawals, 
and served with 10 mg methadone at 8 a.m. 
If withdrawals persist, additional doses of 
methadone would be served every 1-2 
hours by 5 mg each time until there is a 
cessation of withdrawals. 
 
Subjects would then enter the “Titration 
Phase” (Day 2-56). Dose can be adjusted 
on any day depending on presence of 
withdrawals or adverse events. Subjects 
with good social support may receive 
prescription for up to three days each time, 
hence need only to come every three days 
(with the condition that the carer handles 
the methadone). From Day 56-126 (“Re-
duction Phase”), a gradual reduction of 
methadone would be attempted at a dose 
reduction of 2.5 – 5mg a week. However, 
reduction is not mandatory. An attempt 
would only be made depending on patient’s 
tolerability and confidence, and the investi-
gator’s judgement. 
 
Throughout the 18 weeks, subjects would 
be assessed monthly regarding their rela-
tionship with their carers, work perform-
ance, high-risk behaviour and criminal 
activities. Random urine tests were also 
done monthly to detect concurrent heroin 
use. 
 
Results 
Study population 
A total of 46 subjects turned up for screen-
ing, of which 1 patient was excluded due to 
grossly abnormal liver enzymes. Another 5 
subjects dropped out after Day 0 (screen-
ing) and did not undergo methadone initia-
tion. Therefore, only 40 subjects were 
given methadone, and results would be 
based on these subjects. Though it was 
initially planned to recruit 100 subjects, 
were had to stop recruitment after 18 weeks 
as initially planned due to budget con-
straints and ethical committee stipulations. 
We had initially expected to be able to 
recruit 100 subjects within the stipulated 18 
weeks period, but eventually we were only 
able to recruit 46 subjects 
 
The subjects were mainly males, consisting 
of 38 (95%) subjects, with only 2 females. 
Slightly more than half, 23 (57.5%) of them 
were married, 14 (35.0%) were single and 3 
(7.5%) were divorced or separated. Only 23 
(57.5%) of them were employed at screen-
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ing (including 1 college student). More 
than half, 22 (55.0%) of the subjects had 
history of being detained in “Pusat Serenti” 
or jail for drug use or drug related offences. 
 
Dropouts 
There were 30 (75%) subjects that com-
pleted the whole course of the trial. One 
subject dropped out after 56 days after 
being hospitalized in another centre for 
tuberculosis and hence was withdrawn due 
to concomitant use of disallowed medica-
tion. (He still continued on methadone but 
was not included as part of the study). 
Another 9 subjects defaulted follow up, 
where most dropped out early within the 
first month. These 9 subjects dropped out 
after Day 3, 16, 22, 23, 29, 30, 41, 57 and 
76 respectively. Efforts were made to 
contact these patients, where only 5 were 
contactable. Of these, 3 subjects said they 
were unable to commit to coming regularly 
due to work commitments and the other 2 
admitted going back to heroin due to with-
drawals and felt methadone was not helping 
them.  
 
Doses of methadone 
The daily dose of methadone required 
varied from subject to subject, ranging 
from 10mg a day to the maximum of 45mg 
a day. The average dose of methadone 
among all subjects also varied from month 
to month as illustrated below. 
 
Adverse events 
Only 2 (5%) of the subjects had com-
plained of side effects. Both complained of 
pruritus of the face, which resolved after 
their methadone dose was divided into 
twice a day. 
 
Random urine tests 
As expected, all the subjects had a positive 
urine test for opiates at screening (Day 0). 
Thereafter, the proportion of subjects with 
a positive urine test rapidly declined until 
all were negative on Day 120, as illustrated 
below. 
 
Relationship with carers 
Out of the 40 subjects, 32 (80.0%) reported 
a better relationship with their carers, 
where else 7 (17.5%) reported no change. 
Only 1 (2.5%) reported a worsening rela-
tionship since the start of the programme. 
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Figure 1: Average methadone doses 
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Figure 2: Percentages of positive and negative urine tests for opiates 
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Figure 3: Average score of the relationship with carers on the Visual Analog Scale 
 
 
As a group, the average score of how good 
their relationship with their carers gradually 
improved over time. Paired sample t-test 
was done to compare the scores with base-
line and it was noted significant improve-
ment was seen as early as Day 30. 
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Employment/work performance 
Out of the 40 subjects, 24 (60%) reported 
an overall improvement in their work 
performance or had gained employment, 
where else 16 (40%) reported no change. 
None reported worsening work perform-
ance or losing their job since the start of the 
programme. 
 
Out of the 17 subjects who were unem-
ployed at entry into the programme, 8 
subjects eventually found jobs (security 
guards, baker, car dealer etc) and 1 subject 
restarted studies again. 
 
Crime/high risk behaviour 
None of the subjects reported that they had 
been involved with crime or indulged in 
high risk behaviours such as self injecting 
or promiscuous unprotected sex since 
starting the methadone programme. 
 
Discussion 
As expected, the majority of the subjects 
were males, reflecting the pattern of heroin 
use in Malaysia. The fact that more than 
half of the subjects had a history of being 
detained in “Pusat Serenti” or jail for drug 
use or drug related offences was also not 
surprising as it is well recognized that the 
current system used for rehabilitating drug 
dependants had not achieved the desired 
results. The high rate of unemployment at 
screening was also expected, due to the 
disruptive and disorganized nature of 
lifestyle a heroin user leads. 
 
The 75% retention rate achieved in this 
study was a heartening figure despite the 
rather short duration, as this was a pilot 
trial done with no prior experience on how 
to run such a programme in our local 
setting coupled with the overwhelming 
resistance from many areas. Out of the 10 
“dropouts” one subject was excluded, 
though he was still on methadone, as he 
had taken anti-tuberculosis medication 
which was disallowed. For the purpose of 
this trial, concurrent use of medication that 
interacts with methadone is disallowed as 
one of the objectives was to determine the 
average dose of methadone that is required 
for our local population. Out of the remain-
ing 9 “dropouts”, 6 dropped out early, all 
within the first month. A valuable experi-
ence gained here was that if a subject were 
to default, he or she would most likely do 
so early. Therefore the initial period during 
the programme should be a time when 
close follow up and intense psychosocial 
interventions should be in place. 
 
What was surprising from this study was 
the finding that the daily dose of metha-
done found in this study, 10-45 mg, was 
much lower that what has been found 
elsewhere. The average maintenance dose 
of methadone usually quoted ranges from 
60-120 mg a day [6,7,11]. There are two 
possible explanations for this observation. 
Firstly, the quality of heroin used locally is 
extremely poor, frequently containing less 
than 10 % heroin. This could also explain 
the reason why the preference is to inject 
the drugs to get the desired effects. The 
other possible explanation for the low dose 
of methadone needed is the different ge-
netic make up of our ethnic groups, as 
compared to the Caucasian population. This 
certainly would require further studies to 
establish if Asian do need lower doses. 
 
This trial also showed that methadone is a 
safe drug when monitored, as only 2 sub-
jects complained of side effects, which was 
mild and easily dealt with. This study also 
proved what many studies before had, that 
methadone can eventually lead to absti-
nence from heroin, and decreases high risk 
behaviours and crime, and improves work 
performance and relationship with carers. 
In this study the proportion of positive 
urinalysis gradually decreased over time. 
This could be explained that the optimal 
dose of methadone for someone needs 
some time to be established. Therefore 
positive urine tests, especially early on does 
not equate to failure on the subjects part. 
The subject should be reassured that this is 
the process he has to go through, and 
70   Gill JS, et al. 
should not be reprimanded. It is heartening 
that none of the subjects, or their carers 
reported that they had been involved with 
crime or indulged in high risk behaviours 
since starting the methadone programme. 
However, we must bear in mind that these 
are based on self reports This is in keeping 
with numerous other reports citing a reduc-
tion in injecting behaviour in those on 
methadone [12,13].  
 
A majority of the subjects reported an 
overall improvement in their work per-
formance or had gained employment. More 
importantly none reported the worsening of 
work performance or losing their jobs since 
the start of the programme, despite the very 
frequent follow-ups that they have to go 
through. Similarly, many reported an 
overall improvement in their relationship 
with their carers, similar to what other 
studies have shown [14]. Interestingly, one 
subject complained of a worsening rela-
tionship with his wife. This was caused by 
the fact that he was more stable and con-
cerned about his wife’s bad attitudes. In the 
past, he preoccupied with heroin use and 
did not care about his wife’s behaviour. 
 
Though we are producing results that have 
already been proven time and again, we 
feel it is still important as these has never 
been shown in our local setting. Local data 
such as this is extremely important in trying 
to convince the authorities in adopting new 
measures to abolish the drug abuse menace 
and the rise of HIV in Malaysia. 
 
We do recognize some limitations in our 
study. Due to the budget constraints, the 
study population was small, and the follow 
up duration was rather short. A study with 
larger sample size and longer follow up 
period is warrant. 
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Abstract 
Objective: The study examines the effectiveness of a CBT treatment programme over and 
above that of Treatment As Usual (TAU), with children who were referred to an outpatient 
child psychiatric clinic for disruptive behaviour disorders in Singapore. Methods: One hun-
dred and three children aged 8 to 12 (mean±SD=10.22±1.31) who participated in the study 
were assigned to either the CBT+TAU (n= 51) or TAU group (n=52). Children in both the 
CBT+TAU and TAU groups received a standard and typical service offered to children at the 
outpatient child psychiatric clinic. In addition, children in the CBT+TAU group attended the 
CBT treatment programme that consisted of nine 1.5 hour weekly sessions. Results: Findings 
from ANCOVA indicated that children in the CBT+TAU treatment group showed signifi-
cantly lower levels of aggression and significantly lower levels of parental stress at post-
treatment and at 3-month follow-up in comparison to the TAU group. Conclusions: Findings 
from the present study provided some evidence of the effects of CBT in reducing aggressive 
behaviour and parental stress among children with disruptive behaviour disorders. Interpreta-
tion of the findings, recommendations for future research, and implications of the present 
study were presented. 
 
Key words: disruptive behaviour disorders, cognitive behavioural therapy, aggression, 
parental stress 
 
 
Introduction 
Disruptive behaviour disorders are among 
the most prevalent disorders of childhood
 
[1,2]. Children and adolescents with disrup-
tive behaviour disorders often exhibit 
behaviours that are marked by severe 
aggression, violence, defiance, impulsivity, 
antisocial features, and even delinquency
 
[3,4]. These disruptive behaviours cluster 
together and occur at higher rates than 
usual for children of the same age. Normal 
children may also exhibit many of the 
behavioural problems seen in children with 
diagnosed disruptive behaviour disorders, 
but their behaviour problems are fewer and 
occur less frequently. The difficulties of 
these disruptive disorders would pose fewer 
problems if most of these children grew out 
of their disruptive behaviours. However, 
studies found that over 90% of recidivist 
juvenile delinquents had disruptive behav-
iour disorders as children; and 40% of 7 
and 8 year olds with disruptive behaviour 
disorders become recidivist delinquents as 
teenagers
 
[5].  
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Although not all children with disruptive 
behaviour disorders have persistent mental 
health problems to adulthood, it is one of 
the substantial risk factors for a lifetime of 
antisocial behaviour, social dysfunction, 
delinquency, substance abuse, poor peer 
relations, academic failure, and school 
dropout
 
[2,6,7]. Disruptive behaviour 
disorders have been associated with severe, 
aggressive and antisocial behaviours that 
persist over the life course
 
[1,8,9] and are 
often resistant to treatment
 
[10,11]. Taken 
together, these studies suggest that disrup-
tive behaviour disorders may result in 
enormous societal costs - a more violent 
society that brings about psychological, 
social, and economic consequences [12, 
13]. 
 
Current literature suggests that stress within 
the parent-child relationship is often asso-
ciated with behaviour problems in children
 
[14,15]. Parents of children with disruptive 
behaviour disorders often reported high 
levels of child- and parent-related stress 
[16,17]. Parents who are highly stressed 
tend to have lower tolerance of children’s 
misbehaviour, causing parents to behave 
negatively toward the child [18,19]. Almost 
inevitably, these aggressive, disruptive, and 
antisocial behaviours serve as a source of 
negative parent-child interactions. In addi-
tion, mothers of children with disruptive 
behaviour disorders tend to be more nega-
tive and directive, and less responsive to 
child initiations than mothers of non-
disordered children [20]. These studies 
seem to suggest that the characteristics of 
children with disruptive behaviour disor-
ders create an atmosphere of fear, negativ-
ity, and conflict that increase parental stress 
and undermine the quality of parent-child 
relationships [21]. 
 
As a result, disruptive behaviour disorders 
are among the most common reasons for 
referral to child mental health services [22, 
23]. In Singapore, data obtained from an 
outpatient child psychiatric reflected simi-
lar trend. From 2001 to 2003, about 644 
(31.1%) out of 2,072 children referred to 
the outpatient child psychiatric clinic in 
Singapore consisted of children and adoles-
cents with disruptive behaviour disorders 
[24]. This finding indicated that disruptive 
behaviour disorders are most commonly 
seen at the outpatient child psychiatric 
clinic and is a rising concern in Singapore. 
Given the magnitude of the problem, inter-
vention programmes that forestall the 
continuation of disruptive behaviour disor-
ders and prevent its long-term conse-
quences are especially crucial for countries 
like Singapore that depend mainly on 
human resources for growth and develop-
ment [22-24]. As such, disruptive behav-
iour disorders in childhood or adolescence 
need to be taken seriously and addressed in 
Singapore. 
 
Many researchers have suggested interven-
tion programmes that are comprehensive 
and integrated, and directed toward these 
salient features of disruptive behaviour 
disorders [25,26] CBT has gained popular-
ity due to its effectiveness and generalis-
ability [27-29]. These intervention pro-
grammes for children and adolescents 
diagnosed with disruptive behaviour disor-
ders have been based on our emerging 
understanding of the social-cognitive 
difficulties of these children [30,31]. Vari-
ous studies have revealed these children 
often exhibit deficits in social cognition 
such as cognitive appraisal processes and 
interpersonal problem-solving skills 
[32,33]. These children tend to encode 
fewer interpersonal or environmental cues 
before interpreting the intention of the 
behaviour of others and tend to infer hostile 
intent especially in ambiguous situations 
[32,33] They were also found to generate 
more aggressive and ineffective solutions 
to interpersonal problems compared to non-
disordered children [27]. These deficits 
may lead to poor impulse control, low 
frustration and stress tolerance, and limited 
insight of their own feelings as well as 
those of others. As a result, children with 
disruptive behaviour disorders may fre-
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quently face frustrations due to a lack of 
skills on how to cope with their feelings 
and behaviour. 
 
Hence, instead of focusing on the teaching 
of specific skills, the CBT treatment pro-
gramme focuses on modifying the thought 
processes that support aggressive and 
antisocial behaviour and teaching problem-
solving strategies [34]. Exposure to these 
skills enables children with disruptive 
behaviour disorders to enhance positive 
social interactions with family and peers, 
learn non-aggressive methods to resolve 
conflict, and adopt non-aggressive beliefs 
[35]. Findings from various studies exam-
ining the efficacy of CBT have also indi-
cated classroom behavioural improve-
ments, increased self-esteem, perceived 
social competence, and reductions in par-
ents' or teachers’ ratings of aggression 
following intervention [28,36]. Hence, it 
appears that CBT treatment programmes 
have the potential to generalise skills across 
settings [28,36].  
 
Purpose of the study 
This study hopes to determine the effects of 
the CBT treatment programme over and 
above that of Treatment As Usual (TAU) at 
post-treatment and whether gains made (if 
any), are maintained three months follow-
ing the termination of the CBT treatment 
programme. We predicted that children in 
the CBT+TAU group would show signifi-
cantly lower levels of aggression based on 
child and parent measures. In addition, 
children in the CBT+TAU group would 
show significantly lower levels of parental 
stress at post-treatment and at 3-month 
follow-up. There is a large body of research 
evidence documenting the effects of CBT 
treatment programmes in Western contexts 
but limited published research studies can 
be found in Asian contexts [37]. Hence, 
there are limited data to inform teachers, 
counsellors, and those in the child mental 
health services about strategies that work 
best for children with disruptive behaviour 
disorders. Importing Western intervention 
strategies without local verification and 
addressing issues relevant to the local 
context may not be appropriate and effec-
tive [38,39]. There is now increasing evi-
dence that suggest the need for finding 
ways to improve the relevance and effec-
tiveness of intervention programmes 
adopted from the Western context to the 
Asian context [39]. It is then important to 
investigate these issues in an Asian context 
like Singapore.  
 
Methods 
Participants 
One hundred and three children who had 
been attending one of the local child psy-
chiatric outpatient clinics for at least 6 
months participated in the present study. 
These children were included only if they: 
a) were diagnosed by their attending psy-
chiatrists (based on a semi-structured 
clinical interview and psychological as-
sessment of the child) to have disruptive 
behaviour disorders such as Attention 
Deficit Hyperactivity Disorder (ADHD), 
Oppositional Defiant Disorder (ODD), or 
Conduct Disorder (CD), with or without a 
comorbidity of other disorders by the 
DSM-IV criteria [3,4], b) had a T-score 
more than 70 on the aggressive behaviour 
subscale of the Child Behaviour Checklist 
(CBCL) [40], c) were between 8 to 12 
years old (Primary 2 to Primary 6), d) had 
parental consent and e) understood English 
and were English-speaking. In addition, 
children on medications were included in 
the study on the condition that no change of 
medication doses occurred one month prior 
to the participation and throughout the 
study.  
 
The mean age for the sample was 10.2 
years (SD=1.3). Eighty-six per cent of the 
participants were boys while the remaining 
11.4% were girls. The racial composition 
was 89.5% Chinese, 5.7% Malay, 1.9% 
Indian, and 2.9% Others (which includes 
all other ethnic groups not listed). Self 
reported marital status of the parents were 
as follows: 83.8% were married, 2.9% were 
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separate, 10.5% were divorced, 1.8% were 
widowed, and 1% had never been married.  
 
Measures 
The Child Behaviour Checklist (CBCL) 
was designed to quantify a broad range of 
behavioural and emotional difficulties in 
children [40]. For the purposes of this 
study, the Aggressive Behaviour subscale 
of the CBCL (A-CBCL), which consists of 
20 items that measure children’s aggression 
from ages 4 to 18, was used. Parents were 
asked to rate how true each item was using 
the following scale: 0 (Not true) to 2 (Very 
or Often true). Sample items included 
“Argues a lot” and “Gets in many fights”. 
All items on the A-CBCL were summed to 
provide a total score. Higher scores on the 
A-CBCL indicated higher levels of aggres-
sion. Previous studies have reported a 
Cronbach alpha value of .93 for the CBCL 
total score [41,42]. In the present sample, 
the Cronbach alpha value for the pre-
treatment A-CBCL score was .89. 
 
The Parenting Stress Index (PSI) is a scale 
that identifies stress within the parent-child 
relationships, and consists of two domains 
[43]. The PSI screens for dysfunctional 
parenting and predicts the potential for 
parental behaviour problems and child 
adjustment difficulties within the family 
system. The Child domain relates to the 
parents’ perception in which the child may 
be perceived as stressful. The Parent do-
main relates to parents’ view of their own 
functioning. For the purposes of this study, 
a total of 13 items from the Reinforces 
Parent (RE) (Child domain) and Attach-
ment (AT) (Parent domain) subscales were 
used. The RE subscale measures the degree 
of parent-child interaction that results in 
positive affective response in parents. The 
AT subscale measures the level of motiva-
tion to fulfil the role of a parent. Parents 
were asked to rate the description on a 5-
point Likert scale from 1 (Strongly dis-
agree) to 5 (Strongly agree). Higher scores 
on the PSI indicated higher levels of stress 
within the parent-child relationships. Sam-
ple items included “My child rarely does 
things for me that make me feel good” and 
“Most times I feel that my child likes me 
and wants to be close to me.” The PSI can 
be used with parents whose children are in 
preschool to 12 years of age. The reliability 
of the subscales used in this study are .83 
for the RE subscale and .75 for the AT 
subscale [43]. Previous studies have also 
reported Cronbach’s alpha values of .93 for 
PSI total score, .85 for the Parent domain 
and .91 for Child domain [44]. In the 
present sample, the Cronbach’s alpha value 
for the total pre-treatment PSI score was 
.72. 
 
Design and procedures 
The current study was approved by the 
Institute of Mental Health’s Clinical Re-
search Committee and the National Health-
care Group’s Domain Specific Review 
Board. Prior to conducting the study, the 
appropriate approval from parents (or 
guardians) of individual participants was 
obtained. Participation in the study was 
strictly voluntary and only children with 
parental consent were allowed to partici-
pate in the study. Written informed consent 
was obtained from the parents during the 
clinic visits, and research procedures were 
fully explained to the parents. All responses 
obtained were kept confidential.  
 
Power calculations were done to determine 
the appropriate sample size. For a medium 
effect size of .50 to be statistically signifi-
cant (at p<.05) approximately 80% of the 
time, a minimum sample size of 64 would 
be required [45]. Hence, the proposed 
target for the CBT+TAU group and the 
TAU group was 60 respectively. This 
estimation was based on the assumed 
attrition of 50%. Because the CBT treat-
ment programme was to be delivered in the 
context of small groups consisting of about 
6 to 8 children in each group, much time 
was spent for the participant recruitment. In 
addition, it was difficult to predict the 
number of participants to be enrolled into 
the study. Hence, because of these practical 
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constraints, random assignment was not 
fully possible. This resulted in the first 51 
participants referred to the study to be in 
CBT+TAU and the next 52 to be in TAU.  
 
CBT+TAU condition: Fifty-one participants 
in the CBT+TAU group attended nine 1.5-
hour weekly sessions of the group-based 
CBT treatment programme conducted by 
the researcher [46,47] and individually 
administered Treatment As Usual (TAU) 
sessions once every 2 months on average. 
These children were assigned to 9 sub-
groups that consisted of 6 to 8 children in 
each sub-group. The 9-week CBT sessions 
focused on: 1) Self-awareness, 2) Anger 
Coping Techniques, 3) Perspective-taking 
Skills, 4) Social Problem-Solving Skills, 5) 
Fighting Fair and 6) Prosocial Skills. It was 
delivered in the context of small groups (6 
to 8 children in each group) and each 
session followed the same general format: 
(a) Review of previous lesson and home-
work, b) Introduction to a new set of skills, 
(b) Structured skills rehearsal, (c) Group 
activities, (d) Summary and homework 
assignment, and e) Presentation of rewards. 
In order to control for biases, parents and 
children had no prior knowledge about the 
CBT+TAU condition and were told that 
those assigned to the CBT+TAU group 
would be undergoing a series of 9 sessions 
to help them learn some useful problem-
solving skills. 
 
TAU condition: Fifty-two participants in 
the TAU group received individually 
administered TAU sessions, a typical form 
of intervention provided by the outpatient 
child psychiatric to children with disruptive 
and aggressive behavioural problems. The 
conventional therapy is usually provided by 
psychiatrists and consists of medication 
treatment and individual supportive therapy 
and parent training using behavioural 
techniques. Children who received TAU 
met up with the psychiatrist once every two 
months on average.  
 
Treatment integrity: The integrity of CBT 
treatment programme was assessed in the 
following ways. First, the CBT treatment 
programme was conducted by the re-
searcher, who holds a postgraduate degree 
in counselling. The intervention pro-
gramme was manualised in order to adhere 
to intervention procedures. Second, the 
researcher conducted her first intervention 
group with the on-site supervisor, a con-
sultant psychiatrist, as part of the direct 
supervision process. Third, both the re-
searcher and on-site supervisor completed 
checklists that described the specific 
themes to be covered for each session. The 
correlation between researcher-rated and 
on-site supervisor rated protocol adherence 
was .95 (p<.001), Forth, the researcher 
documented children’s progress and unique 
features of each session. Last, on-going 
clinical supervision and feedback were 
provided throughout the study through 
direct observation, review and discussion 
sessions with dissertation and on-site 
supervisor to ensure the adherence with 
intervention procedures and treatment 
fidelity. 
 
Data analysis 
Descriptive statistics were used to analyze 
the demographic characteristics of respon-
dents such as age, gender, ethnicity, educa-
tional level, and parents’ marital status 
from both the CBT+TAU and TAU groups. 
A series of Analysis of Covariance (AN-
COVA) were used. All research partici-
pants, regardless of treatment drop-outs or 
missing data, were included in the intent-
to-treat analysis. The intent-to-treat analy-
sis was conducted with available pre-
treatment data carried forward to replace all 
missing data at post-treatment and 3-month 
follow-up. The intent-to-treat analysis 
limited to 3-month follow-up was deemed 
appropriate [48]. 
 
Results 
Preliminary analyses 
Preliminary analyses of t-tests for continu-
ous variables and chi-square for categorical 
variables were conducted to examine 
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whether participants in the CBT+TAU and 
TAU groups differed at pre-treatment on 
demographic characteristics. These analy-
ses indicated no significant differences 
between the CBT+TAU and TAU groups 
in terms of their age, gender, ethnicity, 
education level, and parents’ marital status. 
In addition, analyses from independent 
samples t-tests revealed no significant 
differences between the CBT+TAU and 
TAU groups at pre-treatment on all meas-
ures. Results of the evaluation of the as-
sumptions of normality of sampling distri-
butions, linearity, homogeneity of variance-
covariance, and homogeneity of regression 
were deemed satisfactory. No significant 
differences were also found between the 9 
subgroups of the CBT+TAU group at pre-
treatment on all measures. The demograph-
ics of the research sample at pre-treatment 
based on gender, age, ethnicity, education 
level, and parents’ marital status are pre-
sented in Table 1. 
 
Treatment outcome 
Table 2 shows the means and standard 
deviations for aggression as measured by 
the Aggressive Behaviour subscale of the 
Child Behaviour Checklist (A-CBCL) and 
the Parenting Stress Index (PSI) at pre-
treatment, post-treatment, and 3-month 
follow-up [40,43]. 
 
Changes in aggression: Analysis of Covari-
ance (ANCOVA) using pre-treatment 
aggression scores measured by the A- 
CBCL as the covariate revealed significant 
differences between the CBT+TAU and 
TAU groups on the A-CBCL at post-
treatment, F(1, 100) = 4.75, p=.04.  Results 
from the ANCOVA indicated that the 
CBT+TAU group showed significantly 
lower levels of aggression as measured by 
the A-CBCL than the TAU group at post-
treatment. 
 
 
 
Table 1: Demographics of research sample at pre-treatment 
 
 Experimental 
(n = 51) 
Control 
(n = 52) 
Total 
(N = 103) 
Statistical 
Test
 
p 
Age 
Mean 
SD 
 
9.98 
1.32 
 
10.46 
1.2 
 
10.22 
1.31 
-1.91
 
 
 
ns 
 
Gender 
Male 
Female 
 
43 
8 
 
48 
4 
 
91 
12 
97 ns 
 
Education level  
Primary 2 
Primary 3 
Primary 4 
Primary 5 
Primary 6 
 
8 
14 
9 
13 
8 
 
4 
8 
16 
9 
15 
 
12 
22 
25 
22 
23 
5.90 ns 
Ethnicity 
Chinese 
Malay 
Indian 
Others 
 
43 
5 
1 
2 
 
49 
1 
1 
1 
 
92 
6 
2 
3 
4.39 ns 
Parents’ marital status 
Married 
Separated 
Divorced 
Widowed 
Never been married 
 
40 
3 
6 
1 
1 
 
46 
0 
5 
1 
0 
 
86 
3 
11 
2 
1 
3.39 ns 
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Table 2: Means and standard deviations for aggression and parental stress at pre-treatment, 
post-treatment and 3-month follow-up 
 
Pre-treatment Post-treatment 3-month follow-up Measure 
mean SD mean SD mean SD 
CBT+TAU 
CBCL 
PSI 
 
20.84 
44.92 
 
7.62 
7.08 
 
18.04 
44.28 
 
8.26 
7.59 
 
14.90 
44.33 
 
7.10 
6.88 
TAU  
CBCL 
PSI 
 
18.46 
45.78 
 
7.61 
6.25 
 
18.61 
46.86 
 
7.10 
6.12 
 
17.50 
47.38 
 
6.92 
5.32 
Note. A-CBCL = Aggressive Behaviour subscale of the Child Behaviour Checklist, PSI = Parenting 
Stress Index. Higher scores on the A-CBCL indicated higher levels of aggression while higher scores 
on the PSI indicated higher levels of parental stress. 
 
 
Table 3: Analysis of Covariance (ANCOVA) at post-treatment and at 3-month follow-up  
 
Source Post-treatment (1,100) 3-month follow-up (1,100) 
A-CBCL 4.75* 15.12** 
PSI 5.18* 6.96** 
Note. A-CBCL = Aggressive Behaviour subscale of the Child Behaviour Checklist, PSI = Parenting 
Stress Index. 
*p < .05, **p < .01. 
 
 
Similar ANCOVA analysis also revealed 
significant differences between the 
CBT+TAU and TAU groups on the A-
CBCL at 3-month follow-up, F(1, 
100)=15.12, p=.001. In line with our hy-
pothesis, results from ANCOVA indicated 
that the CBT+TAU group showed signifi-
cantly lower levels of aggression as meas-
ured by the A-CBCL than the TAU group 
at 3-month follow-up.  
 
Changes in parental stress: ANCOVA 
using the parental stress pre-treatment 
scores measured by the Parenting Stress 
Index (PSI) as the covariate revealed sig-
nificant group differences at post-treatment, 
F(1, 100)=5.18, p=.03. Results from AN-
COVA revealed that the CBT+TAU group 
showed significantly lower levels of paren-
tal stress than the TAU group at post-
treatment. Similar ANCOVA analysis also 
revealed that the CBT+TAU and TAU 
groups were significantly different from 
each other on PSI at 3-month follow-up, 
F(1, 100)=6.96, p=.01. Results from AN-
COVA supported our hypothesis; findings 
indicated that the CBT+TAU group showed 
significantly lower levels of parental stress 
as measured by the PSI than the TAU 
group at 3-month follow-up. Results of the 
ANCOVAs are presented in Table 3. 
 
Discussion 
Findings from the present study revealed 
that the CBT+TAU treatment led to signifi-
cant improvement in the level of parent-
rated aggression in comparison to TAU at 
post-treatment and 3-month follow-up. The 
results of the study provided some evidence 
on the short-term effectiveness of the 
CBT+TAU treatment beyond that of 
Treatment As Usual in helping children 
with disruptive behaviour disorders to be 
less aggressive. Findings from the present 
study were in line with existing literature 
documenting the short-term effectiveness 
of CBT in producing improvements in 
parent ratings of aggression for severely 
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disturbed antisocial children in psychiatric 
inpatient settings and those in the school 
settings [28,36,49,50]. These findings 
indicated that the CBT+TAU treatment 
programme lead to improvement in aggres-
sive behaviour across time, suggesting that 
the skills learned in the clinic were general-
ised to home settings and were maintained 
over time. In addition, improvements in 
aggressive behaviour suggest that children 
with disruptive behaviour disorders can be 
taught skills to respond to anger-provoking 
situations appropriately without resorting to 
aggression. The CBT treatment programme 
provided these children with the under-
standing of anger, effective anger coping 
skills, problem-solving skills, and perspec-
tive-taking skills that can alter their social-
cognitive skills related to aggression before 
inappropriate behavioural responses occur.  
 
Findings from the present study revealed 
that the CBT+TAU treatment also led to a 
significant improvement of parental stress 
in comparison to TAU at post-treatment 
and 3-month follow-up. High levels of 
parental stress are often evident in children 
with disruptive behaviour disorders 
[16,17]. This is because these children’s 
disruptive and aggressive behaviours tend 
to be pervasive, and could lead to dysfunc-
tional, coercive patterns in the family that 
are characterised by frequent yelling and 
punishment [51,52]. As such, parents often 
find it stressful to manage the aggressive 
and disruptive behaviours manifested by 
their children. With the evidence of re-
duced aggressive behaviours on parent 
measures of aggression at post-treatment 
and at 3-month follow-up, parents, perhaps, 
felt more competent, satisfied, and en-
hanced personally in their parenting role. 
These changes may have contributed to the 
significant improvements in the levels of 
parental stress in the present study. 
 
While the limited support for the 
CBT+TAU treatment programme is note-
worthy, findings on the positive outcomes 
on parent measures of aggression should 
not be over-interpreted. There is a tendency 
for parents to be “biased toward perceiving 
improvement following involvement in 
almost any intervention” [53]. Hence, the 
positive outcomes on parent measures of 
aggression may be a function of parent’s 
biased or exaggerated reporting behaviour. 
In addition, the significant improvement on 
parent measures might be caused by the 
factors that were neither examined nor 
controlled, such as children’s maturation 
and regression to mean amongst others. 
 
Limitations 
There are several limitations to the present 
study that should be acknowledged. One of 
the most apparent limitations is that the 
cognitive processes and mechanisms ac-
counting for changes were not investigated. 
While findings from the present study 
revealed significant improvements on 
parent measures, conclusions about the 
changes in processes and mechanisms that 
accounted for significant improvements 
cannot be interpreted. Another limitation of 
the study derives from the use of a quasi-
CBT+TAU design. The constraints im-
posed by the quasi-CBT+TAU study have 
been well documented [54]. Random 
assignment of participants into treatment 
groups was also not achievable in the 
present study because of constraints men-
tioned in the earlier paragraphs. In addition, 
it was not possible to blind parents as to 
which treatment their child was receiving 
because of the nature of the CBT program. 
Children in the CBT+TAU group had to 
attend 9 weekly sessions. Parents of chil-
dren in the CBT+TAU also have access to 
workbooks that could easily allow them to 
identify the type of treatment that the child 
was in. 
 
The sample employed in the present study 
represented a clinical-based sample of 103 
children aged 8 to 12 and thus has limited 
generalisability. Hence, findings from these 
studies should be regarded as tentative until 
further replication studies are conducted on 
larger and more representative samples. 
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The present study relies heavily on parent-
report of aggression, which may be subject 
to biases. Child aggressive behaviour 
reported by the parent may be influenced 
by a biased perception affected by child’s 
negative reputation. It would be interesting 
to examine aggression from the child’s and 
teacher’s perspectives as they may have a  
very different perception of the behaviour. 
 
Implications 
Findings from the present study replicated 
and extended previous literature that is 
relatively sparse in demonstrating the 
effects of CBT treatments in reducing 
aggressive behaviour and improving par-
ent-child relationships with Asian children 
clinically referred for disruptive behaviour 
disorders. Without well-controlled research 
and evaluation studies in an Asian context, 
researchers in Asia could be putting the 
children’s mental health field at risk. 
Hence, it is hoped that findings from the 
present study serve as an impetus for future 
research efforts examining the effects of 
problem-solving based treatments among 
children with disruptive behaviour disor-
ders in Singapore and other parts of Asia. 
This way, services and treatment pro-
grammes that are culturally appropriate can 
be developed to serve these at-risk children 
more effectively. 
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Abstract 
Background: Up to date, there are handful questionnaires that have been validated in Bahasa 
Malaysia (BM). This study aimed to translate the Depression Anxiety Stress Scales 21-item 
(DASS-21) and measure its psychometric properties. Objectives: To determine the construct 
validity and acceptability of the DASS, BM. Methods: Two forward and backward transla-
tions were done in BM in accordance to guideline, and its validation was determined by using 
confirmatory factor analysis. A total of 263 subjects were selected by systematic random 
sampling to represent Malaysian population for reliability and validity purposes. Results: The 
BM DASS-21 had very good Cronbach’s alpha values of .84, .74 and .79, respectively, for 
depression, anxiety and stress. In addition, it had good factor loading values for most items 
(.39 to .73). Correlations among scales were between .54 and .68. Conclusions: BM DASS-21 
is correctly and adequately translated to Bahasa Malaysia with high psychometric properties. 
Further studies are required to support these findings.  
 
Key words: depression, anxiety, stress, reliability, validity, Bahasa Malaysia.  
 
 
 
Introduction 
The Depression Anxiety Stress Scales 
(DASS) have been translated and in various 
languages and validated in different popu-
lations. The original version of DASS is 
42-item. DASS 21-item is a modified and 
shorter version [1]. In this study, the au-
thors focused on the effort of translating the 
DASS-21 into Bahasa Malaysia (BM) and 
eventually validated this version. The 
scoring of 21-item requires the users to 
time 2 of total score 21-item to suit the 
original 42-item. It is not a diagnostic 
questionnaire but rather as a severity meas-
urement (dimensional rather than a cate-
gorical) [2]. DASS is suitable to be used in 
any clinical or non-clinical settings [3]. The 
questionnaire is easy and simple to admin-
ister to general population without any 
special training is needed. Unlike certain 
psychometric tests, by only using this 
questionnaire, researchers would be able to 
gauge levels of depression, anxiety and 
stress at the same time. Almost all 21 items 
in this questionnaire are relatively cultural 
free as none of its item mentioned any 
aspects on certain culture or religion. The 
effort of translation and validation of 
Bahasa Malaysia version were focused on 
DASS-21 before further development of 
BM DASS-42. Furthermore, DASS-21 is 
less been studied across the globe. 
 
This study aimed to translate and validate 
the 21-item of DASS and to produce a well 
adapted BM version of 21-item DASS for 
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Malaysian population. 
 
Methods 
Study design  
This is a randomized multi-center cross 
sectional study. The process of translation, 
pre-test and validation of this project is 
summarized in figure 1. 
 
A special permission from the original 
author of DASS (Peter Lovinbond) was 
also acquired before the commencement of 
this study. Informed consent was obtained 
from the participants after the nature of the 
procedure was fully explained. 
 
Translation process of the DASS 
Translation process was according guide-
line stipulated in US Census Bureau Guide-
line where 2 forward and 2 back transla-
tions were done in parallel by 2 medical 
and 2 language experts. This method was 
done to ensure the translated version would 
be grammatically sounded and the terms 
used were correct. At the same time, mean-
ings and contents of original DASS were 
well preserved. 
 
After the reconcilement of the two forward 
and back translations, sentence revision 
was done by all experts involved in the 
translation in meetings. Good translations 
were reflected by production of two Eng-
lish back translations which almost similar 
to original English version. At the end of 
this process, we produced a harmonized 
version of BM DASS-21 (BM-H).  
 
Harmonized BM version was tested in a 
small group of people before authors em-
barked on real major validation study. Pre-
test was done on eight respondents with an 
objective to identify any flaws in harmo-
nized version, which might affect the 
comprehension of the subjects. At the end 
of pre-test, we produced finalized BM 
version on DASS-21 (BM-DASS). 
 
Validation study 
The finalized BM version (BM-DASS) 
then was tested for its reliability and valid-
ity. Reliability in this study was determined 
by its internal consistency by looking at 
Cronbach’s alpha values. Confirmatory 
factor analysis was used to ensure the 
validity of this BM-DASS by having ac-
ceptable factor loadings (>.4). 
 
Selection of clinics and respondents 
Study population of this study was a gen-
eral population with age range between 14 
to 55 years. The subjects were selected 
from 3 government clinics in Klang Valley 
area. A special permission was obtained 
from regional Ministry of Health authority. 
The selection of the clinics was done based 
on a few considerations. First, the attendees 
or patients that utilize these clinics should 
represent the composition of Malaysian 
population. Which means the location of 
clinic should not be in the areas that were 
highly dense with certain ethnic groups. It 
should not be at private clinics where 
certain economic class would affordable to 
acquire the treatment. At the same time, the 
convenience would also play an important 
factor. Participants were given information 
and consent forms prior to the study. Het-
erogeneous participants were taken care of 
in the aspects of age, gender, race and 
socio-economic class.  
 
Selection of the subjects was also done at 
randomization where every third patients 
registered at the counter were chosen. A 
total of 263 subjects with various age 
groups and ethnicity were enrolled in this 
study. Composition of ethnic groups was 
tried to reflect the actual Malaysian popula-
tion. Based on Malaysian Statistic Depart-
ment (2005) where 54.1% were Malays, 
25% were Chinese, 7.5% were Indians and 
13.2% from other races [4]. 
 
Questionnaires 
1. Demographic questionnaire: age, gen-
der, ethnicity and level of education. 
2) Finalized BM DASS-21Version. 
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Figure 1: Overview of the whole process of cross-cultural adaptation and the validation of the 
DASS 
 
.
The questionnaire was self-administered 
for the participants to answer. It took the 
maximum of 10-15 minutes for completion.  
 
BM language fluency test. 
In this study author created a simple BM 
language fluency test that can be adminis-
tered on the spot, less time consuming and 
easy to assess. It involved building up a 
short sentence based on 3 words. This test 
required good grammar and wide knowl-
edge of BM vocabulary in order to create a 
good sentence. 
 
Steps taken to ensure the accuracy of 
responses 
During the course of BM DASS question-
naire administration, the subjects should be 
left without any interference especially 
from facilitators of the project.  If subjects 
raise any queries about the terminology, 
they should be explained as minimal as 
possible to maintain the objective of this 
study and it should be recorded. In actual 
process, author recorded only 8 subjects 
(3% of the total subjects) needed guidance 
 
Translation into Bahasa by 
medical expert BM1 
Translation 
Phase 
Back translation into English 
by medical expert (E1) 
Back translation into English 
by language expert E2 
Translation into Bahasa by 
language expert BM2 
Original English DASS (Eo) 
Harmonized BM version 
BM-H 
Finalized BM version of 
DASS BM-DASS 
Pilot Study on BM-H 
Subjects do not fulfilled 
inclusion criteria 
Analysis 
Enrollment and 
administration of BM-DASS 
Subjects fulfilled inclusion 
criteria 
Reliability 
& 
Validation 
Process 
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in answering a few items. 
 
Inclusion and exclusion criteria 
1) Inclusion criteria: 
 a) The age of the subjects was between 
14 to 55 years. 
 b) They must be proficient in BM. 
2) Exclusion criteria: 
 a) Subjects with any forms of cognitive 
impairments such as dementia and mental 
retardation would be excluded. 
 b) Those were not able to give informed 
consent 
 c) Subjects who were illiterate and had 
problem to understand BM and failed a 
short BM fluency test.  
 
Results 
Reliabilities of Bahasa Malaysia version 
DASS-21.  
The reliabilities (internal consistencies) of 
BM DASS-21 were determined by looking 
at Cronbach’s alpha values. Cronbach’s 
alpha value for overall items was very good 
.904 (CI 95%). For depression, anxiety and 
stress scales the values were .84, .74 and 
.79 respectively. 
 
Table 1 shows Malays and females were 
dominant in the aspects of ethnicity and 
gender. Chinese was underrepresented in 
this study as compared to actual population 
based on Malaysian Statistics Department 
Census (2005). 
Validity test 
The construct validity was evaluated by 
using confirmatory factor analysis. Factor 
loadings of 0.4 or more were considered 
good.  
 
Tables 2 shows factor loadings for confir-
matory factor analysis (CFA) of each item 
in BM DASS-21. From this table, it proved 
that BM DASS-21 managed to delineate its 
items into 3 main categories (depression, 
anxiety and stress). Three items had factor 
loadings less than .30. Among all items, 
item 18 was the poorest factor loading 
value (.20). This item “mudah tersentuh” (I 
felt that I was rather touchy) did not cross 
culturally sensitive to gauge stress level but 
rather had high factor loading for anxiety 
(0.65). 
 
Items 7 and 12 had moderate factor load-
ings; .29 for anxiety and stress scale re-
spectively. In comparison between depres-
sive, anxiety and stress scales, depressive 
items were generally had good factor 
loadings (.51 to .73) as compared to other 
scales. 
 
Correlations between scales were in the 
range of .54 and .68. There were high 
correlations between stress items with both 
depression and anxiety scales (.65 and .68 
respectively).  
 
 
Table 1: Socio-demographic data 
 
 Number % Total 
Age 
18-29 
30-39 
40-55 
 
97 
115 
51 
 
36.9 
43.7 
19.4 
 
 
 
263 
Race 
Malays 
Chinese 
Indians 
Others 
 
204 
30 
27 
2 
 
77.6 
11.4 
10.3 
0.8 
 
 
 
 
263 
Gender 
Male 
Female 
 
100 
163 
 
38.0 
62.0 
 
 
263 
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Table 2: Item-total statistics 
 
Item Scale Mean if Item 
Deleted 
Scale Variance if 
Item Deleted 
Corrected Item-
Total Correlation 
Cronbach's Alpha 
if Item Deleted 
Q1-S 15.41 75.53 .58 .894 
Q2-A 15.53 77.62 .33 .902 
Q3-D 15.87 76.61 .52 .896 
Q4-A 16.14 77.75 .45 .897 
Q5-D 15.38 74.92 .56 .895 
Q6-S 15.57 76.67 .46 .898 
Q7-A 15.83 77.18 .39 .899 
Q8-S 15.20 74.93 .53 .896 
Q9-A 15.37 75.20 .48 .897 
Q10-D 16.03 76.48 .53 .896 
Q11-S 15.62 73.30 .71 .891 
Q12-S 15.62 74.38 .67 .892 
Q13-D 15.63 74.39 .63 .893 
Q14-S 15.45 75.98 .49 .897 
Q15-A 15.83 75.20 .66 .893 
Q16-D 15.82 76.14 .53 .896 
Q17-D 16.19 76.42 .60 .894 
Q18-S 15.21 76.13 .43 .899 
Q19-A 15.78 76.11 .49 .897 
Q20-A 16.00 77.26 .50 .897 
Q21-D 16.35 79.24 .50 .897 
 
 
Discussion 
Despite randomization in the selection of 
the subjects, this study had limitation in the 
aspect of study population. Its study popu-
lation did not reflect the actual Malaysian 
population. Chinese were under represented 
as only 10% contributed to total population 
as compared to 25% according to Malay-
sian Statistic Department [4]. 
 
There are a few explanations to these 
outcomes. Firstly, the utilizing of govern-
ment or public clinics is normally among 
Malays and Indians, Chinese generally are 
at a higher economic status and prefer to go 
to private clinics as they can afford the 
service costs. Secondly, we noticed that 
there were a large number of Chinese 
subjects selected during the randomization 
refused to participate or had language 
barriers. However, we did not have the 
exact percentage of the refusals.  
 
Internal consistencies found in this study 
(.84, .74 and .79) were slightly low as 
compared to other studies; .92, .84 and .91 
for DASS-21 Spanish version, .88, .82 and 
.90 for English DASS-21 in UK population 
and .81, .73 and .81 obtained by original 
author [5-7]. Retrograde analysis of three 
items (items 7, 12 and 18), which had 
poor factor loadings, revealed that these 
items were commented in pre-test as easy 
to comprehend but less specific to measure 
as purposed. Such as item 18 “mudah 
tersentuh” (I felt that I was rather 
touchy) was rather described the personal-
ity of an individual rather than psychologi-
cal reaction toward unpleasant experience.  
 
Correlations (inter-correlated) between 
scales obtained in this study (.54-.68) were 
slightly lower as compared to figures ob- 
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Table 3: Factor loadings based on confirmatory factor analysis for each item in BM DASS-
21. 
 
Subscale Item summary 
Depression Anxiety Stress 
D3 perasaan positif (positive feeling) .67   
D5 mendapatkan semangat (work up initiative) .73   
D10 tiada diharapkan (nothing to look forward) .56   
D13 sedih dan murung (down-hearted and blue) .51   
D16 tidak bersemangat (unable to become enthusiastic) .75   
D17 tidak berharga  (wasn't worth) .62   
D21 tidak bermakna (meaningless) .57   
A2 mulut kering (dryness of mouth)  .65  
A4 kesukaran bernafas (breathing difficulty)  .55  
A7 menggeletar (trembling)  .29 .52 
A9 panik dan membodohkan (panic and make fool)  .52  
A15 menjadi panik (close to panic)  .39  
A19 Tindakbalas jantung (action of heart)  .52  
A20 takut  (scared)  .62  
S1 sukar ditenteramkan (hard to wind down)   .64 
S6 bertindak keterlaluan (over-react)   .72 
S8 tenaga cemas (nervous energy)   .58 
S11 semakin gelisah (getting agitated)   .42 
S12 sukar untuk relaks (difficult to relax) .53  .29 
S14 tidak dapat sabar (intolerant)   .56 
S18 mudah tersentuh (touchy)  .65 .20 
 
 
 
Figure 2: Correlation between the scales 
Stress 
Depression Anxiety 
.54 
.65 .68 
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Table 4: Statistical summary for each scale 
in BM DASS-21. 
 
 Mean Median Standard  
deviation 
DASS- 21 
Depression 
Anxiety 
Stress 
Total score 
 
4.2 
5.0 
7.4 
16.5 
 
3.0 
5.0 
7.0 
15.0 
 
3.4 
3.3 
3.7 
9.1 
 
 
tained in a study done by Crawford [3] 
where values of .74 to .77 were recorded 
and comparable with study done by origi-
nal authors (.54) [7]. It was also docu-
mented that there were moderate inter-
correlations (.5-.7) between the scales [1]. 
The correlations found in this study support 
the idea that 3 scales in DASS are inter-
correlated, but we are not sure their actual 
relationships. These correlations can be 
causal in nature, such as genetic and other 
predisposing factors, or overlapping symp-
toms [7].  
 
A comparison with clinical diagnosis 
would be interesting to be explored further 
since DASS anxiety scale is corresponded 
to various anxiety disorders in Diagnostic 
and Statistical Manual of Mental Disorders 
(DSM IV), the DASS stress scale corre-
sponds closely to symptom criteria for 
GAD and the DASS depression scale 
corresponds closely to the mood disorders 
[1]. Theoretically, the stress symptoms are 
even overlapping between these entities [8]. 
Result of this study supports the tripartite 
model proposed by Clark and Watson. This 
is also inclining with original DASS theory 
where autonomic arousal is referring to 
anxiety where as hopeless and anhedonia 
are for depression. In this study, items such 
as “unable to become enthusiastic” (tidak 
bersemangat) and “wasn't worth” (tidak 
berharga) contributed high factor loadings 
for depression. There was also the presence 
of third dimension in the items, which was 
distinct from depression and anxiety. This 
was referring to stress subscale. Stress 
items would have loaded modestly on both 
for anxiety and depression factors, rather 
than forming a separate factor as they in 
fact do [7]. Factor analysis of this study 
supports this idea.  
In developing a new instrument for Asian 
population, there is a high tendency that 
people express their psychological disabili-
ties through somatic complaints as com-
pared to western populations [9]. Promi-
nent somatic complaints were not only 
noticed for depressive symptoms but also 
for stress and anxiety [10]. Author feels 
that any instrument intends to be used in 
Asian population should be culturally 
adapted and emphasized on somatic symp-
toms rather psychological in nature. These 
include body weakness and lethargic for 
depression which were not tested in this 
study. Breathing difficulty, dryness of 
mouth and action of heart items loaded 
quite good values in confirmatory factor 
analysis for anxiety in this study. These 
items are in autonomic arousal subscale of 
anxiety.  
 
The present study is providing a prelimi-
nary milestone to the future development of 
BM DASS-21 version where some changes 
may be needful to achieve better results. 
Future research work is needed to look at 
other aspects for instance establishment of 
criterion validity BM DASS-21 where we 
can compare DASS scores with clinical 
diagnosis or with questionnaires that have 
been validated in Malaysian population 
such as Hospital Anxiety and Depression 
Scale. Other aspect is to look at psychomet-
ric properties among clinical samples and 
development of BM DASS-42. So far, we 
can say that BM DASS-21 is applicable for 
non-clinical population in Malaysia but not 
really for clinical samples. We would 
aspect it would be an equivalence or better 
result for clinical sample as proven in the 
previous studies [5,6]. 
 
This BM version may only applicable in 
west part of Malaysia and may not be for 
East Malaysia populations such as Kelan-
tan, Terengganu, Sabah and Sarawak states 
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where they have different dialects.  
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Abstract 
Objective: This study aimed to determine the prevalence of obesity among patients with 
schizophrenia and its association with the demographic profile. Methods: This is a cross 
sectional study. Subjects were selected using systematic sampling. Patients attending the out 
patient psychiatric clinic, Hospital Universiti Kebangsaan Malaysia, who fulfilled the criteria 
and able to give consent were included in this study. Diagnosis of schizophrenia was made 
using Structured Clinical Interview (SCID) for DSM-IV. Demographic profiles of the patients 
were obtained and anthropometric measurements were measured and classified according to 
Body Mass Index (BMI) and Waist Circumference (WC) of Asian population. Results: A total 
of 97 patients were included. The prevalence of overweight (BMI: 23.0- 27.4 kg/m
2
)
 
was 
39.2% (n=38), and the prevalence of obesity (BMI: >27.0 kg/m
2
) was 35.1% (n=34). BMI 
was higher among non-Chinese (Malay and Indian, p=.03) and those who had low total 
household income (p=.03). Sixty-two patients (63.9%) had high WC, which was associated 
with male (p=.003) and non-Chinese (p=.03). Conclusions: Obesity is highly prevalent among 
patients with schizophrenia. The risk factors for obesity include male, non-Chinese and those 
with low total income. The high WC among non-Chinese and male patients suggests that they 
are at a higher risk of developing obesity-related physical illnesses. These findings support 
that obesity is a common critical issue among schizophrenic patients, and it warrants serious 
clinical interventions. 
 
Key words: schizophrenia, obesity, body mass index, waist circumference 
 
 
Introduction  
There are increasing numbers of studies 
that documented high prevalence of obesity 
and metabolic abnormalities among psy-
chiatric populations compared to general 
population [1,2]. Sixty-three percent of 
schizophrenic patients had metabolic 
syndrome [3]. In a study on 29,000 Malay-
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sian adults (≥20 years of age), 20.7% was 
overweight, while 5.8% were obese [4]. In 
the United State, the prevalence of obesity 
among general population was 20% to 30% 
[5]. Unpublished data of one year outcome 
from the National Mental Health Registry 
showed that 4%, 5%, 6.2%, 12.4% and 
41.3% of 339 patients with schizophrenia 
gained weight for more than 20 kg, 15-20 
kg, 10-15 kg, 5-10 kg and 5 kg, respec-
tively [6]. Both men and women with 
schizophrenia had higher prevalence of 
obesity than their counterparts without 
schizophrenia [7,8]. 
 
The nature of schizophrenic illness (e.g., 
negative symptoms, social withdrawal, 
apathy, lack of motivation), as well as the 
patients sedentary life style, further in-
crease their risks of obesity. Recent review 
suggests that approximately 40% to 80% of 
patients taking antipsychotic medications 
experience weight gain that exceed ideal 
body weight for 20% or greater [9]. Al-
though the introduction of newer antipsy-
chotic medications cause minimal side 
effects and improve cognitive function and 
improve quality of social functioning [10],
 
these drugs however cause significant 
weight gain, especially olanzapine and 
clozaril, compared to typical antipsychotic 
medications [11]. Patients with schizophre-
nia both with the first episodes and those 
chronically exposed to conventional medi-
cations have been found to have more than 
three times as much intra-abdominal fat as 
controls matched for age, gender and 
lifestyle [12]. Thus, the magnitude of 
weight gain among them is very high, and 
this would in turn increase morbidity and 
mortality due to diabetes, heart diseases, 
hypertension and other obesity-related 
diseases [13-16]
 
and finally would affect 
their quality of life. Prevention programs 
namely by regular routine monitoring of 
body weight, identifying risk factors and 
introducing wellness program in these 
patients are critical. The effective manage-
ment of obesity requires a strong motiva-
tion and commitment from patients. This is 
significantly lacking in patients with 
schizophrenia. The other important factor is 
that the central acting anti-obesity drugs 
may induce psychotic episodes. These 
critical issues need further extensive studies 
and interventions. Thus, this study aimed at 
examining the prevalence of obesity and its 
associated demographic factors among 
schizophrenic patients attending psychiatric 
clinic, Hospital Universiti Kebangsaan 
Malaysia (HUKM). 
 
Methods 
This study was conducted at Psychiatric 
Outpatient Clinic, Hospital Universiti 
Kebangsaan Malaysia (HUKM) between 
April 2006 and July 2006. HUKM is a 
teaching, tertiary government hospital, 
located in the capital city of Malaysia. It 
receives referral from government clinics, 
i.e., district, primary health, and private 
clinics. Approximately 13 to 14 patients of 
schizophrenia are seen everyday. 
 
The subjects were selected using systematic 
sampling. The diagnosis of schizophrenia 
were reviewed by researchers (a postgradu-
ate psychiatric trainee and a consultant 
psychiatrist) using Structured Clinical 
Interview for DSM-IV Axis Disorder 
(SCID) [17]. The kappa, measuring the 
inter-rater agreement for this study, was 
one. The anthropometric measurements 
were assessed by a single examiner and 
standardized according to Malaysian Prac-
tice Guideline in Management of Obesity 
using beam balance (Health 0 Meter Kilo-
pound Beam) and measurement tape. Body 
Mass Index (BMI) and Waist Circumfer-
ence (WC) were classified according to 
Malaysian Practice Guideline, proposed by 
WHO to be used for Asian population [18]. 
BMIs of 18.5- 22.9 kg/m
2 
, 23-27.4 kg/m
2
, 
27.5 kg/m
2
.are considered normal, over-
weight and obese, respectively. 
 
Waist Circumferences (WCs) of <80 cm 
and <90 cm are considered abnormal for 
female and male, respectively. 
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Inclusion criteria included patients who 
were able to give informed consent, aged 
between 18 to 60 years, had been on antip-
sychotic medications for at least one month 
and has sufficient command and under-
standing of either Malay or English and 
well literate. Diagnosis of schizophrenia 
was made on the SCID based on DSM IV 
diagnostic criteria. Exclusion criteria were 
patients who had mental subnormal or 
marked cognitive deficits, dementia, sub-
stance dependence, medical illness such as 
Cushing’s disease, polycystic ovarian 
syndrome (PCOS), hypothyroidism, severe 
edema and pregnancy. Those received other 
medications contributing significant weight 
changes, e.g., steroid, insulin, orlistat, 
sibutramine, duromine, estrogen, were 
excluded. In addition, patients with BMIs 
less than 18.5 kg/m
2
 were not included.  
 
Statistical analysis 
Comparisons were made using Student-t, 
chi-square tests (for normally distributed 
categorical data) and Mann Whitney U test 
(for not normally distributed data). ANO-
VA was used to compare multiple groups 
with normally distributed continuous data. 
Pearson and spearman correlations were 
used to measure degree of relationship 
between two continuous variables.  
 
Results 
Sociodemographic data 
A total of 97 patients, who met the selec-
tion criteria, were included in this study,  
 
 
Table 1: Socio-demographic characteristics of the respondents.  
 
 Characteristic Total sample 
n=97(%) 
Male  44 (45.4) Gender 
Female 53 (54.6) 
Malay 55 (56.7) 
Chinese 28 (28.9) 
Indian 14 (14.4) 
Ethnic group 
Others 0 (0.0) 
<30  43 (44.3) 
30 to 39  30 (30.9) 
40 to 49  21 (21.6) 
Age (years old); mean±SD=32.0±15.5 
>50 3 (3.1) 
Single 67 (69.1) 
Married 20 (20.6) 
Divorce 6 (6.2) 
Marital status 
Widow 4 (4.1) 
None 0 (0.0) 
Primary 0 (0.0) 
Secondary 58 (59.8) 
Level of education  
Tertiary 39 (40.2) 
Employed 52 (53.6) Occupational status 
Unemployed 45 (46.4) 
low income  
(<1,500) 
49 (50.5) 
middle income 
(1,500-3,500) 
30 (30.9) 
Monthly household income (RM); mean±SD=1,500±1,500 
high income 
(>3,500) 
18 (18.6) 
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consisting of forty four (45.4%) males and 
53 (54.6%) females. Fifty-five (56.7%) 
patients were Malays, 28 (28.95%) patients 
were Chinese and 14 (14.4%) patients were 
Indians. The characteristics of the respon-
dents are shown in Table 1. 
 
Prevalence 
The prevalence of overweight (BMI: 23.0- 
27.4 kg/m
2
)
 
was 39.2%, whilst obesity 
(BMI: >27.0 kg/m
2
) was 35.1% (Figure 1) 
and the prevalence of patient with high 
waist circumferences (WC: male > 90cm, 
female > 80cm) was 63.9%. 
 
The association between obesity and pa-
tients’ sociodemographic profile 
• Age 
Age of respondents had no association and 
relation with BMI (p=.28) and WC (p=.46). 
• Gender 
Mean WC of male respondents was 
93.98±13.16 cm, significantly higher than 
mean WC of female respondents 
86.78±10.22 cm (t=3.04, p=.003*). About 
48.6% (n=17) of male and 51.4% (n=18) of 
female had normal WC, whilst 43.5% 
(n=27) and 56.5% (n=35) of male and 
female respectively had high WC (p=.633). 
However, the difference in BMI between 
male and female respondents were not 
significant (t=0.24, p=.81).  
• Ethnic Groups 
There was significant difference in the 
mean BMI between different ethnic groups 
(ANOVA: F=3.58, p=.03*). Chinese re-
spondents (mean BMI =24.23±.09 kg/m
2
) 
had significantly lower BMI than Malays 
(27.14±.32 kg/m
2
) and Indians (27.06±.12 
kg/m
2
). 
 
Household income 
There was significant difference in mean 
total household income between patient 
who had normal weight (mean=RM 2,700 
±2,825) and obese (mean=1,300±1,025), 
(Z=2.78, p=.006). The total household 
income was found inversely correlated with 
WC of respondents (Spearman Correlation: 
rs=-.22, p=.03*) but not with BMI.  
Occupational status 
Of the total respondents, 52 (53.6%) re-
spondents were employed and 45 (46.4%) 
were unemployed. 71.4% (n=20) of Chi-
nese were employed while only 46.6% 
from non-Chinese respondents were em-
ployed. Employment rate among Chinese 
respondents were significantly higher than 
other ethnic groups (χ
2
=5.03, p=.02*) 
 
Occupational status of the patients had no 
association with the anthropometric meas-
urements. 
Educational level 
There was no difference in BMI and WC of 
respondents in relation to educational level.  
 
Discussion 
Our findings indicate that overweight 
(34.5%) and obesity (33.8%) are highly 
prevalent among patients with schizophre-
nia. About 63.0% of the patients had high 
WC. These findings are three times and 
two times higher than the prevalence of 
general population in Malaysia [20]
 
and 
global prevalence of obesity, respectively. 
 
Other findings also found that schizo-
phrenic patients are more obese than gen-
eral population. Several reasons were given 
to explain, such as the nature of the illness, 
which lead to sedentary life style, lack of 
exercise, diet preference of taking high fat 
and low fiber diet and the effects of the 
medications [21,22] 
 
To our knowledge, this is the first study in 
Malaysia examining the relationship be-
tween various anthropometric measure-
ments in relation to patients’ demographic 
profiles among schizophrenic patients, 
using the WHO classifications proposed for 
Asian populations (BMI and WC). 
 
Three important socio-demographic factors 
(i.e., gender, WC; ethnic group, BMI and 
total household income, WC) were found 
significantly associated with obesity. These 
similar findings have been found by others 
[23,24]. The higher waist circumference 
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among males schizophrenic patients com-
pared to female suggests that they are at the 
higher risk of developing obesity-related 
diseases. This is consistent with the find-
ings that diabetic, hypertension and heart 
problems are highly prevalent among 
American males [25]. 
 
The preponderance of high BMI among 
non-Chinese may be due to various rea-
sons. Culturally the composition of non-
Chinese food contents high calorie ingredi-
ents, i.e., the used of “coconut milk”, and 
ways of preparing the meal. Most Chinese 
food is steamed and boiled, while non-
Chinese one is often fried. Majority of the 
Chinese are working compared to non-
Chinese. However, there is no significant 
difference found between those who are 
employed and unemployed and obesity in 
this study, suggesting that their jobs are 
sedentary in nature. Low total income is 
associated with obesity, this could possibly 
be due to the lack of awareness on the 
importance of taking healthy balance diet, 
exercise, healthy life style and its relation-
ship with health, obesity and chronic physi-
cal illness [26,27]. This may also suggest 
that patients with low total income are 
more likely to take food with high saturated 
fat and calorie as generally this nourish-
ment is cheaper than food containing 
unsaturated fat and high calories [26,27]. 
 
BMI classification for Asian population 
proposed by WHO [18]
 
were used in this 
study, but not the BMI values recom-
mended for non-Asian. This is caused by 
the fact that Asian populations are at a 
higher risk of developing health problems 
at a lower BMI and have higher body 
percentage fat than non-Asian [29,30]. This 
risk would be even higher in schizophrenic 
patients, who are chronically on antipsy-
chotic medications. Antipsychotics particu-
larly atypical antipsychotics, e.g., olanzap-
ine, clozaril, are associated with a high risk 
of metabolic syndrome [31]. Certain demo-
graphic factors are significantly associated 
with WC but not BMI and vise-versa, i.e., 
gender is associated with high WC but not 
BMI. This is because BMI is related to 
percentage of body fat, irrespective of the 
site of fat deposition. Whilst WC is associ-
ated with central obesity, it is an estab-
lished indicator associated with metabolic 
diseases [3]. Since BMI is influenced by 
age, sex, composition of body muscle and 
population dependent, it is less accurate in 
predicting percentage of body fat as well as 
the risk of obesity-related diseases. Al-
though BMI is commonly and widely used 
to estimate the body fat, WC is the most 
accurate indicator among the five anthro-
pometric measurements [32,33]. WC 
should be measured especially in groups, 
who are at a higher risk of developing 
metabolic diseases, as in schizophrenic 
patients. Routine WC monitoring should be 
done on these patients.  
 
This is a cross sectional study, the assess-
ments were only done at one point in time. 
A prospective case control study should be 
carried out, including only new cases (for 
baseline data) and follow-up the patients to 
a certain period to examine the magnitude 
of weight gain. Prospective study would 
also help to ascertain the effects of duration 
of illness and antipsychotic medications on 
patients’ body weight. 
 
The subjects are hospital based. They are 
probably motivated patients and have better 
insight towards their illness, thus these 
findings may not reflect the community 
based population. 
 
In conclusions, the overweight, obesity and 
high waist circumference are highly preva-
lent among patients with schizophrenia. 
Male, non-Chinese patients and low in-
come are predictors of overweight and 
obesity. High waist circumference among 
schizophrenic patients particularly males 
and those from low income suggest that 
these patients are at a higher risk of devel-
oping obesity-related physical illnesses. 
Finally, these findings support that body 
weight is a common critical problem 
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among patients with schizophrenic, and it 
warrants serious interventions. Regular 
monitoring of patients anthropometric 
measurements, including, WC, medical and 
physical assessment, as well as metabolic 
markers, namely lipid and sugar profiles, 
should be done. Otherwise our objective in 
managing our schizophrenic patients that is 
not only to control their symptoms but also 
to ensure good quality of life would not be 
achieved. 
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Abstract  
Objective: To investigate the prevalence of genital arousal disorder and the potential risk 
factors that may impair genital arousal among women at a primary care setting in Malaysia. 
Methods: A validated questionnaire for sexual function was used to assess genital arousal 
function. A total of 230 married women aged 18–70 years old participated in this study. Their 
sociodemographic and marital profiles were compared between those who had genital arousal 
disorder and those who did not. The risk factors were examined. Results: The prevalence of 
genital arousal disorder in the primary care population was 50.4% (116/230). Women with 
genital arousal disorder were found to be significantly higher in groups of more than 45 years 
old (p<.001), among the non-Malay (p=.01), those with lower academic status (p=.025), those 
married for more than 14 years (p=.001), those married to older husbands (aged>55) (p 
=.001), those having 4 children or more (p=.028), those having less sexual intercourse (less 
than 1–2 times a week) (p=.001), and those at post-menopausal state (p=.002). There was no 
significant difference between these two groups in term of salary (p=.29), suffering from 
medical problems (p=.32), dysmenorrhea (p=.95), menarche (p=.5) and hormonal replace-
ment therapy (p=.6). Conclusion: Women with infrequent sexual intercourse are less likely to 
be sexually aroused (OR=0.29, 95% CI: 0.11-0.74).  
 
Key words: genital arousal disorder, potential risk factors, Malaysian women 
 
 
Introduction 
Meaningful sexual relationship is one of 
the gratifying experiences enjoyed by 
couples. This could be achieved when 
normal sexual response cycle takes place 
during sexual activity [1,2]. Genital arousal 
in contrast to subjective sexual arousal has 
been a part of the cycle in the traditional as 
well as the contemporary models of sexual 
response cycle [3,4]. Difficulties in genital 
arousal, which constitute of lack of vaginal 
lubrication (LVL) [4], may prohibit or-
gasm, cause sexual pain and dissatisfaction. 
Lack of vaginal lubrication is not rare 
among women and in fact, it is considered 
as one of the major sexual health problems 
[5], especially with increasing age due to 
menopause or physical illnesses [2]. Lack 
of vaginal lubrication has been indexed as 
one of 7 dichotomous response items in 
sexual dysfunctions [6,7]. Given the vari-
able correlation between genital vasocon-
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gestion and subjective sexual arousal in 
women with and without sexual dysfunc-
tion, there was a smaller subgroup of 
women who remain to able to be subjec-
tively become aroused from a variety of 
non-genital stimuli [3,4]. The women with 
LVL reported loss of sexual excitement 
from genital stimulation and acquired loss 
of any awareness of genital congestion. 
LVL is a form of female sexual dysfunction 
(FSD) [4], which may result from multiple 
factors including anatomical, physiological, 
medical, psychological, cultural and social 
components [1,8,9].  
 
The prevalence of LVL is estimated to be 
about 14% in western population [5]. Even 
though, this is lower than the prevalence of 
FSD in general, which ranges from 25% to 
63% [10,11], it is nevertheless still high. Its 
prevalence in Asian countries is not known. 
However, it is possibly as high as that in 
the western countries, given the fact that 
the prevalence of FSD as a whole is also 
high at 30% [12]. 
 
In Malaysia, the whole area of sexual 
dysfunctions in women especially LVL is 
still largely uninvestigated [13,14]. This is 
despite clear need for the area to be ex-
plored, especially in the context of quality 
of life. Sexual problems among spouses 
have been reported to be the second leading 
cause for divorce between Malay Muslim 
couples. ‘Wife not ready to have sexual 
intercourse’ has been quoted as one of the 
reasons. This may be associated with lack 
of vaginal lubrication leading to sexual 
dissatisfaction and sexual pain [13]. It is 
noted that there have been increasing 
demands for clinical service related to 
sexual problems among men and women 
[13-16]. It is felt that women in this country 
still feel embarrassed to disclose details of 
their sexuality and sexual life and do not 
usually discus them openly [13,14].  
While sexual problems among women have 
started to receive its due attention in the 
western countries, it is not the case in 
Malaysia [13,14]. To date, as far as our 
knowledge, there has been no study looking 
into the area in Malaysia [13]. It is the 
purpose of this study to explore this area in 
further detail. 
 
The objective of this research paper is to 
investigate the prevalence of genital sexual 
arousal disorder during sexual activity and 
the potential risk factors that may impair 
genital sexual arousal in Malaysian women.  
 
Methods 
This was a cross-sectional study on women 
attending a primary health clinic. It was 
conducted over a period of four months 
(March to June 2005) at one of the gov-
ernment primary health care clinics located 
in Bandar Tun Razak, a rather busy subur-
ban area of Kuala Lumpur. This study used 
a non-probability sampling (universal 
sampling) method.  
 
Inclusion criteria included: i) female sub-
ject; ii) aged between 18 and 70 years old; 
iii) married and have a sexually active 
partner; iv) ability to read and understand 
the study languages (Malay or English) and 
(v) consent for participation in the study. 
Exclusion criteria included: i) chronic and 
severe medical illness/illnesses; ii) psychi-
atric illness/illnesses; iii) pregnancy iv) 
postpartum period of 2 months or less.The 
instruments used in this study were: i) 
sociodemographic and marital profile form; 
ii) the Malay version of Female Sexual 
Function Index (MVFSFI) and iii). the 
Mini International Neuropsychiatric Inter-
view (M.I.N.I.). 
 
Sociodemographic and marital profile form 
is a brief questionnaire was devised to 
obtain respondents’ sociodemographic and 
marital information. It includes name, age, 
educational level, employment status, 
monthly family income, medical history, 
menstrual history, duration of marriage, age 
of husband, number of children and fre-
quency of sexual intercourse. Malay Ver-
sion of Female Sexual Function Index 
(MVFSFI) is a Malay translated version of 
the Female Sexual Function Index (FSFI) 
developed by Dr. Raymond Rosen. The 
original FSFI [17] is a 19-item, multidi-
mensional self-report measure of female 
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sexual functioning. It covers 6 basic do-
mains of female sexual functioning: desire, 
arousal, lubrication, orgasm, satisfaction, 
and pain. It is a validated questionnaire and 
has been shown to have discriminate reli-
ability between women with and without 
female sexual dysfunction (FSD) and lack 
of lubrication [17,18]. The domain scoring 
for lack of lubrication is 7, 8, 9 and 10 with 
a minimum score of 0 and a maximum 
score of 20. The validation of MVFSFI 
took place at the same time of this study 
with the permission from the original 
author and was done in multiple aspects 
including the face, content, concurrent 
(criterion – specificity and sensitivity) and 
discriminant validity [19]. The reliability 
test for agreement using Pearson product-
moment correlation coefficient (r) ranged 
from 0.767 to 0.973. The internal consis-
tency using Cronbach’s alpha ranged from 
0.87 to 0.97. The cut-off score for lubrica-
tion domain (genital sexual disorder) was 
established at < 10 for lack of lubrication 
(sensitivity 79% and specificity 87%). The 
lower the scores, the more likely the 
women would suffer from FSD [19]. A 
score of 10 and below on the domain of 
lubrication was taken as positive of having 
genital arousal disorder in this study. The 
Mini International Neuropsychiatric Inter-
view (M.I.N.I.) was used to exclude any 
respondents with psychiatric illnesses from 
this study. This is a brief structured inter-
view for major Axis I psychiatric disorders 
in DSM-IV and ICD-10. The inter-rater 
reliability for this study was ascertained by 
administering the instrument on 10 cases 
selected randomly. This was done by two 
of the authors and yielded a kappa value of 
1. 
 
Approval was obtained to conduct the 
study from the university ethical committee 
as well as from the administration authority 
of the particular clinic. All respondents 
who fulfilled the inclusion criteria were 
given an explanation about the study. A 
written consent was obtained from them. 
They were assured with regards to their 
anonymity and the confidentiality of the 
data obtained. A coding system was used to 
identify the respondents if it was necessary. 
The socio-demographic form and the 
MVFSFI [19] were given to each respon-
dent to be filled up in a room with some 
privacy. After the MVFSFI was completed, 
each respondent was engaged in a clinical 
interview for diagnosing sexual dysfunc-
tion based on the DSM-IV criteria [20] and 
administered the M.I.N.I for exclusion of 
the other psychiatric illnesses. Those who 
were found to have sexual dysfunction 
were referred to a sexologist for further 
management. 
 
Analysis of the data was done using SPSS 
12.0.1 for Windows (SPSS Inc., 2003, 
Chicago). The relationship between the 
studies parameters were analyzed using 
appropriate statistical tests. Chi-square tests 
(χ² tests) were used to determine risk fac-
tors for FSD among categorical variables. 
Regression analysis using Multiple Logistic 
Regression (MLR) with 95% confidence 
interval (95% CI) was used to assess pa-
rameters that were actually considered as 
predictors of FSD.  
 
Results 
Two hundred and forty eight patients who 
attended the Bandar Tun Razak primary 
care clinic, Cheras, Kuala Lumpur were 
invited to participate in the study. How-
ever, 18 patients were unable to complete 
the study because of multiple reasons, such 
as unable to make time (4 patients), did not 
feel comfortable with the questions (7 
patients) and did not bring their reading 
glasses to the clinic (5 patients). The re-
sponse rate was 93% with total subjects of 
230. By the use of MINI, two patients were 
excluded due to the positive screening and 
diagnosis of anxiety disorder and major 
depressive disorder.  
 
The socio-demographic and marital charac-
teristics of the respondents are shown in 
Table 1.  
 
The studied urban women population was 
relatively of younger ages [mean of 39.2 
years, SD=10.5], slightly younger than 
their spouses (mean of 42.7 years, SD= 
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11.3). They had a relatively high level of 
educational background (almost all had 
received at least primary level of education 
and still a majority had received at least 
secondary education). The Malays pre-
dominated other races (76.1 %) as com-
pared with Chinese (13.9%) and Indians 
(8.7%). This was, however, quite represen-
tative as the whole population of the area. 
Most of them come from the lower middle 
socioeconomic status, judging from their 
income levels. This was explained by the 
fact the richer ones would expectedly visit 
the private practitioners who would offer 
more flexible visiting times.  
 
The mean duration of marriage among 
these women was 15.5 (SD=11.3) years. 
More than half of them (66.7%) were from 
the pre-menopausal group. Majority of 
them (43.5%) had between 2 to 5 children, 
40% had less than 2 and 16% had more 
than 5 children. Only 10% of the women 
had sexual intercourse of less than one 
time/month; 32.2% of them had it 1-2 
times/month; a majority of them (44.3%) 
had it 1–2 times/week; and 13.5% had it 
more than 2 times/month. 
 
Out of 230 respondents interviewed, 116 of 
them scored < 10 on genital arousal (lack 
of lubrication, LVL) domain of MVFSFI. 
The prevalence of women with genital 
arousal disorder (LVL) was 50.4% 
(116/230).  
 
The risk factors associated with women 
suffering from genital arousal disorder are 
shown in table 2.  
 
Genital arousal disorder was found to be 
significantly more common among women 
who were over 45 years old (χ²=12.3.0, p 
<.001), the non-Malays (χ²=6.5, p=.01), 
those with lower academic status (χ²=5.04, 
p=.025), those who were married for more 
than 14 years (χ²=11.0, p=.001), those who 
married to an older husband (aged > 55) 
(χ²=11.9, p=.001), those having 4 children 
or more (χ²=4.52, p=.028), those having 
less frequent sexual intercourse (less than  
 
 
Table 1: Sociodemographic and marital 
characteristics of the 230 respondents 
 
Variable Charac-
teristics 
n (%) 
Age (year) < 30 50 (21.7) 
(mean±SD= 30-39 82 (35.7) 
39.2±10.5) 40-49 56 (24.3) 
 ≥ 50 42 (18.3) 
Race Malay 175 (76.1) 
 Chinese 32 (13.9) 
 Indian 20 (  8.7) 
 Others 3 (  1.3) 
Education 
level 
None 2 (  0.9) 
 Primary 53 (23.0) 
 Secondary 142 (61.7) 
 Tertiary 33 (14.3) 
<1000 30 (13.0) Family income 
(RM/month) 
(mean±SD= 
2,165±1,552) 
1000-1999 92 (40.0) 
 2000-2999 67 (29.1) 
 ≥3000 41 (17.8) 
<Once a 
month 
23 (10.0) Frequency of 
sexual inter-
course 
(times/week) 
(mean±SD= 
2.6±0.89) 
1-2 times a 
month 
74 (32.2) 
 1-2 times a 
week 
102 (44.3) 
 3-4 times a 
week 
26 (11.3) 
 >4 times a 
week 
5 (  2.2) 
Menopause Yes 33 (14.3) 
 No 197 (85.7) 
<2 92 (40.0) Number of 
children 
(mean±SD= 
3±2) 
2-5 100 (43.5) 
 >5 38 (16.5) 
<30 38 (16.5) Husband's age 
(year) (mean± 
SD=42.7±11.3 
30-39 62 (27.0) 
 40-49 63 (27.4) 
 ≥50 67 (29.1) 
<14 124 (53.9) Duration of 
marriage 
(year)  
(mean±SD= 
15.5±1.3) 
≥14 106 (46.1) 
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Table 2: Risk factors associated with women with genital arousal disorder 
 
Variables Potential risk factors 
Normal (n = 114) Genital arousal disorder 
(LVL) (n= 116) 
χ²; p-value 
Age    
   ≤45 years old 92 (57.1%) 69 (42.9%) 12.3; <.001 
   >45 years old 22 (31.9%) 47 (68.1%)  
Race    
   Malays 95 (54.3%) 80 (45.7%) 6.5; .01 
   Non Malays 19 (34.5%) 36 (65.5%)  
Salary (RM)    
   <1,875 59 (51.3%) 56 (48.7%) 0.29; .60 
   ≥1,875 55 (47.8%) 60 (52.2%)  
Duration of marriage     
   Married <14 years 74 (59.7%) 50 (40.3%) 11.0; .001 
   Married ≥14 years 40 (37.7%) 66 (62.3%)  
Academic status     
   Higher academic 94 (53.7%) 81 (46.3%) 5.04; .025 
   Lower academic 20 (36.4%) 35 (63.6%)  
Husband’s age     
   Age ≤42 years old 74 (60.2%) 49 (39.8%) 11.9; .001 
   Age >42 years or more 40 (37.4%) 67 (62.6%)  
Number of children     
   ≤3 children 78 (55.3%) 63 (44.7%) 4.25; .028 
   >3 children 36 (40.4%) 53 (59.6%)  
Sexual intercourse    
<3 per month 90 (45.2%) 109 (54.4%) 11.12; .001 
≥3 per mo nth 24 (77.4%) 7 (22.6%)  
Medical problem    
   Yes 15 (41.7%) 21 (58.3%) 1.00 ; .32 
   No 98 (50.8%) 95 (49.2%)  
Dysmenorrhea     
   Yes 32 (49.2%) 33 (50.8%) 0.04; .95 
   No 82 (49.7%) 83 (50.3%)  
Menarchy    
   Yes 81 (48.2%) 87 (51.8%) 0.46; .50 
   No 33 (53.2%) 29 (46.8%)  
Menopause    
   Yes 8 (24.2%) 25 (75.8%) 9.9; .002 
   No 106 (53.8%) 91 (46.2%)  
Hormonal replacement therapy    
   Yes 1 (33.3%) 2 (66.7%) 3.12; .6 
   No 112 (49.6%) 114 (50.4%)  
 
 
 
1-2 times a week) (χ²=11.12, p=0.001), and 
those at post-menopausal state (χ²=9.9, 
p=.002). There was no significant differ-
ence between these two groups in terms of 
salary (χ²=1.12, p=.29), presence of medi-
cal problem/s (χ²=1.0, p =.32), dysmenor-
rhea (χ²=0.04, p=.95), age of menarche 
(χ²=0.46, p=.5) and hormonal replacement 
therapy (χ²=3.12, p=.6). 
 
From Multiple Logistic Regression (MLR) 
analysis, only frequency of sexual inter-
course was found to be significantly predic-
tive of genital arousal disorder among these 
woman (p=.029). From the above model, 
frequency of sexual intercourse has the 
highest influence on lubrication (Wald 
=4.48). Lower frequencies of intercourse 
significantly reduce lubrication level, 
(OR=0.35, 95% CI: 0.13-0.90). 
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Discussion 
The terminology of female genital sexual 
disorder is relatively very new in local 
Malaysian population and appear briefly 
only in the clinical context recently [13], 
even in the Western society [3,4]. Sexual 
excitement – both subjective and physio-
logical can precede sexual desire [4,21]. 
Issues related to genital arousal disorder are 
traditionally considered to be too private to 
be disclosed and could only be shared with 
certain people like parents or traditional 
healers or confined between spouses in the 
bedroom: therefore neglected and remain 
untreated [13,14,22]. To complicate the 
matter, in the past, many researchers cre-
ated their own definitions for sexual disor-
ders, which inevitably led to confusing and 
incongruent results. An attempt to address 
this issue globally was made through a 
panel of experts at the Consensus Devel-
opment Conference on FSD in 1998 [23]. 
With the introduction of academic sexology 
linked to medicine, discussion on female 
sexual disorder would become more ac-
ceptable in Malaysian society [14]. 
 
Research in the area of female sexual 
dysfunction are scanty and at infantile stage 
in Malaysia – and it is hoped that this piece 
of research work would enlighten academi-
cians, politicians and health care policy 
makers in future planning for sex education 
and providing sex counseling to couples 
and women with sexual disorder. However, 
research in sexual difficulties was not given 
adequate attention compared to the male 
sexual function, as there was no apparent 
“cure” or current revolutionary pharmaco-
therapy in women than compare to male – 
and partly because sexual function in 
women are more complex and does not 
follow the linear male sexual response 
cycle [12,21]. Whipple (2002) highlighted 
the difficulties in studying women sexual 
function, in which so many non-anatomic 
and non-physiological factors play a role 
[21]. Male sexual dysfunction can be more 
objectively define and diagnosed, and 
interventions can be more objectively 
ranked regarding efficacy comparing to 
female sexual difficulties [24]. Further-
more, sexual activity frequency, a measure 
used for male sexual function, cannot be 
used as an accurate marker of female 
sexual function because women may still 
be able to remain sexually active with 
partner while experiencing sexual difficul-
ties [25]. Female sexual function may also 
be more dynamic than a male sexual dys-
function. Although there are significant 
anatomic and embryologic parallels be-
tween men and women, the complex nature 
of female sexual dysfunction is clearly 
distinct from that of the male. 
 
This research is an attempt to look on the 
gravity of genital sexual arousal disorder in 
women attending a primary care setting. 
The studied urban Malaysian population 
has relatively younger age with high level 
of educational background. They came 
from the lower middle socioeconomic 
group based on their monthly family in-
come with a majority of them having been 
married for more than 10 years. Nearly half 
of them are very active sexually, with 
frequency of sexual intercourse 1–2 times/ 
week and more than half are from pre-
menopausal group.  
 
The prevalence of females with genital 
sexual arousal disorder was 50.4%. This 
figure is about 3 more times more common 
than the Western population [5]. This is 
also higher than that in another study [26]. 
This international survey [26] on 407 
subjects found 19% of women and 11% of 
men reporting of not considering sex pleas-
urable. Of the women interviewed, 23% 
reported inadequate lubrication, with a 
significant increase of this complaint in 
women aged 50-65 years.  
 
This high prevalence of women reporting 
genital arousal disorder may be explained 
by the fact that they were assessed privately 
using a rather simple questionnaire in a 
medical setting where anonymity was 
assured. In addition, helps could be offered 
if they needed it. This finding shows that 
despite the societal, cultural, and religious 
norms, the chance of Malaysian women to 
disclose their sexual discontentment is 
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high, given the right situation and the right 
way. The high prevalence of sexual diffi-
culties only reported after a systematic 
assessment (rather than spontaneous reports 
to their doctors) also confirmed the finding 
of another study on female sexual difficul-
ties in Asia, which found that nearly half of 
them did not seek treatment for the prob-
lems [12]. 
 
Increasing age as a factor to be associated 
with genital arousal disorder in this study is 
not surprising and has been found in other 
studies [26]. It is rather expected that 
sexual difficulties would be less reported 
among the Malay women, who are syn-
onymously Muslims. The Malays are 
traditionally more inhibited when it comes 
to sex, as well as, Islam prohibits sexual 
disclosure except only for treatment pur-
poses [13]. However, we are not sure 
specifically, why genital sexual arousal 
disorder affects more on the non-Malays 
(mainly Chinese and Indians). This finding 
needs further replication using a larger 
sample size. The non-Malays included in 
this study had to be able to speak the study 
languages (English and Malay). This ability 
reflects higher education levels and being 
more liberated, which may explain the 
spontaneity of reporting sexual difficulties. 
 
We found that the potential risk factors that 
may impair genital sexual arousal in Ma-
laysian women are old age, non-Malay, a 
lower academic status, married longer and 
older husband, having more children and 
having less sexual intercourse (less than 1–
2 times a week). There were no significant 
findings in term of having any medical 
problems, but women at postmenopausal 
age were at risk. We have significantly 
more non-Malays reporting the lack of 
lubrication, probably due to cultural belief 
on sexual issues, despite of more Malays 
were recruited in this study. Having less 
sexual intercourse could be due to the 
complications of genital sexual arousal 
disorder as we could not determine the 
cause and effect in this study. The longer 
period of marriage would provide more 
chances of reporting sexual dysfunction. 
Women with genital sexual arousal disor-
der tend to have more children – probably 
the psychobiological aspect of parity has a 
significant effect on their sexual function-
ing, either due to hormonal changes, in-
crease responsibility to take care of the 
family and due to lack of privacy for sexual 
encounters. The lower educational status 
would reflect their ignorance of sexual 
rights. Interestingly, in our study, salary 
income, medical problem or dysmenorrhea 
was not found to be associated with genital 
arousal disorder. However, serious medical 
and psychiatric disorders that could obvi-
ously impair sexual functioning had been 
excluded from the study [27-29]. 
 
Sexual desire and vaginal lubrication of a 
woman may be affected by hormonal 
changes that occur as a result of normal 
female physiology, such as menstrual 
cycle, postpartum states, lactation and 
menopause – or due to fatigue and decrease 
well-being [28] – or  psychological and 
intimate relationship [1].  
 
There are a few limitations of this research. 
First, relationship issues, e.g., marital 
satisfaction between couple, were not 
investigated in this study. Genital arousal 
disorder during sexual activity could actu-
ally be reflective of lack of intimacy and 
eroticism between couples [1]. Second, we 
did not look into the sexual functioning of 
the male spouses. Sexual difficulties in 
women may be associated with sexual 
dysfunction among their spouses, espe-
cially, erectile dysfunction [30]. However, 
we found that women with genital arousal 
disorder tend to have older husbands with 
possible medical problems. It is known that 
that medical problems among older men 
[12] could affect their sexual performance, 
and this may have indirectly contributed 
the women’s sexual dysfunction [2,4]. 
 
In term of respondents, this study included 
only the married women with sexually 
functioning partners. Those who were not 
married (single, divorce or widow) were 
excluded from this study because most 
Malaysians were unable to accept the 
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extramarital sexual relationship. However, 
there were many unmarried women sexu-
ally were active [Sirat HH personal com-
munication, February 10, 2005]. Those 
who were not married but sexually active 
were approached during the pilot stage but 
they were reluctant to participate due to 
religious and cultural reasons. 
 
Another limitation is the language barrier 
that caused a significant number of the 
Chinese and Indians to be excluded from 
the study. With this limitation, the author 
would recommend the development of 
validated Female Sexual Function Index 
Questionnaire in various languages such as 
in Mandarin or Tamil in the future. 
 
This research has an important impact to 
our current understanding of the magnitude 
of female sexual dysfunction in our pri-
mary care population. It indicates the need 
for treatment and services for sexual dys-
function in the clinical settings, which are 
tailored to the local needs of women popu-
lation. Psychological and intimacy based 
approaches for sexual difficulties in women 
are very crucial in sex therapy [1,2,4,13]. 
Aside from hormone replacement therapy, 
medical management of female sexual 
dysfunction remains in experimental phases 
[2,4,32]. Nevertheless, it is crucial to 
understand that not all female sexual com-
plaints are psychological, and that there are 
possible therapeutic options. 
 
With the improvements of medical atten-
tion, female sexual difficulties have been 
recognized as an important element as in 
their male counterpart in terms of diagnosis 
[33,34] and right for treatment in a more 
widely accepted, and understood diseases. 
The importance of addressing issues of 
sexual difficulties in women has emerged 
recently with more interest to do research 
in this area, including using a validated 
questionnaire [17,18] for health planning 
purpose and improvement of quality of life.  
 
The ideal approach to treat female sexual 
dysfunction, including genital sexual 
arousal disorder, is a collaborative effort 
between psychiatrists and physicians. 
These include a complete medical and 
psychosocial evaluation [1-4], as well as 
inclusion of the partner or spouse in the 
evaluation and treatment process [35].  
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Abstract 
Objective: This study aims to assess benzodiazepine overuse, in particular indications, pro-
longed use, and dependence for usage in out-patients treated at the internal medicine clinic of 
Chiang Mai University Hospital. Methods: The indications of benzodiazepine usage were 
examined by using the Thai Hospital Anxiety and Depression Scale in patients who were 
started on benzodiazepines. The duration of benzodiazepine usage was classified into: i) less 
than 1 month; ii) 1-6 months; and iii) longer than 6 months, and benzodiazepine dependence 
was assessed by using the Severity of Dependence Scale. Results: Of 40 out-patients started 
on benzodiazepines, only one of them (2.5%) had clinically significant anxiety. Of 58 out-
patients receiving benzodiazepines, 42 patients (72.4%) had used benzodiazepines longer than 
6 months. In addition, 8 patients (13.8%) were dependent on benzodiazepines. Conclusions: 
Benzodiazepine overuse is common in physically ill out-patients, even in the university 
hospital. Almost half of the surveyed patients appear to have prolonged benzodiazepine use; 
however, only a few patients are dependent on benzodiazepines. 
 
Key words: benzodiazepine overuse, indication, duration, dependence 
 
 
Introduction 
Benzodiazepines are among the most 
widely prescribed psychiatric drugs in the 
world [1]. They have been used not only in 
psychiatric patients but also in physically 
ill patients. Previous studies found that 
besides psychiatrists, neurologists and 
internists are the doctors who most fre-
quently use benzodiazepines in their prac-
tices [1,2]. Although benzodiazepines are 
considered well tolerated, especially when 
compared with older drugs, their adverse 
side effects can cause a number of prob-
lems, such as sedation, motor incoordina-
tion, cognitive impairment and disinhibi-
tion [3,4]. Moreover, long term use of 
benzodiazepines may leads to dependence, 
tolerance and withdrawal [4,5]. 
 
There are greater concerns about benzodi-
azepine’s side effects particularly in the 
elderly, in whom adverse events include 
falls from ataxia, which cause hip fractures, 
and confusion [4,6]. Although increasing 
awareness of benzodiazepine’s side effects 
may decrease their overall usage [5,7,8], 
they are still frequently prescribed for a 
long period of time, especially in develop-
ing countries where there is no clearly 
recommended guideline. 
 
As a drug class without definite indication, 
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the rationales for the use of benzodiaze-
pines have been controversial. In clinical 
practice, their main indications are treating 
anxiety and depression [1]. However, these 
drugs are commonly prescribed for a vari-
ety of somatic complaints which leads to 
the problem of overuse [9]. Srisurapanont 
and his colleagues carried out a study in the 
northern part of Thailand and reported that, 
for general practitioners, the most common 
use of benzodiazepines is for anxiety with 
insomnia (93%), followed by panic disor-
der (78%) and depression (43%). Some 
general practitioners also gave these medi-
cations for essential hypertension and low 
back pain. Moreover, 45% of them admit-
ted that they had used benzodiazepines too 
much in the past year [10]. 
 
Regarding the duration of benzodiazepine 
treatment, some experts suggest that the 
efficacy of benzodiazepines for insomnia is 
decreased after 2 weeks, for anxiety after 4 
weeks and for panic disorder after 12 
weeks [9]. However, the appropriate dura-
tion for prescribing benzodiazepine is still 
an issue of debate. The UK data sheet for 
diazepam and temazepam recommends that 
benzodiazepines should be used only when 
the disorder is severe, disabling or causes 
marked distress [9]. Its use should be 
limited to short term (2-4 weeks), while 
extensions beyond this time require re-
evaluation of the patient’s status [8, 9]. In 
addition, the USFDA label of benzodi-
azepines states that the efficacy of these 
drugs at longer than 4 months has not been 
assessed by systematic studies [11]. How-
ever, a small number of studies have found 
that benzodiazepines are effective for a 
longer period (4-6 months) [12]. 
 
Benzodiazepine dependence is regularly 
seen. De Las Cuevas and colleagues found 
that 47% of patients using benzodiazepines 
for more than 1 month had benzodiazepines 
dependence [13]. According to the study of 
Uhlenhuth et al.(1998), benzodiazepine 
dependence could occur when doses within 
the clinical range were taken regularly over 
a 6-month period [14].  
 
In several developed countries, various 
steps have been taken to control the pre-
scription of benzodiazepines. Example 
strategies include disseminated documents 
on how to prescribe benzodiazepine (e.g., 
never prescribe on the first visit or to an 
unknown patient), advice about sleep 
hygiene, using sedative antidepressants or 
non-benzodiazepine sedatives instead of 
benzodiazepine, offering non-pharmacolo-
gical supports or psychotherapy as the first 
choice [15,16], and reserving benzodi-
azepines for more severe cases of anxiety 
and insomnia. However, in developing 
countries, such as Thailand, there is still a 
limited concern about the side effects of 
benzodiazepines. 
 
A study of benzodiazepine overuse, in 
particular at the internal medicine out-
patient clinics, would increase the under-
standing of benzodiazepine use problems 
and may be a guide for the development of 
strategies to reduce benzodiazepine pre-
scription. This study therefore aims to 
assess benzodiazepine overuse, mainly 
regarding indications, prolonged use and 
benzodiazepine dependence, in out-patients 
treated at an internal-medicine clinic of a 
university hospital. 
 
Methods 
This prospective study was carried out 
between March and April 2005 at Chiang 
Mai University Hospital, a tertiary general 
hospital in northern Thailand. Chiang Mai 
is the largest city in northern Thailand, with 
approximately 1,650,000 inhabitants in 
2006. 
 
The study evaluated out-patients receiving 
benzodiazepines from the hospital’s inter-
nal medicine clinic. This study was ap-
proved by the Ethics Committee for Human 
Studies, Faculty of Medicine, Chiang Mai 
University. 
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Sample 
This study included all patients at the 
internal medicine out-patient clinic. Par-
ticipants were those who were at least 18 
years old, received benzodiazepines, and 
gave written informed consent. No exclu-
sion criterion was applied. 
 
Instruments 
The instruments used in this study were 
structured questionnaires to collect infor-
mation in several areas. Those included:  
i)  demographic data for age, gender, 
marital status. 
ii) drug use data for duration of benzodi-
azepine use, which were classified into: 
  - Short term (less than 1 month) 
  - Intermediate term (1-6 months) 
  - Long term (longer than 6 months). 
iii) Thai Hospital Anxiety and Depression 
Scale (Thai-HADS) for assessing the 
existence of clinically significant anxiety or 
depression, which are major indications for 
benzodiazepines. The cut-off point indicat-
ing clinically significant anxiety or depres-
sion was 11 points or more. By the use of 
this cut-off point, the sensitivity and speci-
ficity of the Thai-HADS are 100.0% and 
86.0% for anxiety, and 85.7% and 91.3% 
for depression, respectively [17]. This scale 
was used to examine patients that started 
using benzodiazepines during the study. 
iv) Severity of Dependence Scale (SDS) 
for evaluating benzodiazepine dependence. 
The score of 7 points or more indicates a 
dependence on benzodiazepines. By the use 
of this cut-off point, the sensitivity and 
specificity of this measure are 97.9% and 
94.2%, respectively [18]. 
Since benzodiazepine use is more con-
cerned in elderly people, a subgroup analy-
sis of data obtained from subjects aged 65 
years or older was also performed. 
 
Results 
Of the 98 internal medicine out-patients 
receiving benzodiazepines, most were 
female (64.3%) and most were married 
(82.6%). Their mean age was 55.4 years 
(SD=15.3). Of 40 out-patients (40.8%) who 
started receiving benzodiazepines during 
the survey, only one of them (2.5%) had 
clinically significant anxiety. Most of the 
patients were given benzodiazepines for 
more than 6 months (72.4%). Only 20.7% 
and 6.9% received benzodiazepines for 1-6 
months and less than 1 month respectively. 
 
Overall, eight patients (13.8%) were de-
pendent on benzodiazepines. Six and two 
of them received long- and medium-term 
treatment respectively. None of the subjects 
given short-term treatment had benzodi-
azepine dependence (see Table 1). 
 
Thirty-five of the 98 subjects (35.7%) were 
65 years old or older. The subgroup analy-
sis found that, of the 15 elderly patients 
started on benzodiazepines, one of them 
(6.7%) had clinically significant anxiety. 
Fifteen patients (75.0%) received benzodi-
azepines for more than 6 months, and none 
in this subgroup received short-term treat-
ment with benzodiazepines. Three elderly 
subjects (15%), who received long-term 
benzodiazepine treatment, were dependent 
on benzodiazepines. 
 
 
Table 1: SDS score in patients receiving benzodiazepines 
  
SDS score <1 month 
(n=4) 
1-6 months 
(n=12) 
>6 months 
(n=42) 
Total 
(N=58) 
Less than 7 4 
(100%) 
10 
(83.3%) 
36 
(85.7%) 
50 
(86.2%) 
7 or more 0 
(0%) 
2 
(16.7%) 
6 
(14.3%) 
8 
(13.8%) 
SDS = the Severity of Dependence Scale 
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Discussion 
Of the 40 patients who were started on 
benzodiazepines, only one of them had 
anxiety or depression, which indicates that 
97.5% did not meet the major indications 
for the use of benzodiazepines. Based on 
indications and contraindications, a previ-
ous study found that benzodiazepines were 
prescribed inappropriately in 65% of those 
receiving them [19]. Although the indica-
tions and the results of previous and the 
present studies are relatively different, both 
studies found high prevalent rates of the 
off-label use of benzodiazepines. 
 
Up to 72.4% of all patients received benzo-
diazepines for longer than 6 months, al-
though past studies showed there was no 
evidence of efficacy. The percentage of 
long-term treatment found in this study is 
higher than previous studies, which were 
15-37% [20, 21]. 
 
In this study, the point prevalence rate of 
benzodiazepine dependence is 13.8%, 
which is in the range of 3.3% and 97% 
obtained from previous studies [13, 22-25]. 
The wide range of the prevalence rate 
among these studies may cause by the 
population differences, criteria and meas-
urements. 
 
Elderly patients have higher rates of de-
pendence and prolonged use compared to 
the whole studied population. These find-
ings are similar to the previous study, 
which found that old people had a higher 
risk of prolonged use than the general 
population [21]. 
 
The strength of this study is the measures 
used for screening dependence and anxi-
ety/depressive disorders. However, there 
are some limitations, including small 
sample size, assessing the duration of 
treatment by self-reporting, and using 
screening tests for anxiety/depression and 
dependence. 
 
In conclusions, benzodiazepine overuse is 
common in physically ill out-patients, even 
in university hospitals. This problem 
should concern patients, clinicians and 
policy makers. Almost half of the patients 
in this study appeared to have prolonged 
benzodiazepine use. Alternative treatment, 
such as relaxation training and sleep hy-
giene education, should be publicized. 
Despite the overuse problem, few patients 
are dependent on benzodiazepines. As very 
few patients initiated with benzodiazepines 
have clinically significant anxiety or de-
pression, further studies may be needed to 
examine the indications of benzodiazepines 
in this population. 
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Abstract 
Objectives: To evaluate the efficacy, safety, benefits and cost of alcohol detoxification after 
switching from a fixed-dose schedule (FDS) to a symptom-triggered regimen (STR). Meth-
ods: This retrospective study was carried out in inpatients receiving alcohol detoxification. 
The data of alcohol dependent patients receiving STR during March – September 2006 were 
compared with those of patients treated with FDS between August 2005 and February 2006. 
Results: The mean age, alcohol use and history of delirium tremens were not significantly 
different between groups. The mean dosage of benzodiazepines in the STR group (91.3 mg 
equivalent to diazepam) was lower than that of FDS (465.3 mg equivalent to diazepam), 
(p<.001). The mean length of hospitalization was shorter in the STR group (10.6 vs. 16.8 
days, p=.003). There was no significant difference in major complications. Oversedation was 
significantly less frequent in the STR group (p <.001). The treatment cost was significantly 
lower in the STR group (p<.05). Conclusions: Despite the limitations of the study design, 
STR is as effective as FDS with less frequent complications, shorter length of hospitalization 
and decreased cost of treatment. 
 
Key words: alcohol withdrawal, symptom-triggered regimen, fixed-dose regimen 
 
 
Introduction  
Alcohol dependence is a major public 
health problem. It has been ranked as the 
fourth leading cause of disability and health 
care burden in a global report. In addition, 
it contributes to approximately 1.5% of all 
causes of death [1]. In respect to all types 
of alcoholic beverage and spirit consumed 
in 2005, Thai people were ranked as 40th 
and 5th respectively, in comparison to other 
countries [2]. Thus, alcohol-related costs 
adversely affect Thailand healthcare system 
and society at large. 
 
Alcohol enhances gamma-aminobutyric 
acid’s (GABA) inhibitory effects, leading 
to an increase in excitatory glutamate 
receptors. When alcohol is removed 
acutely, withdrawal symptoms occur. 
Withdrawal signs and symptoms are fre-
quently minor but can develop into a se-
vere, even fatal condition. Up to 71% of 
individuals presenting for alcohol detoxifi-
cation manifested significant symptoms of 
alcohol withdrawal [3]. The common ones 
include tremors, craving for alcohol, in-
somnia, vivid dreams, anxiety, hypervigi-
lance, agitation, irritability, loss of appetite, 
nausea, vomiting, headache, and sweating 
[4]. The most severe form of the with-
drawal syndrome is alcohol withdrawal 
delirium, also known as delirium tremens 
112   Likhitsathian S, et al. 
(DTs). Untreated DTs has a 20% mortality 
rate [5]. The best treatment for DTs is 
prevention. Therefore, the patients with 
recognized alcohol withdrawal symptoms 
should be carefully monitored to prevent 
the development of alcohol withdrawal 
delirium [5]. Detoxification is the first step 
towards the treatment of alcohol dependent 
persons. Some patients, especially those 
with a history of alcohol withdrawal sei-
zure or delirium, are likely to be admitted 
for inpatient detoxification.  
 
In Maharaj Nakorn Chiang Mai Hospital, 
the number of inpatients receiving alcohol 
detoxification has increased enormously 
since 2004. In the psychiatric ward, the 
fixed-dose schedule (FDS) of benzodi-
azepines had been used prior to the imple-
mentation of symptom-triggered regimen 
(STR) of benzodiazepines in early 2006. 
Although FDS has been considered as a 
standard treatment for individuals with-
drawing from alcohol, during 2004-2005, 
56% of alcohol dependent inpatients re-
ceiving FDS at the psychiatric ward devel-
oped delirium within the first week of 
treatment. Not uncommon, patients receiv-
ing medication more than necessary results 
in drug-induced delirium, prolonged dura-
tion of treatment, and wastefulness of 
personnel [6]. Recent recommendations for 
treating alcohol withdrawal syndrome 
suggest a symptom-triggered approach 
based on frequent objective assessment of 
the patient [7,8].  
 
STR, a personal adaptation of medication 
dosage, uses questionnaires that evaluate 
the occurrence and intensity of alcohol 
withdrawal. Instruments such as the revised 
Clinical Institute Withdrawal Assessment 
for Alcohol scale (CIWA-Ar) [9] and 
Alcohol Withdrawal Scale (AWS) [10] 
have been used. There are many studies 
determining the use of STR together with 
those objective scales. STR has been re-
ported more effective than FDS by shorten-
ing the duration of hospitalization and 
benzodiazepine treatment [12-14]. Reoux 
and Miller [15] also demonstrated the 
decrease of hospitalization and benzodi-
azepine treatment by using STR in alcohol 
withdrawal patients in a general hospital. 
Rate of complication, including DTs, 
occurred less frequently in the symptom-
triggered approach compared with the 
fixed-dose approach [8,16]. 
 
As mentioned above, the symptom-
triggered regimen of benzodiazepines was 
proved to help reduced complications 
during the treatment of alcohol withdrawal. 
To our knowledge, there has been a little 
evidence in the application of this regimen 
in less developed countries, especially with 
respect to treatment cost. The purpose of 
this study was to compare the treatment 
efficacy, safety, benefits and cost of STR 
modified by our patient care team and the 
usual care (the FDS) in alcohol withdrawal 
patients. Our STR called Assessing and 
Benzodiazepine Dosing Regimen for 
Alcohol Withdrawal (ABDRAW) [See 
Appendix] was modified from an Austra-
lian Guideline [11]. 
 
Methods 
Subjects 
We retrospectively identified psychiatric 
inpatients receiving alcohol detoxification 
at our psychiatric ward between 1st August 
2005 and 30th September 2006. The study 
was approved by the Ethics Committee for 
Research, Faculty of Medicine, Chiang Mai 
University. 
 
The inclusion criteria were: i) aged of 20 
years old or older, ii) meeting the DSM-IV-
TR diagnostic criteria for alcohol depend-
ence and iii) alcohol abstinence no longer 
than 7 days. Patients who initially pre-
sented with alcohol withdrawal delirium 
were excluded.  
 
Identified patients were divided into two 
groups. The first one is the pre-
implementation group (Aug. 2005 - Feb. 
2006), who were treated with FDS. Patients 
in group two (Mar. - Sep. 2006) were 
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treated by the use of ABDRAW in which 
the Alcohol Withdrawal Scale [10] was 
used as a guide for benzodiazepine dosing. 
 
Assessment  
Age at admission, sex, alcohol use history, 
medical and psychiatric comorbidities and 
history of previous alcohol withdrawal 
complications were collected from the 
medical records of eligible patients. Out-
comes of treatment were determined by the 
total benzodiazepine dosage equivalent to 
diazepam (in milligrams); current compli-
cation of alcohol withdrawal including 
seizure, delirium, oversedation; length of 
hospital stay; and cost of treatment. 
 
Interventions 
For FDS, the medical staff gave flexible 
doses of benzodiazepines at the best judge-
ments. By applying the ABDRAW, physi-
cians evaluated the severity of alcohol 
withdrawal symptoms, and the nurse fol-
lowed through the protocol instructions. 
Benzodiazepine doses were guided by the 
AWS scores of the patient. If the patient 
had an AWS score of 5 or higher, he would 
receive the starting dose of diazepam, 
which was 5-10 mg (or 1-2 mg of loraze-
pam). One hour after taking each dosage, 
withdrawal symptoms were reevaluated, 
and additional benzodiazepines were ad-
ministered as long as the AWS scores 
remained at 5 or higher. The monitoring of 
alcohol withdrawal severity was discontin-
ued if the AWS scores were lower than 5 
for 72 consecutive hours. 
 
Statistical analysis 
Descriptive analysis was used for alcohol 
use history and patients’ characteristics. To 
evaluate the effect of treatment, mean 
differences were assessed by the use of 
student (unpaired) t-test, and Fisher’s Exact 
test was used to compare categorical vari-
ables. Two-tailed, p-values less than .05 
were considered as statistical significances. 
 
Results  
Characteristic of subjects 
Forty-one consecutive patients were admit-
ted into psychiatric ward for alcohol de-
toxification between August 2005 and 
September 2006. All subjects were men 
who had alcoholic beverages within 7 days 
prior to admission. Four of twenty (20.0%) 
patients receiving FDS and 3 of 21 (14.3%) 
patients given STR were excluded due to 
delirium upon admission. The numbers of 
subjects included in this analysis were 16 
for the FDS group and 18 for the STR 
group. 
 
There was no significant difference be-
tween groups with respect to age, marital 
status, and employment (see Table 1). In 
addition, alcohol consumption, duration of 
alcohol use and time since last drink and 
medical and psychiatric comorbidities were 
also similar. Previous episodes of alcohol 
withdrawal delirium were documented in 5 
patients of the STR group (27.8%) but none 
in the FDS group (p=.18).  
 
Benzodiazepine treatment 
The total amount of benzodiazepines 
equivalent to diazepam were calculated. 
The STR group received a significantly 
smaller amount of benzodiazepines than the 
FDS group (91.31±107.09 mg vs. 465.34± 
249.70 mg, p<.001) (see Table2). Duration 
of benzodiazepine treatment was also 
significantly shorter for the STR group.  
 
Complications and adverse events 
The incidence rates of oversedation and 
seclusion/restraint were significantly less 
frequent in the STR group (0 vs. 9 for 
oversedation, p<.001; 3 vs. 9 for seclu-
sion/restraint, p=.03). Delirium was found 
in 2 and 4 patients receiving STR and FDS, 
respectively (p=.39). The occurrences of 
other complications and adverse events, 
including, seizure, aggressive behavior and 
falling, were not significantly different (see 
Table 2). 
 
Length of stay and cost of treatment 
Compared to the FDS group, the STR 
group had significantly shorter hospitaliza-
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tion (10.6±3.5 days vs. 16.81±7.44 days, 
p=.003) and lower cost of treatment 
(6,515.17±2,432.66 Thai baht vs. 
11,845.56±7,693.02 Thai baht, p=0.009) 
(see Table 3). The service and accommoda-
tion cost, but not the medication and inves-
tigation costs, was significantly lower in 
 
Table 1: Demographic characteristics and alcohol use history 
 
Characteristic Fixed-doses group 
(N=16) 
Symptom-triggered 
group (N=18) 
p-value 
Age, yrs (mean± SD) 50.44 ± 7.37 46.11 ± 7.61 .10 
Sex,% Male, 100 Male, 100  
Current marital status 
Married 
Separated/divorced/widowed 
Single  
 
10 
5 
1 
 
10 
5 
3 
 
 
 
 
Currently employed 13 17 .32 
Alcohol use history 
Alcohol consumption 
   Duration of alcohol use, yrs. 
   Time since last drink, days 
 
 
22.81 ± 9.36 
1.61 ± 1.98 
 
 
17.67 ± 8.35 
0.64 ± 1.37 
 
 
.10 
.11 
Previous withdrawal history 
Seizure  
Delirium 
Hallucinations 
 
1 
0 
3 
 
6 
5 
3 
 
.09 
.18 
1.0 
Comorbid psychiatric condition 
Depression 
Bipolar 
Others 
 
4 
3 
0 
 
2 
1 
2 
 
.39 
.32 
.49 
Comorbid medical condition 
GI (i.e. cirrhosis) 
CVS (i.e. hypertension) 
CNS (i.e. old CVA) 
Others 
 
6 
0 
1 
6 
 
3 
2 
0 
2 
 
.25 
.49 
.47 
.11 
 
 
Table 2: Comparison of treatment outcomes by treatment groups 
 
Characteristic Fixed-doses group 
(N=16) 
Symptom-triggered group 
(N=18) 
p-value 
Benzodiazepine treatment 
Total benzodiazepine dosage 
equivalent to diazepam (mg) 
 
465.34 ± 249.70 
 
 
91.31 ± 107.09 
 
<.001 
 
Complications 
No. of seizure 
No. of delirium 
No. of oversedation
a
 
 
0 
4 
9 
 
0 
2 
0 
 
 
.39 
<.001 
Adverse events 
Aggressive 
Falling 
Seclusion or restrained 
 
1 
1 
9 
 
1 
0 
3 
 
1.0 
.48 
.03 
a
Oversedation was defined as sleepiness or drowsiness and instability, and those resulted in disruption 
of the sleep-wake cycle, impairment in daily functioning, diminished ability to attend therapeutic 
activities, and discomfort. 
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Table 3: Comparison of the hospitalization and cost of treatment between groups 
 
 Fixed-doses group 
(N=16) 
Symptom-triggered 
group (N=18) 
p-value 
Length of hospital stay, days  16.81 ± 7.44 10.61 ± 3.47 .003 
Type of Cost (Thai Baht) 
Medication 
Lab & X-ray 
Service & accommodation  
Total  
 
1,246.69 ± 2,340.07 
1,734.37 ± 1,374.49 
8,677 ± 4,904.67 
11,845.56 ± 7693.02 
 
975.11 ± 867.84 
1,076.68 ± 777.20 
4,413.39 ± 1736.06 
6,515.17 ± 2432.66 
 
.67 
.10 
.004 
.009 
 
 
the STR group (p=.004). Because the 
service and accommodation was the main 
part of the total cost of treatment, the total 
cost of treatment in the STR group was, 
therefore, significantly lower (p =.009). 
 
Discussion 
Despite of the lower dose of benzodiazepi-
nes, STR is at least as effective as FDS for 
alcohol detoxification. In comparison to the 
alcohol dependent patients receiving FDS, 
those given STR are less likely to have 
oversedation and seclusions/restraints. In 
addition, STR also leads to a shorter dura-
tion of hospitalization and a lower cost of 
treatment.  
 
The results of this study are in consistence 
with previous trials in western countries 
[12,13], and in Thailand [14,17]. All stud-
ies show that STR is as effective as FDS 
but superior to FDS in respect to lower 
doses of benzodiazepine, fewer complica-
tions and shorter hospitalizations. There 
has been very little evidence on the cost 
savings of treatment, and this study shows, 
even in treatment settings with fewer 
resources, STR is also helpful in reducing 
the cost of inpatient alcohol detoxification.  
Despite the obvious evidence, the nursing 
staff involved in this study preferred to 
have an objective scale to guide their 
medication dosing. The nurses, who previ-
ously used CIWA-Ar, mentioned that the 
AWS is more practical and less compli-
cated than the former. Suspiciously, a few 
subjects experienced delirium tremens after 
discontinued monitoring withdrawal symp-
tom. This was probably due to an abrupt 
discontinuation of benzodiazepines at the 
time of hospitalization. So it was important 
to realize that withdrawal scales are not 
diagnostic instruments, and the withdrawal 
score on its own may not be enough to 
indicate progression to a more serious form 
of withdrawal. Clinicians should not rely 
on withdrawal scale scores alone to moni-
tor withdrawal, but must also use their 
clinical judgements and other observations.  
 
Although these findings may have certain 
applicability in managing alcohol with-
drawal patients, it is important to recognize 
some limitations in the generalisability. 
First, all subjects were in a psychiatric unit, 
where medical comorbidities occurred less 
frequently. Therefore, it may not hold true 
for other settings, such as general medical 
ill patients. However, this study did not 
exclude patients having other medical 
conditions. Second, there is potential 
weakness with this study inherent in a 
retrospective study design. The defect of 
the data collection system was discovered. 
We identified patients through discharge 
diagnosis and verified those by reviewing 
their records during admission. Third, in 
contrast with other studies, which used the 
CIWA-Ar for evaluating the occurrence 
and intensity of alcohol withdrawal [7-8, 
12-17], this study used the AWS. Forth, 
while we made an effort to account for 
variables that would affect outcomes, other 
possible confounders were the exact nature 
of alcohol withdrawal symptoms, espe-
cially insomnia, might have an impact on a 
higher dose of diazepam even though the 
AWS score is lower than 5. Other limita-
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tions of this study included a small sample 
size, no assessment training for nursing 
staff and relying solely on the subjects’ 
estimation and recollection of alcohol use 
history. Further studies should be con-
ducted in a larger numbers of patients and 
staff who are well trained to use the regi-
men. 
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Appendix 
Assessing and Benzodiazepine Dosing Regimen for Alcohol Withdrawal (ABDRAW) 
 
 
 
 
*DZP= Diazepam 
Note  
• Physician’s decision is also based on other conditions of the patients and resources available at the 
point of time. 
• Physician should start at  if the patient has a AWS score less than 5 but has a history of alcohol 
withdrawal seizure or delirium 
• Physician should administer lorazepam 1 mg equivalent to Diazepam 5 mg for elderly patients and 
those who have severe hepatic diseases. 
• Physician has to reevaluates the patient’s condition and the dosing regimen every 24-48 hrs. 
• Nurse has to notify physician if  
• The patient is in stuporous condition. 
• The patient has a respiratory rate of 14/minute or less 
• The patient received a total dosage of 80 mg diazepam (or equivalent) or more within 8 hrs 
• The patient has severe withdrawal (AWS score of 15 or more) or delirium for 4 consecutive 
hours 
• The patient has moderate to severe withdrawal (AWS score of 10-14) for 6 consecutive hours 
 
Modified from:  
1. John B. Saunders, Clinical Protocols for Detoxification in Hospital and Detoxification Facilities. 
(2002)  
2. Mayo-Smith MF. American Society of Addiction Medicine Working Group on Pharmacological Man-
agement of Alcohol Withdrawal. Pharmacological Management of Alcohol Withdrawal: a meta-analysis 
and evidence-based practice guideline. JAMA. 1997;278:144-151. 
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Abstract 
Objective: To determine the cost of treatment for schizophrenic patients in Social Security 
scheme, Thailand. Methods: The paper reviewed available evidence in Thailand on the cost of 
schizophrenia treatment in different hospital settings and data of health service utilization 
obtained from various sources. The sensitivity analysis of direct health care cost of schizo-
phrenia was conducted in social security system, both in outpatient and inpatient services. The 
cost for schizophrenia coverage per individual social security applicant was estimated in 
different contexts. Results: The total cost of treatment depends on the service utilization rate 
and unit cost of treatment. The annual direct health care cost of schizophrenic outpatients in 
Thai social security scheme was averagely estimated at about 171 million Baht. (Range: 28.5 
million to 372 million Baht in sensitivity analysis). The annual direct health care cost of 
schizophrenic inpatients in Thai social security scheme was averagely estimated about 265.3 
million Baht (Range; 22.7 million to 531 million Baht in sensitivity analysis). Aggregation 
the outpatient and inpatient treatment for schizophrenic employees accounted for 436.5 mil-
lion Baht/year (Range from 436.5 million to 903 million Baht). The cost for schizophrenia 
coverage per individual social security applicant was about 48 Baht/year. (Range 5.63 Baht to 
99.22 Baht). Conclusion: This study illustrated the cost of schizophrenia treatment in Thai 
social security scheme in various contexts, which might be useful in planning, preparing, 
budgeting and decision making. However, the huge societal impacts of schizophrenia should 
be carefully considered for policy makers. 
 
Key words: schizophrenia, social security scheme, Thailand, cost of treatment 
 
 
Introduction 
As identified in the social security scheme, 
Thailand has had the full-fledged social 
security system under which the employees 
will be protected in term of accident, ill-
ness, disability and death, either related or 
unrelated to work performance [1]. How-
ever, in the “social security against illness”, 
the important category in social security 
system, presented the coverage of social 
security fund including physical illnesses 
mostly. Except acute psychosis (last for 15 
days or less, the Social Security Office 
excludes all other psychoses from the 
social security benefit. This leads to ineq-
uity in receiving proper compensations and 
services. Psychoses not only cause stigma 
but also contribute to the misunderstanding 
of differentiation between “psychoses” and 
“other psychiatric illnesses”. Some em-
ployees with psychiatric disorders are, 
therefore, not be able to receive their treat
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ment benefits. Efforts to push for full 
realization of mental problems in social 
security system have been made continu-
ously through the Psychiatric Committee in 
order to increase the opportunities of access 
to treatment for psychiatric problems. In 
our opinion, the major problem that is 
worth coverage due to its huge impact to 
society unless proper treatment is schizo-
phrenia. 
 
In order to reach the decision making, one 
of their concerns is how much to pay for 
the addition of schizophrenia into the 
illness coverage. Although cost analysis 
studies for schizophrenia treatment in 
Thailand, both outpatient and inpatient 
setting, have been performed previously, in 
this study, we would like to focus on 
schizophrenic patients in social security 
scheme specifically.  
 
Method 
We gathered the data from prior cost analy-
sis studies concerning mental illnesses in 
Thailand. 
 
Information of schizophrenic patient in 
social security system (see Table 1) 
The data were gathered from: 
• The number of social security members. 
The most recent data from Social Security 
Registry in July 2007 included compulsory 
subscribed employees (8,735,863 persons) 
and voluntary subscribed employees 
(363,681 persons), for a total of 9,099,544 
persons [2]. 
• Morbidity rate of schizophrenia in Thai 
population. The data were taken from the 
national survey in Thai population, 2001 
[3], under the basic assumption that there is 
no significant changes of schizophrenic 
morbidity rate between years.  
• Health services utilization ratio in Thai 
patients. Health services utilization ratio in 
Thai patients both in outpatient department 
(OPD) and inpatient department (IPD) 
services, estimated by expert focus group 
and from the social security office report. 
[4] 
 
Data of unit cost in IPD and OPD treat-
ment for schizophrenia  
Cost analysis studies of schizophrenia 
treatment from two main institutes, 
Ramathibodi hospital studied in 2000 [5] 
and the Department of Mental Health, 
Ministry of Public Health studied in 2005 
[6] were reviewed and represented as unit 
cost in medical school hospitals and gen-
eral hospitals. The unit cost consisted of the 
direct health care cost and indirect health 
care cost that were adjusted to the value in 
calendar year 2007, using consumer index 
price, the Bureau of Trade and Economic 
Indices, Ministry of Commerce, Thailand 
[7]. Details are shown in Table 2. 
 
 
Table 1: General data* 
 
Number of social security members 9,099,544 
Morbidity rate of schizophrenia in Thai population 0.17% 
Number of estimated schizophrenia in social security scheme 15,470 
Mental health service utilization for schizophrenia 
i) OPD 
    - Estimated by focus group of experts 
    - Data from social security office 
ii) IPD 
    - Estimated by focus group of experts 
    -Data from social security office 
 
 
4 visits/man/year 
2.58 visits/man/year 
 
1 admission/man/year 
0.047 admission/man/year  
*Excluding those of members who did not access to mental health service utilization. 
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Table 2: Unit cost of schizophrenia treatment 
 
OPD ( cost/visit) IPD (cost/admission)  
Sources of cost Cost in year 
of study 
Cost in 
2007* 
Cost in year 
of study 
Cost in 
2007* 
Unit cost of schizophrenia (Ramathibodi 
study,2000) (Baht) 
5,019 
(942-9,088) 
6,010.41 28,660 34,321.23 
Unit cost of Schizophrenia 
    (Study of Department of Mental Health, 
Ministry of Public Health,2005) ( Baht) 
662 714.81 28,902 31,207.73 
* Adjusted by consumer index price, Bureau of Trade and Economic indices, Minister of Commerce, 
Thailand 
 
 
Table 3: Estimated direct health care cost of schizophrenia, outpatient department (OPD), in 
Thai social security scheme. 
 
Number of schizophrenia in 
social security member
a
 
Mental health service 
utilization
b
 
Unit cost  
c
 
(Baht/visit) 
Total cost 
(a*b*c)
 
(Baht/year) 
Ramathibodi study 
6,010.41 
371,924,170.80 Maximum utilization 
4 visits/man/year 
(expert group estima-
tion) 
Dep. Mental Health 
study  714.81 
44,232,442.80 
Ramathibodi study 
6,010.41 
239,891,090.17 
15,470 
Minimum utilization 
2.58 visits/man/year 
(Social Security Office 
data) 
Dep. Mental Health 
study  714.81 
28,529,925.61 
 
 
Table 4: Estimated direct health care cost of schizophrenia, inpatient department (IPD), in 
Thai social security scheme. 
 
Number of schizo-
phrenia in social 
security applicants 
 a
 
Mental health service 
utilization  
b
 
Unit cost  
c
 
( Baht/visit) 
Total cost 
(a*b*c)
 
(Baht/year) 
 
Ramathibodi study 
34,321.23 
530,949,428.10 Maximum utilization 
1 admission/man/year 
(expert group estimation) Dep. Mental Health study 
31,207.73 
482,783,583.10 
Ramathibodi study 
34,321.23 
24,954,623.12 
15,470 
Minimum utilization 
0.047 admis-
sion/man/year 
(Social security office 
data) 
Dep. Mental Health study 
31,207.73 
22,690,828.41 
 
 
Assuming mental health services are as-
sessable, schizophrenic patients in social 
security scheme have probability to use 
both outpatient and inpatient services in a 
year with expected utilization rates. We 
performed the sensitivity analysis of total 
cost to pay in a year for schizophrenia 
treatment in OPD and IPD. The lowest and 
highest total costs were presented by apply-
ing various contexts, in term of service 
utilization rate and unit cost of treatment. 
Also, average cost per 1 social security  
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Table 5: The annual cost and cost per applicant for schizophrenia treatment in Social Security 
Scheme. 
 
Schizophrenia in 
Social Security Scheme 
 
OPD cost 
 
IPD cost 
 
Total cost ( OPD + IPD) 
Cost for all applicants (Baht)    
Max 371,924,170.80 530,949,428.10 902,873,598.90 
Min 28,529,925.61 22,690,828.41 5,1220,754.01 
Average 171,144,407.34 265,344,615.68 436,489,023.02 
Cost per one applicant (Baht)    
Max 40.87 58.35 99.22 
Min 3.14 2.49 5.63 
Average 18.81 29.16 47.97 
Number of all social security applicants = 9,099,544 
 
 
employee was calculated to illustrate the 
incremental cost if schizophrenia coverage 
is feasible. 
 
Results 
Estimated number of schizophrenic patients 
in social security member in 2007 is about 
15,470 persons. Table 3 presents the total 
cost of OPD treatment for all schizophrenic 
patients in the social security scheme using 
various service utilization rate and unit 
costs of treatment. The outcome reveals the 
OPD treatment costs per year from highest 
to lowest cost. If all patients have the 
largest number of OPD visits and the 
highest OPD cost, the total cost per year 
will be approximately 371,924,170.80 
Baht. If the patients have the largest num-
ber of OPD visits with the lowest OPD 
cost, the total cost per year will be 
44,232,442.80 Baht. For the smallest 
number of OPD visits with the highest 
OPD cost, the total cost per year will be 
239,891,090.17 Baht. Alternatively, for the 
smallest number of OPD visits with the 
lowest OPD cost, the total cost per year 
will be 28,529,925.61 Baht. 
 
Table 4 shows the total cost of IPD treat-
ment for all schizophrenic patients in the 
social security scheme using various ad-
mission rates and unit costs of IPD treat-
ment. Similar to the outcomes of OPD 
settings, the total cost depends on the 
estimated number of IPD admissions in a 
year and the cost of IPD treatment. There-
fore, the total IPD cost of schizophrenic 
treatment is between 22,093,855.74 
Baht/year as the minimum cost and 
516,780,687.49 Baht/ year as the maximum 
cost. 
 
In Table 5, we present the expected total 
OPD and IPD costs of schizophrenia treat-
ment to be covered in the social security 
system. The maximum, minimum and 
average costs are illustrated. The highest, 
the lowest and the average incremental 
costs per social security applicant are 
99.22, 5.63 and 47.97 Baht/year, respec-
tively.  
 
Discussion 
The sensitivity analysis has illustrated the 
significant difference of treatment cost for 
schizophrenia patients in the social security 
scheme. The wide range of results provides 
the fact in our mental health services. The 
total cost of treatment depends on the 
databases used for the analysis. The main 
variables influencing the outcomes are 
service utilization rate and unit cost of 
treatment. Concerning the service utiliza-
tion rate, a marked difference is presented 
in the IPD service admission rate. Data 
from the expert group (psychiatrists) is 
much higher than the data obtained from 
the social security office (1 admission and 
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0.047 admission a year). Most psychiatrists 
in the focus group work in medical schools, 
which are tertiary care settings, so it is 
possible that most patients are severe cases 
that need more frequent admissions than ill 
employees, the target group of social 
security office. 
 
Accord to the unit cost of IPD and OPD 
treatment settings, there are some differ-
ences between two institutes representative 
of medical school hospitals and general 
hospitals. Much higher labor cost and 
medication cost make the unit cost of OPD 
service in medical school hospitals mark-
edly different from that in general hospi-
tals. In this study, we use the minimum and 
maximum utilization rates and unit costs in 
order to perform the sensitivity analysis. 
This information may respond to the ques-
tion of addition payment needed to include 
schizophrenia in the social security cover-
age. Various contexts in this study may be 
useful in planning, preparing and decision 
making if application is established in 
various conditions. 
 
Some may suspect the benefits of adding 
schizophrenia into the social security 
coverage because their functional impair-
ment may stigmatize them as the one who 
cannot employ or earn at all. Actually, 
schizophrenia has a wide range of severity 
and prognosis [8]. Some of them can work, 
earn and live independently, in particular, 
those receiving effective treatment and 
being adherent to treatment. Non-adherence 
to treatment, either due to the financial 
problems or poor compliance, is the most 
important factor in determining long term 
prognosis and burden to society [9]. Un-
successful treatment of schizophrenic 
patient leads to a high hospitalization rate 
[10], failure in education, unemployment, 
lost earning, disability, suffering, violence, 
crime and premature death from suicide 
and homicide. These are enormous conse-
quences to our society. 
 
Beyond the health care cost, the economic 
consequences to society are categorized 
into direct non-health care cost (e.g., in-
formal care cost, criminal cost: prison, 
police, justice) and indirect cost (productiv-
ity, lost due to unemployment, patients’ or 
carers’ absence from work, premature 
mortality) [11]. Many studies in various 
countries, such as UK, USA and Canada, 
have analyzed the monetary impact of 
schizophrenia. The findings in England in 
2007 show that the direct cost of treatment 
is about 2 billion pounds but the burden of 
indirect cost and non health care cost to the 
society are huge with the amount of 4.7 
billion pounds [12]. In 2002, the overall 
cost of schizophrenia in the US was ap-
proximately 62.7 billion US dollars in 
which 22.7 billion US dollars exceed the 
direct health care cost. The direct non 
health care excess cost estimated to be 7.6 
billion US dollars, and the indirect excess 
costs were estimated to be 32.4 billion US 
dollars [13]. The analysis of the economic 
burden of Canada in 2004 found the direct 
health care cost and non-health care cost of 
2.2 billion CAN dollars, the indirect cost 
from unemployment and mortality loss of 
4.83 billion CAN dollars, which led to the 
estimated total cost of 6.85 billion CAN 
dollars [14]. These data show that the 
largest component of the total cost (about 
70%) is the productivity losses associated 
with schizophrenia. 
 
Not only schizophrenia, but other mental 
illnesses also provide a similar pattern that 
that the indirect cost is higher than the 
direct health care cost [15-17]. Indirect cost 
and direct non-health care cost would 
increase if the treatment is not effective. 
Even the large part of direct health care 
cost (hospital cost or IPD cost) would also 
increase in treatment failure. [18,19] There-
fore, in societal view of economic evalua-
tion, we can conclude that non-treatment 
(or ineffective treatment) option is more 
costly than the effective treatment. The 
most effective way to reduce the overall 
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societal cost is to develop effective and 
well accepted treatment [20]. 
 
In conclusions, these several lines of evi-
dence support the idea of including schizo-
phrenia into the social security coverage in 
order to prevent societal impacts and to 
reduce the large amount of indirect cost. At 
present, schizophrenic employees receiving 
no benefit from the social security fund 
have a higher risk for nonadherence to 
treatment. They are also at risk to be 
chronic schizophrenia with poor prognosis 
and being a big burden to society unless 
receiving health supports. Policy makers 
need to recognize the width of invisibly 
economic impacts beyond the out of pocket 
health care cost. 
 
Conflict of interest: none. 
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Abstract 
Objective: The aim of this study was to evaluate common problems in consultation-liaison 
psychiatry, characteristics of consulted patients, and medical and psychiatric diagnoses of the 
patients in Maharaj Nakorn Chiang Mai Hospital. Methods: We performed a retrospective 
descriptive study from June 2005 to August 2006. All participants were medically ill inpa-
tients who consulted for psychiatric problems. The authors reviewed the demographic data 
such as age, sex, ward, systemic disease, medical disease, psychiatric provisional diagnosis 
and psychiatric diagnosis. Results: Four hundreds patients were consulted for psychiatric 
evaluation, 0.82 % of all general hospital inpatients, 235 (58.8 %) males and 165 (41.2 %) 
females. The modal age group was between 20 - 49 years old (58.8 %) mostly referred by the 
department of internal medicine and surgery. At discharge, common diagnoses were adjust-
ment disorder (35.0 %), delirium (32.5 %), substance-related disorders (17.0 %), depressive 
disorders (13.3 %), and psychotic disorders (4.3 %). Sensitivity rates for diagnosis of these 
psychiatric disorders were 12.1%, 50.8%, 75 %, 43.4% and 64.7% respectively. Conclusion: 
Patients with high suicidal risk, in particular adjustment and depressive disorders are common 
in consultation-liaison psychiatry. Attention should also be given to patients with high risks of 
aggression, disruption, or disorganization, such as delirium, substance abuse, and psychotic 
disorders.  
 
Key words: consultation, medically ill patients, adjustment disorder 
 
 
Introduction 
Consultation-liaison psychiatry deals with 
patients who have both psychological and 
physical symptoms under the care of other 
medical specialties. Psychiatrists have to 
identify mental disorder, diagnose, as well 
as work with the medical team for treat-
ment plan. In western countries, the branch 
of consultation-liaison psychiatry is well 
established. There are also many studies in 
this area. Patients with medical illness such 
as disease of nervous system, endocrine 
disorder, delirium and substance use disor-
ders may have co-morbidity of psychiatric 
problems. Moreover, patients with chronic 
medical illness may have many problems in 
coping with their health and present with 
anxiety, depression or suicidal ideation.  
 
In developing countries, consultation- 
liaison psychiatry is a new branch of psy-
chiatry. Only few psychiatrists are avail-
able in most general hospitals. From this 
point of view, we would like to survey the 
patterns of consultation-liaison psychiatry 
in our setting. The results will be analyzed 
and used to improve our services, as well as 
shaping the resident training program in the 
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future. 
 
Methods 
The psychiatric consultation-liaison service 
is provided by the Department of Psychia-
try, Faculty of Medicine, Chiang Mai 
University. Maharaj Nakorn Chiang Mai 
Hospital is a 1,800-bed university hospital 
in the Northern part of Thailand. When a 
patient is referred, interviews and consulta-
tions will be done on-site by staff psychia-
trists and 3rd year psychiatric residents. 
Referrals for psychiatric consultation 
require a physician’s order for such a 
request, specifying the reason for the con-
sultation. 
 
A retrospective review of psychiatric 
consultation reports completed by the 
residents during a 15-month period be-
tween June, 2005 and August, 2006 was 
undertaken. Copies of consultation reports 
kept on file were abstracted and coded for 
data analysis.  
 
Extracted data included demographic data 
and medical/psychiatric diagnoses given at 
the times of consultation. Chi-square analy-
ses and Pearson’s correlation tests were 
performed to determine the significant 
differences. Defining all of the patients 
referred to the psychiatric consultation 
service as the population, accuracy, sensi-
tivity and specificity rates were also calcu-
lated. 
 
Results  
Forty-nine thousands and one patients were 
admitted to the hospital during the study 
period. Four hundred patients were con-
sulted for psychiatric assessment (0.82 %). 
Their demographic data are shown in 
Tables 1-3. 
 
There was no significant different between 
consulted and nonconsulted groups in most 
diagnosed systems. The proportions of 
patients with reproductive/genitourinary 
disorders and dermatological disorders 
were significantly lower in consulted 
group. (p=.00 and .03, respectively).  
 
There is no significant different between 
groups in many disease diagnoses except 
drug overdose, burns, trauma and degenera-
tive disease (p=.005, .012, .003, and .013, 
respectively).  
 
Provisional and final diagnosis 
Common final diagnoses were adjustment 
disorder (n=140, 35.0%), delirium (n=130, 
32.5%), substance-related disorders (n=68, 
17.0%), depressive disorders (n=53, 
13.3%), and psychotic disorders (n=17, 
4.3%). 
 
 
Table 1: Demographic data 
 
Characteristics Male Female Total 
Sex  [n (%)] 235 (58.8%) 165 (41.2%) 400 (100.0%) 
Mean age [mean + SD] 44.5+17.0 38.5+19.0 42.0+18.1 
Ward    
   Medicine [n (%)] 103 (25.8%) 82 (20.5%) 185 (46.3%) 
   Surgery [n (%)] 71 (17.7%) 33 (8.2%) 104 (25.9%) 
   Orthopedics [n (%)] 37 (9.2%) 16 (4.0%) 53 (13.2%) 
   Rehabilitation [n (%)] 11 (2.8%) 4 (1.0%) 15 (3.8%) 
   ENT [n (%)] 8 (2.0%) 6 (1.5%) 14 (3.5%) 
   Eye [n (%)] 2 (0.5%) 0 (0.0%) 2 (0.5%) 
   Pedriatric [n (%)] 3 (0.8%) 10 (2.5%) 13 (3.3%) 
   OB-Gyn [n (%)] 0 (0.0%) 14 (3.5%) 14 (3.5%) 
Total [n (%)] 235 (58.8%) 165 (41.2%) 400 (100.0%) 
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Table 2: Systemic diagnosis 
 
Systemic diagnosis Male Female Total p 
Neurological system [n (%)] 49 (12.2%) 37 (9.2%) 86 (21.4%) .725 
Endocrinological system [n (%)] 4 (1.0%) 6 (1.5%) 10 (2.5%) .330 
Musculoskeletal system [n (%)] 42 (10.4%) 23 (5.7%) 65 (16.1%) .284 
Immunological system [n (%)] 7 (1.8%) 4 (1.0%) 11 (2.8%) 1.000 
Cardiovascular system [n (%)] 11 (2.8%) 3 (0.8%) 14 (3.6%) .169 
Respiratory system [n (%)] 19 (4.8%) 6 (1.5%) 25 (6.3%) .092 
Gastrointestinal system [n (%)] 47 (11.7%) 31 (7.7%) 78 (19.4%) .745 
Rhematological system [n (%)] 1 (0.3%) 2 (0.5%) 3 (0.8%) .572 
Reproductive/genitourinary system [n (%)] 2 (0.5%) 16 (4.0%) 18 (4.5%) .000* 
Dermatological system [n (%)] 10 (2.5%) 1 (0.3%) 11 (2.8%) .030* 
Hematological system [n (%)] 7 (1.8%) 7 (1.8%) 14 (2.6%) .585 
Others [n (%)] 32 (8.0%) 27 (6.7%) 59 (14.7%) .458 
Multi-system involvement [n (%)] 4 (1.0%) 2 (0.5%) 6 (1.5%) 1.000 
Total [n (%)] 235 (58.8%) 165 (41.2%) 400 (100.0%)  
* indicates significant difference between male and female groups 
 
 
Table 3: Medical diagnoses in 400 consulted patients. 
 
Disease diagnosis Male Female Total p 
Drug overdose/toxic substance ingestion [n (%)] 30 (7.5%) 39 (9.8%) 69 (17.3%) .005* 
Alteration of consciousness [n(%)] 6 (1.5%) 1 (0.3%) 7 (1.8%) .247 
Infection [n (%)] 36 (9.0%) 15 (3.7%) 51 (12.7%) .069 
Malignancy [n (%)] 38 (9.5%) 34 (8.5%) 72 (18.0%) .269 
Burns [n (%)] 9 (2.2%) 0 (0.0%) 9 (2.2%) .012* 
Trauma [n (%)] 52 (13.0%) 18 (4.5%) 70 (17.5%) .003* 
Seizures [n (%)] 10 (2.6%) 12 (2.9%) 22 (5.5%) .265 
Stroke [n (%)] 23 (5.7%) 8 (2.0%) 31 (7.7%) .087 
Metabolic [n (%)] 7 (1.8%) 6 (1.5%) 13 (3.3%) .779 
Degenerative disease [n (%)] 7 (1.8%) 15 (3.7%) 22 (5.5%) .013* 
Other [n (%)] 14 (3.5%) 16 (4.0%) 30 (7.5%) .181 
Multiple diagnoses [n (%)] 3 (0.7%) 1 (0.3%) 4 (1.0%) .646 
Total [n (%)] 235 
(58.8%) 
165 
(41.2%) 
400 
(100.0%) 
 
* indicates significant difference between male and female groups 
 
 
Adjustment disorder 
• Accuracy rates, sensitivity and specificity  
Among 20 consulted patients with provi-
sional diagnosis of adjustment disorder, 
only 17 patients (85%) were finally diag-
nosed with adjustment disorder. On the 
other hand, the 123 consulted patients 
(32.4%) with other provisional diagnoses 
were diagnosed with adjustment disorder 
finally. The sensitivity rate for a diagnosis 
of adjustment was 12.1% (male=7.4%, 
female=16.7%). The specificity rate for this 
diagnosis was 98.8% (male=100% and 
female=96.8%).  
• Age group and sex difference 
There was no significant difference among 
age groups (χ
2
=9.793, df=7, p=.201). Peak 
ages of adjustment disorder in male and 
female patients were 40-49 and 20-29 years 
old, respectively (table 4). Significantly 
more females (43.6%, 72/165) than males 
(28.9%, 68/235) were finally diagnosed  
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Table 4: Common psychiatric disorders in consulted male and female patients classified by 
age groups. 
 
Adjustment 
disorder 
Delirium Substance-
related disor-
ders 
Depressive 
disorder 
Psychotic 
disorder 
Age 
group 
male female male female male female male female male female 
< 19 8 11 1 0 0 0 1 5 0 0 
20-29 11 21* 7 8 4 2 8 9* 2 2 
30-39 14 9 18 6 18 0 11* 1 2 3* 
40-49 15* 12 21* 9* 26* 2 3 1 4* 1 
50-59 9 11 14 6 11 1 4 3 1 0 
60-69 6 5 14 5 2 1 1 1 1 0 
70-79 4 2 10 4 0 0 1 3 1 0 
> 80 1 1 4 3 1 0 1 0 0 0 
Total 68 72 89 41 62 6 30 23 11 6 
* Peak ages of common psychiatric disorders in male and female patients 
 
 
with adjustment disorder (χ
2
=9.208, df=1, 
p=.002). 
 
• Associated medical conditions 
The patients with adjustment disorder 
mainly had drug overdose or corrosive 
ingestion (n=47/140, 33.6%), cancer 
(n=34/140, 24.3%) and trauma (n=17/140, 
12.1%). Other medical conditions included 
infection (especially, HIV infection), 
degenerative disease, stroke, burns and 
seizures. There was a correlation between 
adjustment disorder and drug overdose/ 
corrosive ingestion (r=.310, p<.001). 
 
Delirium  
• Accuracy rates, sensitivity and specificity 
Among 67 consulted patients with provi-
sional diagnoses of delirium, 66 patients 
(98.5%) were finally diagnosed with delir-
ium. On the other hand, 64 consulted 
patients (19.2%) with final diagnosis of 
delirium had previously provisional diag-
noses of other psychiatric conditions (false 
negative). Only one consulted patient 
(1.5%) with a provisional diagnosis of 
delirium was finally diagnosed with an-
other psychiatric disorder (false positive). 
The sensitivity rate of diagnosis in delirious 
patients was 50.8% (male=58.4%, fe-
male=34.1%). However the specificity was 
99.6% (male=100%, female=99.2%). 
 
• Age group and sex difference  
There was a significant difference among 
age groups (χ
2
=39.933, df=7, p<.001). The 
peak age of delirium in both males and 
females was 40-49 years old (see Table 4). 
Significantly more males (37.9%, 89/235) 
than females (24.8%, 41/165) were ulti-
mately diagnosed with delirium (χ
2
=7.495, 
df=1, p=.006). 
 
• Associated medical conditions 
Primary physicians could diagnose 50.8% 
of delirium correctly. Other reasons for 
referral for assessment were psychotic 
disorders (23.1%, 30/130) and substance 
use disorders (16.2%, 21/130). Patients 
with delirium mainly had substance use 
disorders (21.5%, 28/130) trauma (20.8%, 
27/130), cancer (17.7%, 23/130), infection 
(17.7%, 23/130) and stroke (14.6%, 
n=19/130). Other medical conditions were 
degenerative disease, burns and seizures. 
 
Substance-related disorders  
• Accuracy rates, sensitivity and specificity  
Among the 53 consulted patients with 
provisional diagnoses of substance-related 
disorders, 51 patients (96.2%) were diag-
nosed correctly. On the other hand, 17 
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consulted patients (4.9%) with a final 
diagnosis of substance-related disorders 
had previously provisional diagnoses of 
other psychiatric conditions (false nega-
tive). However, the two consulted patients 
(3.8%) with a provisional diagnosis of 
substance-related disorders were ultimately 
diagnosed with other psychiatric disorders 
(false positive). The sensitivity rate for 
these patients was 75% (male=74.2%, 
female=83.3%), while the specificity was 
99.4% (male=99.4%, female=99.4%).  
 
• Age group and sex difference 
There was a significant difference among 
age groups (χ
2
=42.398, df=7, p<.001). The 
peak age of substance-related disorders in 
males was 40-49 years old, while there was 
no peak age difference in female (see Table 
4). Significantly more males (26.4%, 
62/235) than females (3.6%, 6/165) were 
finally diagnosed with substance-related 
disorders (χ
2
= 35.547, df=1, p<.001). 
 
• Associated medical conditions 
We found that 41.2% of patients (28/68) 
with substance-related disorders also had 
delirium together. Patients with substance-
related disorders mainly had trauma 
(27.9%, 19/68), infection (17.6%, 12/68), 
seizures (11.8%, 8/68) and stroke (11.8%, 
8/68). Other medical conditions were 
cancer, drug overdose, and metabolic 
disturbance.  
 
Depressive disorders 
• Accuracy rates, sensitivity and specificity  
Among 91 consulted patients with a provi-
sional diagnosis of depressive disorders, 
only 23 patients (25.3%) were finally 
diagnosed with depressive disorders (male= 
30.2%, female=20.8%). On the other hand, 
only 30 consulted patients (9.7%) with a 
final diagnosis of depressive disorders had 
a previously provisional diagnosis of other 
psychiatric conditions (false negative). In 
addition, 68 consulted patients (74.7%) 
with a provisional diagnosis of depressive 
disorders were finally diagnosed with other 
psychiatric disorders (false positive). The 
sensitivity rate of the diagnosis was 43.3% 
(male=43.3%, female=43.5%) with a 
specificity rate of 80.4% (male=80.5%, 
female=73.2%). 
 
• Age group and sex difference 
There was no significant difference among 
age groups (χ
2
=11.868, df=7, p=.105). The 
peak age of depressive disorders in men 
was 30-39 years old and 20-29 years old 
for women (see Table 4).  
 
• Associated medical conditions 
The consulted patients with a final diagno-
sis of depressive disorders had some medi-
cal conditions, including drug overdose or 
corrosive ingestion (34.0%, 18/53), trauma 
(22.6%, 12/53), infection (13.2%, 7/53) and 
cancer (11.3%, 6/53). Other medical condi-
tions included seizures, stroke, degenera-
tive disease and metabolic distance. Some 
patients had multiple medical conditions.  
 
Psychotic disorders 
• Accuracy rates, sensitivity and specificity  
Among 45 consulted patients, 11 patients 
(24.4%) were finally diagnosed with psy-
chotic disorders (males=27.3%, female= 
21.7%). On the other hand, six patients 
(1.7%) with a final diagnosis of psychotic 
disorders had previous provisional diagno-
ses of other psychiatric conditions (false 
negative). In addition, 34 consulted patients 
(75.6%) with a provisional diagnosis of 
psychotic disorders were finally diagnosed 
with other psychiatric disorders (false 
positive). Hence, the sensitivity rate for the 
diagnosis of psychotic patients was 64.7% 
(male=54.5%, female=83.3%), while the 
specificity was 91.1% (male=92.9%, fe-
male=88.7%). 
 
• Age group and sex different for psychotic 
disorder 
There was no significant difference among 
age groups (χ
2
=5.132, df=7, p= .644). The 
peak age of psychotic disorders in males 
was 40-49 years old, while the females 
were 30-39 years old as shown in Table 4. 
Proportions of male and female patients 
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referred for psychotic disorders were not 
significantly different (χ
2
=.260, df=1, 
p=.610). 
 
Reasons for referral and medical illnesses 
Primary physicians diagnosed 64.7% 
(11/17) of psychotic disorder correctly. 
Other reasons for the referral were suicide 
attempts, substance use disorders, and 
aggressive behavior. Patients with psy-
chotic disorders mainly had drug overdose 
(n=4/17, 23.5%), stroke (n=3/17, 17.6%), 
infection (n =3/17, 17.6%), trauma (n=2/17, 
11.8%). Other medical conditions included 
seizures, degenerative diseases, cancer and 
metabolic disturbance. One patient had 
multiple medical illnesses.  
 
Discussion 
The consultation rate of 0.82% in our 
general hospital is comparable to those of 
other studies in Thailand (0.54% to 0.60%) 
[1,2], and lower than those in western 
countries (1.56%-3.30%) [3,4]. As in other 
studies [1,2,5], the consultation rates from 
medical and surgical departments were 
higher than others. Most common psychiat-
ric disorders in this study, including ad-
justment disorder, delirium, substance use 
disorders, depression and psychotic disor-
ders, are similar to previous studies [1,2,4].  
 
Patients with adjustment disorder associ-
ated with suicide attempts are prevalent in 
patients with drug overdose or corrosive 
ingestion, cancer, trauma, infection (espe-
cially, HIV infection), degenerative dis-
ease, stroke, burns and seizures. In another 
study
 
[6], these patients were referred 
significantly more often for the problems of 
anxiety, coping and depression. They had 
fewer psychiatric illnesses in the past and 
were rated as minimal functional impair-
ment- all consistent with the construct of 
adjustment disorder, a maladaptation to a 
psychosocial stressor. For this diagnosis, 
medical staff requesting for consultation 
psychiatry service usually describe only the 
psychiatric symptoms (i.e., referred for 
suicide attempts or depressed mood) with-
out the specification of the diagnosis. 
Although adjustment disorder was the most 
common final psychiatric diagnosis 
(35.0%) in this study, which is comparable 
to 24.1% to 29% in other studies [6,7]. The 
sensitivity rate for the diagnosis of this 
condition was very low (12.1%). 
 
In this study, we found that delirium was 
significantly more common in older than 
nonconsulted patients and commonly 
caused by trauma, cancer, infection, stroke, 
degenerative disease, burns and seizures. 
Co-morbidity with delirium was substance 
use disorders, especially alcohol depend-
ence, and most delirious patients had more 
than one medical problem. As in other 
studies, many nonpsychiatric specialists 
failed to recognize a majority of patients 
with delirium and referred for other per-
ceived reasons such as psychotic disorders. 
Therefore, it may of concern that symptoms 
of delirium may be overlooked or misinter-
preted [8]. The sensitivity rate for diagnosis 
of this condition was only 50.8%.  
 
In comparison to other psychiatric disor-
ders, the medical staff was relatively com-
petent in recognizing substance-related 
disorders in the studied population. The 
sensitivity and specificity rate of substance 
use disorders were higher than other psy-
chiatric illnesses (75% and 99.4%). The 
problems were more prevalent in male 
patients. Patients with substance-related 
disorders mainly had infection, trauma, 
seizures and stroke.  
 
The sensitivity rate of depressive disorder 
was only 43.4%. In the consultation request 
forms, medical staff described only the 
psychiatric symptoms without giving any 
specific diagnosis. The main reason for 
consultation was suicide attempts. Patients 
with depressive disorders mainly had drug 
overdose or corrosive ingestion, trauma, 
infection, cancer, seizures, stroke, degen-
erative disease and metabolic disturbance. 
Some patients had multiple medical ill-
nesses in which their physical symptoms 
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might mimic depression, e.g., fatigue, sleep 
difficulties and appetite disturbances.  
 
The sensitivity rate for making a diagnosis 
of psychotic disorders was 64.7%. These 
patients mainly came up with drug over-
dose, stroke, infection, trauma, seizures, 
degenerative disease, cancer and metabolic 
distance. Medical staff failed to differenti-
ate patients with psychotic disorder from 
delirium. 
 
Primary physicians may be more concern 
on patient safety, e.g., consulted for suici-
dal assessment or confusion, than making a 
proper psychiatric diagnosis. Previous 
research has demonstrated that referring 
services focus on behavior problems rather 
than identifying and treating underlying 
psychiatric disorders [9,10]. 
 
Medically ill patients with psychiatric 
complications pose a great challenge to 
clinicians. Their behavioral
 
disturbance and 
psychiatric symptoms can cause non-
compliance to treatment. The findings of 
this study suggest that a large proportion of 
patients seen by medical staff have psychi-
atric disorders but, without psychiatric 
consultation, mental problems are identi-
fied in only a small number of them. Physi-
cians should have knowledge of common 
psychiatric disorders such as adjustment 
disorder, depression, delirium, substance-
related disorders and psychotic disorders. 
Moreover, psychiatrists should advise 
primary physicians on the management of 
these problems, in particular, suicide at-
tempt, which can be associated with ad-
justment disorder, depression, substance-
related disorders, psychosis and delirium. 
From a study report [11], ascertaining 
which components of suicide prevention 
programs are effective in reducing rates of 
suicide and suicide attempt is essential in 
order to optimize use of limited resources. 
All of these strategies may help promote 
the psychiatric care for patients with com-
plex medical conditions, as well as foster 
further improvement in quality of training 
and research in this important area.  
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Abstract 
Background: The Medical Outcomes Study 36-item Short Form (SF-36)
 
is a widely used 
measure of health-related quality of life.
 
Normative data are the key to determine whether a 
group or
 
an individual score above or below the average for their country,
 
age or sex. Pub-
lished norms for the SF-36 exist for other countries
 
but have not been previously published for 
Thailand.
 
 Methods: The multi-site studies of Thai Quality of Health were the cross- sectional 
study involving 1,148 randomly selected Thai men and
 
women aged 15 years or more living 
in Bangkok metropolitan. The
 
information collected included the SF-36, a measure of health-
related
 
quality of life. These provided a unique opportunity to develop
 
age- and sex-adjusted 
normative data for the Thai population.
 
Results: Thai women scored substantially higher than 
men
 
on role physical, bodily pain, role emotional and physical component summary, whereas 
men scored higher than women on social functioning. Conclusion: The scores of Bangkok 
people are lower than their US counterparts on all SF-36
 
domains, although many of the
 
differences were not large. The differences in the SF-36 scores between
 
age groups, sexes and 
countries confirm that these Thai
 
norms are necessary for comparative purposes. The data will
 
be useful for assessing the health status of the general population
 
and patient populations, and 
the effect of interventions
 
on health-related quality of life. 
 
Key words: quality of life, SF-36, normative data, Bangkok, Thailand 
 
 
Introduction 
Over the past 20 years, there has been an 
increasing recognition
 
of the patient's point 
of view as an important component of the 
assessment of health care outcomes. This 
has resulted in
 
the development of several 
instruments to measure health-related
 
quality of life. One of the most widely used 
and psychometrically
 
sound instruments is 
the Medical Outcomes Study 36-item Short
 
Form (SF-36) [1,2]. This relatively brief 
and simple questionnaire
 
contains 36 items 
covering 8 health concepts chosen on the 
basis
 
of reliability, validity and frequency 
of measurement in health
 
surveys. Two 
summary scores for physical and mental 
health have also been developed for
 
the SF-
36 [3]. 
 
The reliability and validity of the SF-36 
have been well documented
 
by the devel-
opers of the instrument. [4-7]. A compari-
son of
 
a series of generic health status 
measures has indicated that the
 
SF-36 is not 
only psychometrically sound but is also 
more responsive
 
to clinical improvement 
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than the other instruments [8,9]. Moreover, 
health functioning changes in the hypothe-
sized direction
 
with increasing age, socio-
economic status and disease status
 
in a 
population-based longitudinal study of the 
SF-36, which
 
suggests that the instrument 
is sensitive to changes in assessing the
 
health of the general population [10]. 
 
A Thai version of the SF-36 has been 
successfully constructed with apparent 
equivalence to the original SF-36 and with 
an acceptable level of reliability [11]. 
Establishing norms is an important step in 
the translation and
 
cultural adaptation of a 
scale. Because the absolute number
 
of a 
scale score has little meaning by itself, 
norms provide
 
anchors to interpret an 
individual's or a group's score in relation
 
to 
those of others [12]. 
 
Furthermore, normative data are the key to 
determine whether a group or
 
an individual 
scores below or above the average for their 
country,
 
age or sex. Published norms now 
exist for the United States [13], the Queen-
sland region of Australia [14], the United 
Kingdom [15,16]. Comparable
 
norms do 
not yet exist in the Thai population. This 
forces researchers
 
and policy-makers to 
compare data from Thai studies to those
 
from other countries. This study aimed to 
present the normative data of Thai SF-36 
obtained from a randomly selected sample 
of women and men aged 15 years or more 
living in Bangkok Metropolitan. 
 
Methods 
The sample was pooled from the normal 
control subjects included in previous stud-
ies using SF-36 [17-20]. All of these stud-
ies were carried out in Bangkok Metropoli-
tan. Individuals aged 15 years or more were 
included. Sociodemographic characteristics 
of the sample were collected by means of 
an interviewer-administered questionnaire. 
Health status was measured by self-
administered Thai SF-36 at the end of the 
interview. 
 
The SF-36 contains 36
 
items that, when 
scored, yield eight domains. Physical 
functioning
 
(10 items) assesses limitations 
of physical activities such
 
as walking and 
climbing stairs. The role physical (4 items)
 
and role emotional (3 items) domains 
measure problems related to work
 
or other 
daily activities, which are the results of 
physical health and
 
emotional problems, 
respectively. Bodily pain (2 items) assesses 
limitations
 
due to pain, and vitality (4 
items) measures energy and tiredness.
 
The 
social functioning domain (2 items) exam-
ines the effect of physical and emotional 
health on normal social activities. Mental 
health (5 items) assesses happiness, nerv-
ousness
 
and depression. The general health 
perceptions domain (5 items)
 
evaluates 
personal health and the expectation of 
changes in
 
health. All domains are scored 
on a scale of 0 to 100, with
 
100 represent-
ing the best possible health state. One 
additional,
 
the unscored item compares the 
respondent's assessment of her or
 
his cur-
rent health with that of one year before. 
Summary scores
 
for a physical component 
(physical functioning, role physical,
 
bodily 
pain and general health perceptions) and a 
mental component
 
(vitality, social function-
ing, mental health and role emotional)
 
can 
also be derived.  
 
Table 1: Characteristics of the sample 
 
Sample characteristic N (1148) % 
Sex   
    Male 436 38.0 
   Female 712 62.0 
Age (15-77 years)  
Mean age 36.3 (SD12.5) 
  
   15-24 239 20.8 
   25-34 311 27.1 
   35-44 268 23.3 
   45-54 217 18.9 
   >=55 113 9.8 
Education   
   Primary school 39 3.6 
   Secondary school 401 37.1 
   High school 254 23.5 
   College 120 11.1 
   Undergraduate 214 19.8 
   Graduate 54 5.0 
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Sample characteristics are presented de-
scriptively (frequencies and percentages). 
In order to perform a gender comparison, 
independent t-tests were carried out. To 
determine the differences between age 
groups, one-way ANOVA was conducted. 
 
Results 
Characteristic of the sample (see Table 1) 
Data were collected between January 2001 
and June 2003. All of the 1,148 subjects 
were the control cases that had completed 
the Thai SF 36. Their mean age was 36.3 
(SD
 
12.5), range 15-77 years. Approxi-
mately, 38% of the samples were men with 
a mean age of
 
36.1 [SD 12.8] years, range 
15-77 years, and 62% were women
 
with a 
mean age of 36.4 [SD 12.4] years, range 
15-73 years.  
 
The standardized scores for the eight do-
mains and the
 
two summary scales (physi-
cal component and mental component) of
 
the SF-36 varied with age (see Table 2). 
The group of 55-77 years had lower scores 
than other age groups in four domains 
 
 
Table 2: Mean + SD, (95% CI) scores of the 8 domains of SF-36 of Bangkok people 
 
Age group 
15-24 25-34 35-44 45-54 > 55 
p-value 
SF 36 
n=239 n=311 n=268 n=217 n=113  
Physical  
Functioning 
73.5+20.8 
(70.9-76.2) 
76.8+18.9 
(74.7-78.9) 
72.1+20 
(69.7-74.5) 
72.5+20.8 
(69.7-75.3) 
59.7+25.4 
(55.0-64.5) 
.000 
Role  
physical 
81.8+25.8 
(78.5-85.1) 
88.1+21.0 
(85.8-90.4) 
83.0+25.4 
(80.0-86.1) 
81.4+27.6 
(77.8-85.1) 
65.9+38.5 
(58.7-73.1) 
.000 
Bodily pain 71.1+15.5 
(69.1-73.0) 
73.3+16.6 
(71.5-75.2) 
71.7+16.6 
(69.7-73.7) 
71.6+20.7 
(68.8-74.4) 
60.0+26.6 
(55.0-65.0) 
.000 
General health  
perceptions 
63.3+16.2 
(61.3-65.4) 
65.5+16.7 
(63.7-67.4) 
62.7+16.5 
(60.7-64.7) 
63.2+17.7 
(60.9-65.6) 
60.4+17.1 
(57.2-63.6) 
.716 
Vitality 62.9+13.6 
(61.2-64.6) 
65.2+13.3 
(63.7-66.7) 
62.2+13.4 
(60.6-63.9) 
64.4+15.2 
(62.4-66.4) 
61.3+14.0 
(58.7-63.9) 
.130 
Social  
functioning 
67.3+17.3 
(65.0-69.5) 
68.3+18.0 
(66.3-70.3) 
69.1+18.8 
(66.8-71.3) 
64.3+22.6 
(61.3-67.4) 
68.4+25.5 
(63.6-73.1) 
.355 
Role emotional 73.4+32.1 
(69.3-77.4) 
79.2+30.8 
(75.8-82.6) 
76.0+34.0 
(71.9-80.1) 
81.7+28.5 
(77.9-85.5) 
66.7+40.3 
(59.1-74.2) 
.001 
Mental  
health 
70.4+13.7 
(68.6-72.1) 
73.0+13.4 
(71.5-74.5) 
69.7+14.2 
(68.0-71.4) 
70.6+16.4 
(68.5-72.8) 
69.0+15.3 
(66.1-71.8) 
.442 
 
 
Table 3: Mean + SD scores of the Thailand normative data for the 8 domains of SF-36 
 
Male Female p-value 
SF 36 
n=436 n=712  
Physical functioning 72.98 (20.84) 72.25 (21.25) .56 
Role physical 79.59 (28.40) 83.74 (26.11) .013 
Bodily pain 68.29 (18.84) 72.42 (18.59) .001 
General health perceptions 63.11 (16.12) 63.72 (17.30) .54 
Vitality 64.06 (13.94) 63.17 (13.83) .29 
Social functioning 70.53 (19.61) 65.68 (19.76) .001 
Role emotional 73.47 (33.63) 78.32 (32.02) .015 
Mental health 70.47 (14.72) 71.06 (14.35) .5 
134   Kongsakon, et al. 
 
Table 4: Mean + SD (95% CI) scores of the Thailand normative men data for the 8 domains 
of SF-36 health survey: Bangkok metropolitan 
 
Age group 
15-24 25-34 35-44 45-54 55-64 
p-value 
SF 36 
n=101 n=107 n=99 n=83 n=46  
Physical  
functioning 
71.5+21.4 
(67.3-75.8) 
76.9+18.8 
(73.3-80.5) 
73.3+20.1 
(69.3-77.3) 
75.1+20.0 
(70.7-79.4) 
62.7+24.2 
(55.5-69.9) .003 
Role physical 
77.5+28.4 
(71.9-83.1) 
87.4+20.1 
(83.5-91.2) 
81.3+26.6 
(76-86.6) 
77.4+30.9 
(70.7-84.2) 
66.3+37.7 
(55.1-77.5) .001 
Bodily pain 
70.4+14.9 
(67.4-73.3) 
70.5+16.2 
(67.4-73.6) 
71.1+14.5 
(68.2-74.0) 
66.9+21.6 
(62.2-71.6) 
54.9+28.1 
(46.5-63.2) .000 
General health  
perceptions 
65.0+15.8 
(61.9-68.2) 
64.7+14.4 
(61.9-67.4) 
63.4+17.2 
(59.9-66.8) 
59.9+17.0 
(56.2-63.6) 
60.4+15.8 
(55.7-65.1) .130 
Vitality 
64.8+13.8 
(62.1-67.5) 
65.1+13.2 
(62.6-67.7) 
63.6+14.7 
(60.6-66.5) 
64.1+14.6 
(60.9-67.3) 
60.9+13.2 
(57-64.8) .487 
Social functioning 
67.9+16.7 
(64.6-71.2) 
74.1+18.3 
(70.6-77.6) 
73.6+17.2 
(70.2-77.0) 
68.4+22.4 
(63.5-73.3) 
65.2+25.4 
(57.7-72.8) .016 
Role emotional 
70.3+33.0 
(63.8-76.8) 
78.2+29.7 
(72.5-83.9) 
72.7+35.4 
(65.7-79.8) 
77.5+30.8 
(70.8-84.2) 
63.8+42.1 
(51.3-76.3) .088 
Mental health 
70.1+14.4 
(67.3-72.9) 
72.4+14.3 
(69.6-75.1) 
70.1+14.9 
(67.1-73.0) 
69.1+16.4 
(65.5-72.7) 
70.2+12.8 
(66.4-74.0) .618 
 
 
Table 5: Mean + SD (95% CI) scores of the Thailand normative women data for the 8 do-
mains of SF-36 health survey: Bangkok metropolitan 
 
Age group 
15-24 25-34 35-44 45-54 55-64 
p-value 
SF 36 
n=138 n=204 n=169 n=134 n=67  
Physical  
Functioning 
75.0+20.2 
(71.6-78.4) 
76.7+19.0 
(74.1-79.4) 
71.4+20.0 
(68.4-74.4) 
71.0+21.3 
(67.3-74.6) 
57.7+26.1 
(51.3-64.1) .000 
Role physical 
85.0+23.3 
(81-88.9) 
88.5+21.5 
(85.5-91.5) 
84.0+24.8 
(80.3-87.8) 
84.0+25.2 
(79.7-88.3) 
65.7+39.4 
(56.1-75.3) .000 
Bodily pain 
71.6+15.9 
(68.9-74.3) 
74.8+16.7 
(72.5-77.1) 
72.1+17.8 
(69.4-74.8) 
74.5+19.7 
(71.1-77.9) 
63.5+25.2 
(57.4-69.7) .000 
General health  
Perceptions 
62.1+16.5 
(59.3-64.9) 
66.0+17.9 
(63.5-68.5) 
62.3+16.1 
(59.9-64.8) 
65.3+17.9 
(62.3-68.4) 
60.4+18.1 
(56-64.8) .049 
Vitality 
61.5+13.4 
(59.3-63.8) 
65.2+13.4 
(63.4-67.1) 
61.5+12.5 
(59.6-63.4) 
64.6+15.6 
(62-67.3) 
61.6+14.5 
(58.1-65.2) .022 
Social functioning 
66.8+17.7 
(63.8-69.7) 
65.3+17.1 
(62.9-67.6) 
66.4+19.2 
(63.5-69.3) 
61.8+22.4 
(58-65.7) 
70.5+25.5 
(64.3-76.8) .043 
Role emotional 
75.6+31.3 
(70.3-80.9) 
79.7+31.4 
(75.4-84.1) 
77.9+33.1 
(72.9-82.9) 
84.3+26.7 
(79.8-88.9) 
68.7+39.3 
(59.1-78.2) .015 
Mental health 
70.6+13.3 
(68.3-72.8) 
73.3+12.9 
(71.5-75.1) 
69.4+13.9 
(67.3-71.5) 
71.6+16.3 
(68.8-74.4) 
68.1+16.9 
(64-72.2) .035 
 
 
including physical functioning, role physi-
cal, bodily pain and role mental. Women 
had higher scores than men in role physi-
cal, bodily pain, social function and role 
emotional. (Table 3). When men and 
women data were separately analyzed we 
found that the influence of age on each 
domain score was different between gen-
ders. There were significant differences 
among age grounds on the scores of all  
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Figure 1: Mean scores for the Thai versus US normative data for the
 
8 domains 
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Figure 2: Mean age- and sex-standardized SF-36 and summary scale scores for Thai men 
(dark grey bars) and women (light grey bars). * is a statistically significant difference between 
men and women (p<.05) 
 
 
136   Kongsakon, et al. 
 
domains in women (Table 4), but only four 
domains in men showed the significant 
differences of scores among age groups. 
(Table 5). 
 
Figure 1 shows the comparison of the SF-
36 normative data of Thai population living 
in Bangkok Metropolitan and the normative 
data of United State. The
 
Thai norms were 
lower than the US norms in all eight do-
mains, although many of the
 
differences 
were not large. 
 
The age- and sex-standardized scores for 
Thai men and women
 
varied with age and 
sex (Tables 3 and 4). As in the entire
 
sam-
ple, several domains exhibited a ceiling 
effect (87.4% for
 
men and 88.5% for 
women in the role physical domain), but a 
strong floor effect did not clearly shown 
(51.3 % for women
 
in physical functioning 
and 51.3 for men in the role emotional 
domain). 
 
The mean scores of Thai men and women 
are shown in Figure 2.
 
Men scored nonsig-
nificantly higher than women on physical 
functioning and social functioning of the 
SF-36. Thai women scored substantially 
and statistically significantly higher than 
men
 
on role physical, bodily pain, role 
emotional and social functioning (p <.05).  
 
Discussion 
Normative data for the SF-36 have been 
obtained from the normal control subjects 
included in previous studies. All of these 
studies were carried out in Bangkok Met-
ropolitan and could be used as an important 
basis in comparison to future studies. 
 
By the use of SF-36, Thais have relatively 
lower scores than the US counterpart on all 
eight domains and two summary scales. 
The differences between these two groups 
may be due to the methodological
 
differ-
ences rather than representing the true 
differences. For example,
 
the US normative 
data are based not on a random sample but,
 
rather, on the responses of 2,474 partici-
pants in the National
 
Survey of Functional 
Status, who were selected to receive a
 
mailed version on the basis of previous 
participation in a General
 
Social Survey. 
These differences in methodology will 
introduce variation in
 
the normative data 
for international comparisons. Thus, a clear
 
description of methods is a vital part of the 
interpretation
 
of normative data.
 
 
 
The
 
variability of the scores by age under-
scores the need of appropriate age-specific 
normative data.  
 
There are differences between men and 
women in the Thai sample. Women scored 
substantially and significantly higher than 
men
 
on role physical, bodily pain, role 
emotional and social functioning. This 
differs from those found in Norway [21], 
Turkey [22] and Canada [23], in which 
men had nonsignificantly higher scores 
than women on all domains. 
 
This study is the first normative data of SF-
36 in Thailand. However, our results could 
not be generalisable to the whole Thai 
population because our study sample was a 
pooled sample from previous SF-36 studies 
in Bangkok.  
 
In conclusions, the differences of the SF-36 
scores between
 
age groups, sexes and 
countries confirm that these Thai
 
norms are 
necessary for comparative purposes. These 
data are useful on the assessment of health 
status of the general population
 
and of the 
patient populations, as well as the effect of 
interventions
 
on the health-related quality 
of life. 
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